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Thesis Abstract 
Cell line engineering strategies for improved biopharmaceutical production in 
mammalian cells often involve the expression of one/multiple genes to try and 
improve the cellular processes involved in recombinant protein production.  Most 
strategies are relatively simple, involving the use of a strong constitutive promoter for 
expression of one or more proteins to help increase production.  Results often vary 
and can be cell line and product specific and mean a generic strategy is unlikely to be 
found.  There is a need for more sophisticated expression systems which can express 
multiple genes but in a controlled fashion and tuned to meet the needs of a specific 
product.  This thesis can be split into two distinct parts but both concern the 
expression of multiple genes in mammalian cells and recombinant protein production. 
A tunable mammalian expression system for multi-gene engineering composed of 
elements of the mammalian unfolded protein response has been developed.  ATF6 
(activating transcription factor 6) and its binding element (ERSE – ER stress response 
element) were used to control the expression of the reporter proteins SEAP (secreted 
alkaline phosphatase) and GFP (green fluorescent protein).  By expressing different 
amounts of ATF6 and by inserting different numbers of ERSEs upstream of a SV40 
(Simian virus 40) promoter, driving SEAP/GFP gene transcription, the level of reporter 
protein expression could be manipulated in a controlled fashion.  The system was 
capable of controlled/tunable expression of both reporter proteins when expressed 
alone and when they were co-expressed.  This a novel use for ATF6 and ERSE and the 
first step towards the development of a tunable mammalian expression system for 
multi-gene engineering.  This system could also be easily modified to include or use 
different transcription factors and binding sites as well as having the potential to use 
completely synthetic components.  This work also showed that the presence of 
‘promoter interference’ (the negative influence of one promoter on another) could be 
used to our advantage to increase the range of expression. 
The SV40 early, human CMV (cytomegalovirus) major immediate-early and human 
EF1α (elongation factor 1 alpha) are constitutive promoters frequently used in 
recombinant protein production.  The former being used mainly for expression of 
selection genes and the latter two for strong expression of recombinant proteins.  The 
differences in the strengths of the promoters was demonstrated in CHO (Chinese 
hamster ovary) cells (CMV > EF1α > SV40) and also their abilities to negatively affect 
the expression from a co-expressed promoter.  The negative influence of one 
promoter on another is termed ‘promoter interference’.  The CMV promoter was 
shown to have the greatest negative effect on expression from another promoter, 
decreasing both SEAP mRNA and protein expression, while the SV40 had the least.  
SEAP expression from the SV40 was reduced the most by the presence of a competing 
promoter.  The level of interference inflicted by a competing promoter (CMV > EF1α > 
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SV40) seemed to be relative to its strength.  This is the first time these three important 
promoters have been compared in a way which not only demonstrates their relative 
strengths but also their ability to interfere with another promoter when present in the 
same transient expression system.  This also has implications for their use in multi-
gene engineering strategies if there is a need for controlled/tunable expression of 
multiple genes.  The work with ATF6 and ERSE showed how ‘promoter interference’ 
could be used to our advantage and not necessarily be just a negative occurrence. 
One hypothesis for why promoter interference occurs is there is competition between 
promoters for shared transcription factors (TFs).  The promoters were analysed for 
potential transcription factor binding sites (TFBSs) using the programs MatInspector 
and ModelInspector.  The analysis showed that the SV40 promoter had the least 
number and variety of potential TFBSs.  Both the CMV and EF1α had greater numbers 
and variety of potential TFBSs.  All three promoters had common potential TFBSs but 
the SV40 promoter shared a greater proportion of its sites with the other two 
promoters.  The number of potential TFBSs and the proportion which were shared 
reflected both the strength and the ability of a promoter to interfere with another.  All 
three contained TFBSs for the SP1 (specificity protein 1) family of TFs and over-
expression of SP1 counter-acted the effects of promoter interference showing that it 
can affect the expression of all three promoters.  However, promoter interference will 
involve more than just a single TF and also more than just competition for 
transcriptional activators.  This is the first time these three promoters have been 
compared in terms of the potential TFBSs they contain.  The TFBS analysis highlighted 
the complexity in the control of these promoters and with the effects of promoter 
interference means that they will be ill suited for the controlled expression of multiple 
genes without modification.   
The work in this thesis was directed towards the controlled expression of multiple 
genes in mammalian cells for recombinant protein production.  We have presented 
one novel way of controlling the expression of one/two genes with the rest of the 
thesis looking at the phenomenon of ‘promoter interference’ between three 
commonly used promoters.  This thesis tries to highlight the importance of multi-gene 
expression systems as well showing that these three promoters may not be suitable 
without further modification and also the importance of considering promoter 
interactions when more than one is present in the same system.  The switch to 
completely synthetic multi-gene control systems is something we envisage happening 
in the future as the complexities and capabilities of these systems grow. 
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Chapter 1 – Introduction and Research 
Aims/Objectives 
1.1 – Introduction 
Global sales of biopharmaceuticals were a reported $99 billion in 2009 and is an  
industry which continues to grow (Walsh, 2010).  It has come a long way since the 
production of the first therapeutic protein produced in Chinese hamster ovary (CHO) 
cells in the mid 1980s (Kaufman et al., 1985).  The production yields of recombinant 
proteins have increased >20 fold over the last ~30 years (De Jesus & Wurm, 2011).  
CHO cells are the main cell line used for the production of recombinant therapeutic 
proteins and especially monoclonal antibody (MAb) products (O'Callaghan & James, 
2008).  It has now become routine to be able to produce therapeutic recombinant 
proteins in g L-1 amounts in large scale bioprocesses (De Jesus & Wurm, 2011).  This is 
thanks to improvements in all the major processes which are involved in recombinant 
protein production including improved stable cell line creation/selection (Fan et al., 
2013; Lai et al., 2013; Fan et al., 2012), improved bioprocesses (like optimized media 
and feeding strategies) (Wurm, 2004), to genetic manipulation of cell lines for 
improved growth, survival and recombinant protein production (Li et al., 2010). 
With the recent publication of the CHO genome we have entered a new era for the 
production of biopharmaceuticals (Brinkrolf et al., 2013; Lewis et al., 2013; Li et al., 
2010).  The publication of the CHO genome has lead to the development and use of 
omics technologies for the analysis of CHO cell lines producing recombinant proteins 
which were much tougher to carry out without it.  There is also an increasing number 
of novel therapeutics which are being developed.  However, some of these products 
and more conventional MAb products suffer from unexpectedly low titres which 
hinder their prospects of becoming a clinically important biopharmaceutical.  In the 
future there is going to be a need for sophisticated rational multi-gene engineering 
strategies which are optimized and based on the requirements of a specific product 
rather than a generic approach.  For this to occur, new multi-gene expression systems 
are needed which can not only express multiple genes simultaneously (Kriz et al., 
20 
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2010) but which can also discretely control (tune) the expression levels of multiple 
genes in CHO cells. 
Although details of some systems for mammalian cells have been published (Endo et 
al., 2013; Stapleton et al., 2012) there are currently no published papers describing a 
system which can be used for the controlled/tunable expression of multiple genes in 
CHO cells.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
Nathan West The University of Sheffield 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
Nathan West The University of Sheffield 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
Nathan West The University of Sheffield 
1.2 – Research Aims and Objectives 
1.2.1 – Aims 
To develop a mammalian tunable protein expression system were the expression of 
one or multiple genes can be controlled and expressed at a desired level. 
To investigate the effects of ‘promoter interference’ between three promoters, the 
SV40 (Simian virus 40) early promoter, the human CMV (cytomegalovirus) major 
immediate-early promoter and the human EF1α (elongation factor 1 alpha) promoter, 
all commonly utilized in biopharmaceutical production with a view to assessing their 
suitability in multi-gene engineering strategies. 
 
1.2.2 – Objectives 
1. Construct a system for the controlled/tunable expression of one/two proteins 
2. Compare the strengths and promoter interference effects of three promoters 
(SV40, CMV and EF1α) 
3. Analyse the SV40, CMV and EF1α promoters for their potential transcription 
factor binding sites.  For differences and similarities between the promoters 
which could potentially impact both their expression and their ability to 
interfere with another promoter 
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Chapter 2 – Literature Review 
2.1 – The Development of Biopharmaceutical Production 
in Mammalian Cells 
2.1.1 – Introduction 
CHO cells have been the predominant mammalian cell line used for the research and 
production of biopharmaceuticals over the last 25-30 years (O'Callaghan & James, 
2008; Birch & Racher, 2006; Walsh, 2006).  They are used due to their ability to 
produce fully glycosylated recombinant proteins as well as having a long and 
favourable track record with drug regulators (O'Callaghan & James, 2008; Dinnis & 
James, 2005).  Other mammalian cell lines such as murine lymphoid (NS0 and SP2/0), 
human embryonic kidney (HEK)-293 and BHK21 (baby hamster kidney) cells have also 
been used (O'Callaghan & James, 2008; Birch & Racher, 2006).  CHO cells have been 
used to produce a variety of recombinant therapeutic proteins including blood factors 
(e.g. – coagulation factor VIII), thrombolytics (e.g. – tissue plasminogen activator 
(tPA)), growth factors (erythropoietin (EPO)) and hormones (e.g. – thyrotrophin-α) 
(Walsh, 2010).  However, recombinant monoclonal antibodies (MAb) are probably the 
biggest and most important class of therapeutic proteins and their sales in 2009 
accounted for over a third ($38 billion) of the $99 billion global biopharmaceutical 
market (Walsh, 2010). 
CHO cells originated from an immortalised cell taken from a primary culture of ovarian 
cells from a Chinese hamster (Cricetulus griseus) in 1957 (Hacker et al., 2009).  
Although not initially used for the production of biopharmaceuticals, it was in the 
1980s when they were first used in the production of recombinant therapeutic 
proteins.  The first recombinant protein to be FDA-approved was tPA in 1986/7 (Kim et 
al., 2012; De Jesus & Wurm, 2011; Kaufman et al., 1985).  A typical production run for 
a batch culture lasted around a week in the 1980s with low maximum cell densities (1-
2 x 106 cells mL-1) and low specific (10-20 pg cell-1 day-1) and volumetric (50-100 mg L-1) 
productivities (Wurm, 2004).  In the last 25 years through improvements in the 
bioprocessing of recombinant proteins we now have fed-batch cultures whose 
production runs can last three weeks, achieve maximum cell densities of 15 x 106 cells 
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mL-1 and titres of 5 g L-1 (De Jesus & Wurm, 2011).  Some biopharmaceutical 
companies have claimed, mainly through conference presentations, to have 
bioprocesses which have achieved over 10 g L-1 for the production of MAb’s, but high 
titres such as these are still limited by downstream purification processes (Kelley, 
2009).  These increases have been made through a combination of different methods 
but have mainly been through optimization of cell media and improvements in the 
bioprocesses of large scale production so that cells remain healthier at higher cell 
densities for longer in culture and thus produce more recombinant protein. 
 
2.1.2 – Media optimization and the development of large scale 
bioprocesses 
Commercial chemically defined (CD) media, which is usually of excellent consistent 
quality, is readily available for academic research and is suitable for some production 
processes.  However, many biopharmaceutical companies use custom made media 
which are usually optimised for the production of a specific product (Wurm, 2004).  
Often different media formulations will be used for different stages of a production 
process (Wurm, 2004).  The exact composition of such media and even the commercial 
media remains undisclosed by the companies producing it and the biopharmaceutical 
companies using it to protect their intellectual property.  One known change which has 
occurred as the biopharmaceutical industry grew is the removal of serum and other 
animal derived components and the switch to CD media.  Serum was used to provide 
the factors which were important for growth such as carbohydrates, lipids, growth 
factors and other peptides but was removed due its heterogeneous character, its high 
cost and the risk of virus transmission (Grillberger et al., 2009; Wurm, 2004).  In fact 
serum and other animal derived products are avoided in commercial production 
processes with pressure from drug regulators being another major reason for their 
removal. 
Additives which improve media performance in the absence of serum and have been 
reported in the literature include insulin and insulin-like growth factors (IGFs) which 
have been shown to have anti-apoptotic effects and help maintain high viable cell 
densities (Morris & Schmid, 2000; Sunstrom et al., 2000; Baserga et al., 1997).  The use 
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of non-animal derived hydrolysates which contain mixtures of lipids, oligopeptides, 
amino acids, iron salts, vitamins and other small molecules in trace amounts have also 
been shown to increase both cell specific growth rate and cell specific productivity but 
not necessarily both at the same time (Kim & Lee, 2009; Sung et al., 2004).  However, 
the complex composition of hydrolysates means there is lot-to-lot variation and there 
can be significant variability in different batches of media if they are used.  CD media 
containing specific amounts of vitamins, inorganic salts, trace elements, lipids, amino 
acids, insulin or IGFs and proprietary components have been developed over many 
years through methods for optimizing media composition including medium blending, 
single component titration, spent medium analysis and metabolite profiling (Li et al., 
2010).  As mentioned earlier media may be customised for a specific product but this 
can be an extremely time-consuming task but this can be shortened through the use of 
a design of experiment (DOE) approach (Castro et al., 1992). 
The actual culture process itself has not changed too dramatically.  The production of 
recombinant therapeutic proteins from mammalian cells is still carried out mainly in 
large-scale stirred-tank bioreactors and the culture can still be split into three phases – 
seeding, inoculation and production.  However, the technology for monitoring, analysis 
and control of culture parameters and the feeding strategies for large scale cultures 
have been improved dramatically.  An optimized feed medium and feeding strategy 
will likely be developed while developing the media for a process.  This is due to the 
feed composition sometimes being similar to the bulk media but also because similar 
considerations are taken in to account.  These include its effects on cell growth and 
productivity, lactate and ammonia accumulation as well as nutrient consumption 
including levels of glucose, glutamine and other amino acids in the media which are all 
inherently linked (Khattak et al., 2010; Li et al., 2010; Zhou et al., 1997; Zhou et al., 
1995).  Limiting lactate and ammonia accumulation is essential due to their known 
deleterious effects on cell growth, productivity and product quality (Khattak et al., 
2010; Altamirano et al., 2006; Chee Furng Wong et al., 2005; Altamirano et al., 2001). 
The monitoring, analysis and control of physical (agitation speed, gas flow rates, 
temperature etc), chemical (dissolved oxygen and CO2, pH, osmolality etc) and 
biological (viable cell concentration, viability, NADH and LDH levels etc) parameters 
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have also improved bioprocess performance and all can affect the quality of the 
product produced including important post-translational modifications such as 
glycosylation (Grainger & James, 2013; Gawlitzek et al., 2009; Walsh & Jefferis, 2006).  
Monitoring and analysis of process parameters can occur both online and offline, with 
online analysis allowing continuous monitoring and the ability to adjust parameters 
quickly and efficiently, while offline analysis is used to measure parameters which are 
difficult or too costly to measure online as well validating online measurements.  The 
growth in our capabilities for monitoring bioprocess parameters has allowed us to gain 
a greater understanding of the parameters which most affect culture performance, 
such as pH (Wayte et al., 1997) and lactate accumulation (Altamirano et al., 2006; 
Chee Furng Wong et al., 2005; Altamirano et al., 2001), and allow us to make 
adjustments accordingly.   We can already monitor numerous parameters producing 
huge amounts of data even for a single production run.  The challenge in the future is 
to be able to analyse such large data sets and to extract meaningful results and this 
will involve developments in data mining techniques and multivariate analysis (Le et 
al., 2012). 
 
2.2.3 – Creation and selection of high producing stable cell clones 
Although the increases in production of recombinant therapeutic proteins has mainly 
been through improvements in the large scale culture of mammalian cells, processes 
upstream of this are also vitally important and development of these processes has led 
to some good increases in productivity but have mainly seen dramatic decreases in the 
time and labour required and have lowered the cost of manufacturing.  The major 
upstream process is that of creating a stable cell line which expresses the desired 
therapeutic protein at a sufficiently high enough expression level to make it viable for 
use in the large scale production of the product.  Like many of the processes involved 
in recombinant protein production the creation of stable cell lines is time and labour 
intensive.  Therefore methods which help create and select high expressing cell clones 
in a more efficient and time effective way have been developed to help reduce the 
time and labour required.  This has been achieved through our greater understanding 
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of molecular biology and both improvements in expression systems and clone 
selection technology. 
The first part of creating a high expressing stable cell line is the transfection and then 
incorporation of an expression vector, containing the genes for both the recombinant 
protein and a selection marker, into one of the cells chromosomes.  This usually occurs 
through homologous recombination but the expression of both the selection gene and 
recombinant protein can be negatively affected by its random integration site within a 
chromosome (Kim et al., 2004; Zahn-Zabal et al., 2001).  Different DNA elements can 
be inserted into expression vectors to negate the positional effects of the site of 
chromosomal integration.  Scaffold and matrix attachment regions (S/MAR) can be 
inserted into expression vectors and act to insulate the recombinant genes after 
integration from negative positional effects by maintaining a transcriptionally active 
chromatin structure (Girod et al., 2007; Mirkovitch et al., 1984).  The β-globin MAR, 
chicken lysozyme 5’ MAR and the β-interferon SAR have all been successfully used to 
increase the numbers of high producing cell clones (Girod et al., 2005; Kim et al., 2005; 
Kim et al., 2004).  Another element that insulates recombinant genes from negative 
positional effects is the ubiquitous chromatin opening element (UCOE) which has been 
shown to maintain chromatin in an open transcriptionally active state and increase 
both the numbers of high producing clones and recombinant protein production (Ye et 
al., 2010; de Poorter et al., 2007; Benton et al., 2002). 
Insertion of recombinant genes through homologous recombination results in their 
random integration into chromosomes but through site-specific recombination they 
can be incorporated more selectively into highly transcriptionally active areas of 
chromosomes (Huang et al., 2007).  This has been accomplished using a number of 
differing strategies.  The Flp/FRT system, from Saccharomyces cerevisiae and marketed 
as Flp-In™ by Life Technologies (Paisley, UK), and the Cre/LoxP system, from 
bacteriophage P1, have both been used to create stable cell lines expressing 
recombinant proteins in mammalian cells (Kameyama et al., 2010; Huang et al., 2007; 
Wiberg et al., 2006; Kito et al., 2002).  Other systems, which use the λ and ΦC31 
integrases, which target attP and attB sites respectively, have also been used for site-
specific recombination of recombinant proteins (Campbell et al., 2010; Russell et al., 
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2006; Smith & Thorpe, 2002).  These integrase systems have the advantage of 
irreversible integration of your recombinant protein when compared to the Flp/FRT 
and Cre/LoxP systems. 
The main expression systems used in CHO cells are Lonza’s GS (glutamate synthetase) 
expression system™ (Bebbington et al., 1992) (Lonza Biologics, Slough, UK) and the 
DHFR (dihydrofolate reductase) expression system (Kaufman & Sharp, 1982).  Both 
require cell lines were there is deficient or the absence of expression of a particular 
selection gene, GS for the Lonza system and DHFR- cells (Urlaub & Chasin, 1980) for the 
corresponding system, and also the use of a selection drug, MSX (methionine 
sulphoximine) which inhibits GS and MTX (methotrexate) which inhibits DHFR.  The 
DNA expression vector containing the gene for the recombinant protein will also 
contain the gene for either GS or DHFR and allow cells which incorporate the vector to 
survive in the presence of the appropriate selection drug.  Through multiple rounds of 
cell selection using increasing concentrations of a selection drug, gene amplification 
can occur (Schimke, 1984) making some cells even more resistant to the drug while 
also increasing the expression of the therapeutic protein in some of these cells.  
Recently researchers at Eli Lily (Indianapolis, US) improved the GS system by both 
creating full GS knockouts of the Lonza CHOK1SV cell line and weakening the promoter 
(SV40) used to express the GS gene thus increasing the selection stringency for high 
producers when used to make stable cell lines (Fan et al., 2013; Fan et al., 2012).  A 
new version of the GS system, called GS Xceed™ (http://www.lonza.com/custom-
manufacturing/development-technologies/gs-xceed-gene-expression-system.aspx) 
was released in 2012 by Lonza which uses the GS knockout version of the CHOK1SV cell 
line.  Improvements for the DFHR system have included both codon de-optimization of 
the selection gene and insertion of protein destabilizing elements to weaken the 
selection protein (Westwood et al., 2010; Ng et al., 2007).  Another method for 
improving a neomycin expression system included mutating the selection protein to 
have less affinity for binding the selection drug (Sautter & Enenkel, 2005).  All these 
methods lead to increasing stringency in selection of cells producing high levels of 
recombinant proteins. 
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Even though improvements in the insertion of expression vectors and expression 
systems have improved the proportion of high producing cells in a pool stably 
expressing a recombinant protein, they are still relatively rare.  Isolation of high 
producing clones was traditionally done by limited dilution cloning and, although 
simple, this is a long and time consuming process with many limitations.  More 
advanced high-throughput methods can be used to find higher numbers of high 
producing clones and include the use of FACS (fluorescent-activated cell sorting) and 
automated methods such as the ClonePix system (Genetix, Sunnyvale, US) and 
CellExpress™ + LEAP™ (laser-enabled analysis and processing) (Richardson et al., 2010). 
FACS is a high-throughput technology that is capable of sorting thousands of cells in a 
short period of time analysing multiple fluorescent wavelengths.  It sorts cells by 
measuring the fluorescence signal associated with individual cells and since most 
recombinant proteins are secreted the major challenge for this technique is to create a 
fluorescent signal that remains associated with the cell.  Several techniques have been 
developed for the use of FACS to select cell clones producing high levels of secreted 
recombinant protein.  Some involve the immobilization of the secreted recombinant 
protein so that it is still associated with the cell and then the addition of fluorescent 
antibodies which has been shown to improve clone selection, but preparation of cell 
samples in this fashion can be time consuming and technically very challenging 
(Atochina et al., 2004; Manz et al., 1995).  Another method used the hypothesis that 
the amount of secreted recombinant protein associated with the cell surface 
correlated with the production capacity of the cell and this was tested by cooling cells 
to between 0-4 °C and applying fluorescent antibodies and then sorting by FACS 
(Brezinsky et al., 2003).  Other methods involve fluorescently tagging cells 
intracellularly.  This has been done through the co-expression of a fluorescent protein 
as a separate secondary selection protein and fluorescently tagging the selection 
protein metallotheonine (Bailey et al., 2002; Meng et al., 2000).  Fluorescent labelling 
of MTX has also been used to tag cells using the DFHR expression system and have an 
advantage in that it did not require the expression of a secondary selection protein 
(Yoshikawa et al., 2001). 
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The ClonePix FL system uses semi-solid media containing fluorescein isothiocyanante 
(FITC) conjugated antibodies, which can isolate single colonies of cells, capture their 
secreted recombinant protein, produce a halo of fluorescence surrounding the colony 
which can then analysed and high producing colonies selected and removed for further 
characterization (Dharshanan et al., 2011).  The process is automated and is an 
extremely efficient system capable of screening 10,000 cells an hour while being 
sensitive enough to isolate high producing clones who make up only 0.003% of an 
entire population and has already been successfully used in the isolation of high 
producing clones for a variety of recombinant proteins (Lai et al., 2013; Dharshanan et 
al., 2011; Serpieri et al., 2010). 
The Cell Xpress + LEAP platform is a fully automated self contained system which uses 
microplates which can capture secreted recombinant proteins (Richardson et al., 2010; 
Browne & Al-Rubeai, 2007; Hanania et al., 2005).  It detects fluorescence associated 
with either cells or their secreted recombinant protein to detect the highest producing 
clones within a well.  Other cells are then destroyed using a laser to leave only high 
producing clones within a well which can then be allowed to grow further before 
removal and expansion in larger wells (Browne & Al-Rubeai, 2007; Koller et al., 2004).  
This system has been shown to be capable of routinely selecting clones with specific 
productivities of > 50 pg cell-1 day-1 (Hanania et al., 2005).  One drawback of the system 
is the laser may also damage high producing clones (Browne & Al-Rubeai, 2007). 
 
2.2.4 – Genetic engineering of mammalian cell lines 
Various genetic engineering strategies have also been used in attempts to improve 
recombinant protein production in mammalian cells.  These have included the 
expression of recombinant genes and the suppression of endogenous genes for the 
extension of culture duration, maximising viable cell density, increasing growth rates 
and the expression of genes to increase the protein folding and vesicle 
trafficking/secretion capacities of mammalian cells.   
Through the expression/suppression of genes involved in apoptosis (type I 
programmed cell death) mammalian cells producing recombinant proteins have been 
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engineered to survive longer in culture and in some studies produce increased 
amounts of recombinant protein.  The process of apoptosis is controlled by positive 
and negative regulators and both have been targeted for cell line engineering.  The 
anti-apoptotic protein Bcl-2 (B-cell lymphoma 2) has been over-expressed and shown 
to promote the survival and increase protein production in recombinant protein 
producing cells both in the presence and absence of the apoptosis inducing agents 
such as sodium butyrate (NaBu) (Lee & Lee, 2003; Kim & Lee, 2001; Fussenegger et al., 
2000; Tey et al., 2000).  More recently a CHO cell line expressing both Bcl-2 and the 
pro-autophagy protein Beclin-1 has been developed which extended both culture 
duration and maintained a higher viability then a cell line only expressing Bcl-2 (Lee et 
al., 2013).  Bcl-xL (B-cell lymphoma-extra large) and Mlc-1 (Megalencephalic 
leukoencephalopathy with subcortical cysts 1) are also anti-apoptotic proteins which 
have been over-expressed and were also shown to increase product titres and increase 
viability in CHO cells (Majors et al., 2008b; Chiang & Sisk, 2005; Figueroa et al., 2003).  
Bcl-x(L) has also been shown to increase production and viability in a transient 
expression system (Majors et al., 2008b).  Bak (Bcl-2 homologous antagonist/killer) and 
Bax (Bcl2-associated X protein) are pro-apoptotic factors and have been deleted in a 
CHO cell line resulting in increased cell densities and product titres (Cost et al., 2010).  
The apoptotic signalling pathway is mediated by capases, such as capase-3, -7, -8 and -
9, interference with either their expression or function has been shown to have 
beneficial effects on cell growth and in some cases productivity (Sung et al., 2007; Yun 
et al., 2007; Kim & Lee, 2002).  In another study four CHO cell lines expressing IFN-γ 
(Interferon gamma) were engineered for either the over-expression of FAIM (Fas 
apoptosis inhibitory molecule) or FADD (Fas-associated deathdomain), or the knock-
down of ALG-2 (Apoptosis-linked gene 2) or REQUIEM, all of which are involved in 
apoptosis (Wong et al., 2006b).  All four cell lines showed an increase in viability and 
reductions in apoptosis while ALG-2 and REQUIEM increased the maximum viable cell 
density.  All four were also shown to increase the final product titre of IFN-γ.  XIAP (X-
linked modifier of apoptosis) is an inhibitor of capases (-3, -7 and -9) and its over-
expression has been shown to significantly decrease apoptosis in both CHO and HEK-
293 cells (Sauerwald et al., 2003; Sauerwald et al., 2002).  A cell line combining the 
expression of XIAP and unfolded protein response (UPR) protein XBP1 (X-box binding 
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protein 1) (which can decrease growth and induce apoptosis) was shown to increase 
recombinant protein production and improve maximum cell density and viability 
compared to a cell line only expressing XBP1 (Becker et al., 2010). 
As well as inhibiting apoptosis, the inhibition of autophagy (type II programmed cell 
death) is another cellular target for engineering of mammalian cells producing 
recombinant proteins and has been observed in the late stages of culture when 
nutrients become exhausted (Han et al., 2011; Hwang & Lee, 2008).  Over-expression 
of Akt (protein kinase B), which plays a role in cell survival, was shown to delay the 
onset of both autophagy and apoptosis in CHO cells in batch culture (Hwang & Lee, 
2009).  Bcl-2 expression has also been shown to interact with the autophagy mediator 
Beclin-1 and as mentioned previously both proteins have been over-expressed in the 
same cell line for extension of culture duration and higher viabilities (Lee et al., 2013; 
Kim et al., 2009).  A chemical inhibitor of autophagy (3-methyl adenine) has also been 
shown to significantly improve the yield of tPA in a CHO fed-batch culture (Jardon et 
al., 2012). 
Mammalian cells producing recombinant proteins have also been engineered for an 
increase in cell specific growth rate and/or maximum viable cell density.  The cell cycle 
transcription factor E2F-1 has been over-expressed in CHO cells and led to both an 
extra day of proliferation and increased viable cell density when compared to a control 
cell line (Majors et al., 2008a) while over-expression of c-Myc (v-myc avian 
myelocytomatosis viral oncogene homolog), which is involved in cell cycle progression, 
increased cell specific growth rate and maximum viable cell density (Kuystermans & Al-
Rubeai, 2009).  Over-expression of two proteins which were shown to be up-regulated 
in fast growing cells, Cdkl3 (Cyclin-Dependent Kinase-Like 3) and Cox15 (Cytochrome c 
oxidase assembly protein COX15 homolog), led to increases in proliferation rates and 
maximum viable cell densities respectively in mammalian cells (Jaluria et al., 2007).  
However, significant increases in the production of recombinant proteins were not 
seen when these proteins were over-expressed.  When mTOR (mammalian target of 
rapamycin), a global metabolic sensor, was over-expressed increases in proliferation, 
cell size, viability and cell specific productivity in a CHO cell line producing a 
therapeutic recombinant protein was observed (Dreesen & Fussenegger, 2011).  The 
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multiple effects of mTOR over-expression reflect its role as a global metabolic sensor 
and the multiple cellular processes which it is involved in.  These include ribosomal 
protein synthesis (translation initiation and elongation) (Ma & Blenis, 2009; Richter & 
Sonenberg, 2005), cell survival (inhibition of autophagy) (Kim et al., 2011; Jung et al., 
2010; Sudarsanam & Johnson, 2010), cell proliferation (promotes proliferation) and 
cell growth (Fingar & Blenis, 2004; Fingar et al., 2004; Fingar et al., 2002) and positively 
regulating mitochondrial ATP synthesis capacity (Schieke et al., 2006) among many 
others (Laplante & Sabatini, 2012). 
As well as engineering cells for increased survival/growth/viability, cell engineering 
strategies have been attempted which try to increase the capacity of mammalian cells 
to produce and secrete recombinant protein.  This has involved the modulation of 
genes involved in protein synthesis, secretion and the UPR. 
Molecular chaperones are proteins involved in the assembly and disassembly, and the 
folding and unfolding of proteins and are found mainly in the endoplasmic reticulum 
(ER), but can also be found in the nucleus and in mitochondria.  Their roles in protein 
production make them an obvious genetic engineering target and numerous studies 
have been carried out for their effects on recombinant protein production in 
mammalian cells.  The ER molecular chaperone PDI (protein disulfide-isomerase), 
which helps form disulfide bonds in newly assembled proteins (Freedman et al., 1994), 
has been over-expressed in a number of studies.  It was shown to increase the cell 
specific productivity of MAb producing CHO cell lines (Mohan et al., 2007; Borth et al., 
2005), but not to have any effect on cell lines producing the recombinant proteins such 
as a TNFR:Fc (tumor necrosis factor receptor:Fc) fusion protein and TPO 
(thrombopoietin) (Mohan et al., 2007; Davis et al., 2000).  Another isoform of PDI, 
ERp57, was shown to increase the production of TPO (Hwang et al., 2003).  
Simultaneous over-expression of two proteins involved in protein folding and quality 
control in the ER, calnexin and calreticulin, also resulted in increased TPO production 
(Chung et al., 2004).  The protein BiP (Binding immunoglobulin protein) is also found in 
the ER and is important in both protein folding and assembly (Dorner & Kaufman, 
1994; Haas & Wabl, 1983) and has previously been a engineering target but over-
expression was showed to have no significant effect on recombinant protein 
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production (Borth et al., 2005; Dorner & Kaufman, 1994).  However, more recently BiP 
has been shown to increase MAb production from a stable mammalian cell line alone 
and in combination with other chaperones such as PDI, ERO1Lβ (Endoplasmic 
reticulum oxidoreductin-1-like beta) (Nishimiya et al., 2013).  In another more recent 
study the molecular chaperones BiP, PDI and CypB (Cyclophilin B), an ER peptidyl-
prolyl-isomerase (Meunier et al., 2002), were over-expressed with a panel of 
transiently expressed MAb whose final production titre differed >4-fold (Pybus et al., 
2013).  Both BiP and CypB increased the final titre while BiP and PDI over-expression 
caused increases in cell specific productivity.  However, this only occurred for a small 
number of the MAbs expressed, which shows along with the other studies mentioned 
that although the over-expression of molecular chaperones can improve recombinant 
protein production they are likely to be protein specific, depending on the bottleneck 
of protein production.  For improved expression, investigation of the rate limiting step 
for production is likely to be required and one study showed that the bottleneck in a 
high expressing human MAb CHO cell lines was ER-Golgi transport (Hasegawa et al., 
2011). 
The movement of proteins between intracellular compartments and to the cell surface 
for extracellular secretion is carried out by a complex vesicle trafficking system and the 
proteins involved are also cell engineering targets.  One family of proteins which are 
important are the Sec1/Munc18 (secretory blood group 1/mammalian uncoordinated-
18 (SM)) proteins and the SM proteins Sly1 (also known as SCFD1 - sec1 family domain 
containing 1) and Munc18 have been over-expressed in a MAb producing CHO cell line 
(Peng & Fussenegger, 2009).  Over-expression of each protein alone increased 
production significantly, dual expression increased production further, while 
expression of both these proteins along with the UPR factor XBP1 increased 
production further still.  SNARE (soluble N-ethylmaleimide-sensitive factor attachment 
receptor) proteins are another set of proteins important in vesicle trafficking and over-
expression of the exocytic SNAREs, SNAP-23 (synaptosomal-associated protein, 23kDa) 
and VAMP8 (vesicle-associated membrane protein 8), were both shown to increase 
recombinant protein production in mammalian cells along with a MAb in a CHO cell 
line (Peng et al., 2011).  Interestingly other exocytic SNAREs had no positive effect on 
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recombinant protein production in the same study (Peng et al., 2011).  CERT (ceramide 
transfer protein) is a protein involved in protein transport between the Golgi and the 
plasma membrane and its over-expression increased the cell specific productivities and 
final titre of a therapeutic protein in CHO cells (Florin et al., 2009).  In a more recent 
study a mutant form of CERT, which is resistant to phosphorylation, was over-
expressed in a tPA producing CHO cell line and specific productivity was increased 
(Rahimpour et al., 2013).   
The UPR is an intracellular response to a build up of unfolded proteins in the ER and 
modulated through a number of different proteins which can affect the function and 
expression of multiple target proteins to help alleviate such build ups (Kohno, 2010; 
Mori, 2009) (a more detailed description is given in figure 2.1).  It has long been 
thought that the expression of recombinant proteins, especially those that are highly 
expressed and also proteins which are termed ‘difficult-to-express’, may induce a UPR 
and has made it a natural target for cell engineering.  Indeed it has been shown in 
transient expression experiments in mammalian cells that recombinant proteins can 
induce a UPR, while stable cell lines in the late stages of culture and have shown 
increases in the UPR induced XBP1 protein (Pybus et al., 2013; Ku et al., 2010).  The 
negative effects of an UPR can be to down regulate global and specific mRNA 
translation, induce ERAD (ER associated degradation) potentially degrading your 
recombinant protein and also potentially induce apoptosis and cell death (Kohno, 
2010; Mori, 2009).  This can result in low specific productivities.  However, there are 
aspects of a UPR that might be beneficial for recombinant protein production and 
these include inducing the expression of ER proteins which aid the folding and 
processing of proteins (molecular chaperones – e.g.:- PDI, BiP etc.), as well as 
expanding the ER (endoplasmic reticulum) and improve secretion (Hetz, 2012).  
Therefore there has been work carried out to engineer cells to help negate the 
negative aspects of the UPR and also take advantage of the beneficial parts. 
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Figure 2.1 – Diagram of the unfolded protein response.  The unfolded protein response (UPR) is an 
intracellular response to ER stress such as an accumulation of mis-folded/unfolded protein.  When 
unfolded protein begins to accumulate in the ER the molecular chaperone BiP disassociates from the three 
ER transmembrane UPR receptors to bind unfolded protein so it is retained within the ER.  1. PERK – 
(protein kinase-like endoplasmic reticulum kinase) disassociation of BiP from PERK leads to PERK 
dimerization and phosphorylation.  Phosphorylated PERK can in turn phosphorylate eIF2a (eukaryotic 
initiation factor 2 alpha) which attenuates global mRNA translation preventing a further increase of 
unfolded protein inside the ER.  Allowing the ER time to refold the unfolded protein or degrade it.  
Although translation is attenuated some proteins can be translated.  One of these is ATF4 which has pro-
survival functions.  ATF4 can induce expression of CHOP which can lead to dephosphorylation of eEF1a 
thus allowing global mRNA translation to resume.  This creates a negative feedback loop but this only 
occurs if the unfolded protein has been processed accordingly.  2. ATF6 – (activating transcription factor 
6) after BiP dissociation the ATF6 protein it translocates to the Golgi were it is cleaved by S1/S2 
proteases from a 90 kDa form (ATF6(90)) to a 50 kDa form (ATF6(50)).  ATF6(50) is then free to move 
to the nucleus were it acts as a potent transcriptional activator of UPR target genes which are important in 
protein folding and secretion.  It targets UPR genes by binding ER-stress response elements (ERSE) 
which are upstream of these genes.  3. IRE1 – (inositol-requiring kinase 1) like PERK, IRE1 forms a 
homodimer and is phosphorylated.  Phosphorylation of IRE1 leads to the splicing of XBP1µ (X-box 
binding protein 1) mRNA which can then be translated into an activating transcription factor (XBP1s) 
which like ATF6(50) can induce the expression of target genes involved in protein folding and secretion.  
XBP1s is also involved in ERAD (ER associated degradation).  If unfolded protein persists in the ER and 
this accumulation of protein is not removed a UPR can eventually induce apoptosis (Chakrabarti et al., 
2011). 
 
XBP1 is the most studied UPR protein for increased recombinant protein production 
and is a transcription factor which induces the expression of target genes involved in 
protein entry into the ER, protein folding, ERAD, glycosylation, redox metabolism, lipid 
biogenesis, vesicular trafficking and autophagy (Acosta-Alvear et al., 2007; Lee et al., 
2005; Shaffer et al., 2004; Lee et al., 2003).  XBP1 over-expression was first shown to 
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increase production of a glycosylated reporter protein, as well as human VEGF 
(vascular endothelial growth factor) in CHO cells (Tigges & Fussenegger, 2006).  The 
transient expression of EPO was also improved by XBP1 over-expression, but no 
increases in a MAb, IFN-γ or EPO production were seen from stable cell lines for these 
recombinant proteins (Ku et al., 2010; Ku et al., 2008).  In another study, XBP1 over-
expression was shown to increase the size of the ER and also the final titre of a MAb in 
stably expressing CHO cells (Becker et al., 2008).  It has also been shown to increase 
the expression of low expressing ‘difficult-to-express’ MAb’s in a transient study 
(Pybus et al., 2013).  XBP1 was stably expressed along with the oxidoreductase ERO1Lα 
(Endoplasmic reticulum oxidoreductin-1-like alpha) for creation of a CHO cell line 
developed specifically for transient gene expression and showed increased MAb 
expression compared to the CHO-S cell line (Life Technologies, Paisley, UK) (Cain et al., 
2013). 
The UPR target genes ATF4 (activating transcription factor 4), GADD34 (growth arrest 
and DNA damage-inducible protein 34) and CHOP (C/EBP homologous protein) have 
also been targets for cell line engineering.  Over-expression of the transcription factor 
ATF4 and one of its target genes GADD34, which are involved in reversing the 
attenuation of translation caused by PERK (protein kinase-like endoplasmic reticulum 
kinase) phosphorylation of eIF2α (eukaryotic initiation factor 2 alpha), were both 
shown to increase the production of AT-III (Antithrombin III) in CHO cells (Haredy et al., 
2011; Ohya et al., 2008).  Another target of ATF4, CHOP, which plays a role in 
apoptosis, was shown to increase the expression of a MAb from a mammalian cell line 
both alone and also in combination with other UPR related proteins and ER 
chaperones such as ERdj3, ERdj5, BiP, PDI and ERO1Lβ (Nishimiya et al., 2013).  
Combinations of CHOP and the other proteins increased MAb titre more than CHOP 
alone. 
Along with XBP1, ATF6 is another important transcription factor which induces the 
expression of variety of target genes involved in protein folding and ER homeostasis 
when a UPR is induced (Bobrovnikova-Marjon & Diehl, 2007).  Compared with XBP1 
there is only a single study which showed ATF6 to successfully increase the production 
of recombinant proteins in mammalian cells (Pybus et al., 2013). 
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One reason why proteins such as ATF6, XBP1 and mTOR are interesting targets for cell 
line engineering strategies is the fact they affect multiple targets.  Many cell genetic 
engineering strategies involve the expression of a single protein which has a single or 
limited number of targets.  Both of these approaches as already mentioned are often 
cell line and product specific.  With the development of novel therapeutic proteins 
which can sometimes suffer from low product titres and increased understanding of 
the processes involved in recombinant protein production there will be both the 
product and the knowledge for identifying production bottlenecks and rationally 
designing more sophisticated cell engineering strategies for improving recombinant 
protein production in mammalian cells.  This will be aided by the further development 
of –omics approaches and the development of mathematical models which can be 
used to both describe cellular processes important in recombinant protein production 
and also be used to identify potential engineering targets (Pybus et al., 2013; Baik et 
al., 2011; Doolan et al., 2010; Wong et al., 2006a; Wong et al., 2006b).  For some 
products for improved production there will likely be the need for the expression of 
multiple genes/proteins to improve multiple cellular processes.  This will require novel 
and more sophisticated strategies for controlled multi-gene expression. 
 
2.2.5 – Multi-gene engineering in mammalian cells 
There are very few published multiple gene engineering strategies which can be used 
to control/tune the expression of multiple genes simultaneously in mammalian cells.  
This has been done more frequently in lower organisms such as prokaryotes and 
eukaryotic microbes (Dehli et al., 2012; Wang et al., 2009). 
One interesting strategy which was carried out in CHO cells showed that the 
expression of three different proteins could be controlled by light inducible promoters 
which responded to different wavelengths of light (Muller et al., 2013).  The time of 
induction of each individual gene could be controlled by exposure to these different 
wavelengths of light.  However, they did not demonstrate that they could control the 
actual levels of protein expression. 
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Another study showed that they could control the level of expression of two proteins 
simultaneously by engineering the cis-regulatory 5’-UTR (untranslated region) of each 
proteins corresponding mRNA (Endo et al., 2013).  Through this they were able to tune 
the translational efficiency of each proteins mRNA and simultaneously control the 
expression of two proteins.  This was carried out in HeLa cells but due to their 
mechanism of control it should be easily transferable to other mammalian cells like 
CHO cells. 
The development of further novel systems for the controlled/tunable of multiple genes 
will likely rely on the future developments in mammalian synthetic biology which is an 
exciting and fast growing research area (Grushkin, 2012). 
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Chapter 3 – Utilizing Elements of the UPR 
to Create a Tunable Protein Expression 
System for Mammalian Cells 
3.1 – Abstract 
In this chapter the development of a system for controlling the expression of one or 
more proteins in mammalian cells using elements of the mammalian unfolded protein 
response (UPR) is described.  Over-expression of the active form of ATF6 (ATF6(50)) 
was used along with vectors for expression of SEAP/GFP containing either none or 
multiple copies (1x, 3x, 6x and 9x) of the ATF6 binding site, the ER stress response 
element (ERSE), to manipulate SEAP and GFP expression both separately and 
simultaneously in CHO cells.   
Increasing amounts of an ATF6(50) vector increased SEAP expression when ERSEs were 
present via transactivation and decreased SEAP expression when ERSEs were not 
present by ‘promoter interference’.  We took advantage of this ‘promoter 
interference’ effect to increase the range of expression of our system.  We also 
showed that increasing numbers of ERSEs, from 1x to 9xERSE, and co-expression of 
ATF6(50) caused increases in both SEAP and GFP expression. 
This system was then used to control the expression of both SEAP and GFP 
simultaneously.  Again this involved using different amounts of ATF6(50) along with 
differing numbers of ERSEs.  Nine different combinations of simultaneous SEAP and 
GFP expression were achieved. 
Further development is required to make this a more viable system for the controlled 
expression of one/multiple genes but these are the first steps towards a system which 
could not only be useful in the biopharmaceutical industry for cell line engineering 
strategies, for so called ‘difficult to express’ proteins as one example, but also in other 
areas of biotechnology and biological research. 
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3.2 – Introduction 
Previously elements of the UPR, such as the UPR activators XBP1 and ATF6, have been 
used to try and increase the productivity of mammalian cells producing therapeutic 
recombinant proteins with varying degrees of success (Cain et al., 2013; Pybus et al., 
2013; Becker et al., 2008; Campos-da-Paz et al., 2008; Ku et al., 2008; Tigges & 
Fussenegger, 2006).  Their DNA binding elements, ERSE and UPRE, have been inserted 
into DNA vectors for the detection and quantification of endogenous and induced 
UPR’s (Du et al., 2013).  Endogenously these elements combine in the activation of 
UPR target genes to help alleviate an accumulation of unfolded protein but they have 
not been used together as part of a cell/synthetic biology engineering strategy (see 
figure 2.1 for a summary on the UPR). 
The work in this chapter combined transient expression of a recombinant form of ATF6 
with co-expression of a recombinant reporter protein (either SEAP (secreted alkaline 
phosphatase) a secreted glycoprotein or GFP (green fluorescent protein) an 
intracellular protein) which contains repeats of the ATF6 binding element (ERSE) 
upstream of its promoter (see figure 3.1). 
ATF6 and ERSE were chosen due to them being known to endogenously act together 
for the activation of UPR target genes (Yoshida et al., 2001b; Li et al., 2000; Ubeda & 
Habener, 2000).  The ERSE sequence is also relatively short (19 bp) (Yoshida et al., 
1998) meaning its number can be varied without creating extremely large vectors or 
vectors that vary to greatly in size.  ATF6 was also shown to have a more of positive 
effect, in terms of increased expression, when co-expressed with ERSE containing 
vectors than XBP1 (figure 3.3). 
It was hypothesized that vectors containing ERSEs would respond via transactivation 
by ATF6 co-expression and that by using differing numbers of ERSEs (1x, 3x, 6x and 
9xERSE) as well as different amounts of ATF6 there would be different levels of 
transcriptional activation resulting in controlled expression of SEAP/GFP.  This could 
be described as a tunable protein expression system for mammalian cells. 
Although gene expression can be controlled, via gene copy number/DNA vector load, 
the majority of the time strong constitutive promoters are used and result in near ‘all 
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or nothing’ responses making it difficult to achieve discrete/fine control over 
expression when it is desired.  However, tunable expression allows for such control. 
 
3.2.1 – Brief Background – Tunable Promoters 
Tunable protein expression is not a new idea and two of the oldest inducible 
expression systems, the Tet-On/Off (tetracycline-On/Off) and metallothionein (metal 
inducible promoters) systems, date back to the late 80’s and early 90’s (Gossen & 
Bujard, 1992; Dickerson et al., 1989; Bunch et al., 1988).  There has always been a 
need in biological research for the controlled expression of recombinant proteins and 
for the further progression of biological research and especially synthetic biology this 
requirement is ever increasing.  Protein expression can be controlled at the 
transcriptional level as well as post transcriptionally (i.e. – translation) (Farzadfard et 
al., 2013; Dehli et al., 2012; Stapleton et al., 2012; Tigges et al., 2009; Mijakovic et al., 
2005).  This can involve the redesign/alteration of endogenous promoters as well as 
the creation of completely synthetic promoters (Yim et al., 2013; Qin et al., 2011; Alper 
et al., 2005; Tornoe et al., 2002). It can also involve co-expression or the presence of 
an effector molecule such as a transcription factor or chemical and also the insertion of 
post transcriptional regulatory sequences to control protein expression (Farzadfard et 
al., 2013; Stapleton et al., 2012; Tigges et al., 2009; Bulter et al., 2004). 
Discrete control of protein expression has been achieved in the form of 
inducible/repressible promoters for time dependent expression (Blount et al., 2012; 
Hurley et al., 2012; Bowers et al., 2004; Bateman et al., 2001) and oscillator systems 
for mimicking biological rhythms (Purcell et al., 2010; Tigges et al., 2009; Stricker et al., 
2008).  Also libraries containing large numbers of promoters that vary in strength in 
slight increments (Qin et al., 2011; Tornoe et al., 2002; Jensen & Hammer, 1998), but 
sometimes over several orders of magnitude, have been essential in areas such as 
metabolic control analysis (Solem et al., 2008; Solem & Jensen, 2002).  
One of the future challenges for this area of research is towards the discrete control of 
multiple genes in a system (Dehli et al., 2012; Mijakovic et al., 2005) and there already 
has been some successful research published (Muller et al., 2013; Wang et al., 2009).   
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The majority of the research has been done in prokaryotic and eukaryotic microbial 
systems.  Research has been done in mammalian systems but there is less published 
literature.  However this is changing and mammalian synthetic biology is currently one 
of the strongest and most innovative biological disciplines (Grushkin, 2012).   
Synthetic biology, in the near and distant future, will have an ever increasing impact on 
not only biological research but also on practical applications in both the medical and 
biotechnology industries. 
 
3.2.2 – Description of the tunable protein expression system 
The system (fig 3.1) is currently a transiently expressed two/three vector system, one 
vector containing the gene for recombinant ATF6 and the other/s containing the gene 
for the reporter protein, either SEAP or GFP. 
The ATF6 vector utilizes the CMV promoter for strong constitutive expression of ATF6.  
An ATF6 vector utilizing an SV40 promoter was also created but was not used due to it 
not having any effect on reporter vectors containing ERSEs.  This was probably due to 
the weaker expression which is usually seen from a SV40 promoter compared with the 
CMV in some cell lines and which is demonstrated later in this chapter. 
The SEAP and GFP reporter vectors contained an SV40 promoter and ERSE sequences 
were inserted upstream of this.  The SV40 promoter was chosen for the expression of 
the reporter proteins due to its weak expression capabilities.  This made it more 
amenable to manipulation of its transcriptional strength.  ERSEs were also inserted 
upstream of the CMV promoter in a SEAP expressing vector but when co-expressed 
with the ATF6 vector no effect on SEAP expression was observed.  Again this probably 
occurred due to the strength of the CMV promoter. 
The ERSE sequence is 19 base pairs (bp) long (5’ – CCAATCGGAGGCCTCCACG – 3’) 
(Yoshida et al., 1998).  The active form of ATF6 binds the CCACG part of the sequence 
while the constitutively expressed NF-Y transcription factor binds CCAAT with both 
being required for transcriptional activation (Yoshida et al., 2001b; Li et al., 2000; 
Ubeda & Habener, 2000).  Both SEAP and GFP vectors containing 1x, 3x, 6x and 9x 
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copies of the ERSE sequence were created using a method for the unidirectional (same 
5’ to 3’ orientation) insertion of repeated DNA sequences (Jobbagy et al., 2002).  
Multiple ERSE sequences were separated by 13 bp.  We expect reporter vectors 
containing more ERSE sequences and therefore more ATF6 binding sites to give higher 
levels of reporter protein expression when ATF6 is co-expressed. 
The ATF6 vector and the reporter vector/s are co-transfected together and transiently 
expressed.  Figure 3.1 illustrates the hypothesized mechanism of our system. 
 
Figure 3.1 – Diagram of the tunable protein expression system.  The diagram shows how the system 
will function.  Transfection of a DNA vector containing the ATF6 gene will lead to the expression of 
recombinant ATF6 protein.  The active form of ATF6 will then be able to bind ERSE elements upstream 
of the SV40 promoter in the co-transfected reporter vector and cause an increase in transcription from this 
vector.  Altering the amount of ATF6 and number of ERSE will lead to different levels of mRNA 
transcription and overall recombinant protein expression. 
 
 
 
 
49 
Nathan West The University of Sheffield 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
Nathan West The University of Sheffield 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
Nathan West The University of Sheffield 
3.3 – Aims and Objectives 
Using the system created, we aim to discretely control protein expression in 
mammalian cells by manipulating the transcriptional activity of a commonly used 
promoter using components of the UPR (ERSE and ATF6).  We also aim to show that it 
can be used to control the expression of two recombinant proteins simultaneously.  All 
the work carried out has been done using a transient expression platform.  A more 
detailed description of our system can be found in the previous section of this chapter. 
The aims/objectives of this chapter are as follows: 
1. Show that expression of recombinant ATF6 is capable of transactivating vectors 
containing ERSE upstream of their SV40 promoter 
2. Show that changing the amount of ATF6 and the number of ERSE can lead to 
differing levels of expression 
3. Show that this can be achieved for both a secreted (SEAP) and intracellular 
(GFP) reporter protein 
4. Show that our system can be used to control the expression of two reporter 
proteins, a secreted (SEAP) and intracellular (GFP) reporter protein 
simultaneously 
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3.4 – Materials and Methods 
3.4.1 – Cell line and cell culture 
CHOK1SV cells (Lonza Biologics, Slough, UK) were cultured in Erlenmeyer shake flasks 
(Corning, Surrey, UK) using CD-CHO medium (Gibco®, Life Technologies, Paisley, UK) 
supplemented with 6 mM L-glutamine (Gibco®, Life Technologies, Paisley, UK).  Cells 
were cultured in 125 or 250 mL cap-vented Erlenmeyer flasks in a shaking incubator 
set at 37°C, 5% CO2 and 140 rpm.  Cells were passaged every 3-4 days.  Viability (%) 
and viable cell concentration (cells mL-1) were measured using the Vi-Cell automated 
cell counter (Beckman Coulter, Brea, CA, USA).  The required amount of cells for a 
concentration of 0.2 x106 cells mL-1 in the new culture were centrifuged at 200 g for 5 
minutes.  The old medium was removed and the cells were resuspended in fresh 
medium and added to a new flask.   
 
3.4.2 – DNA vectors used and vector engineering 
The UPR vectors ATF6(90), ATF6(50), XBP1µ and XBP1s were created by Dr. S. 
Schlatter.  All four genes are based on the mouse (Mus musculas) coding DNA 
sequences (CDS) and were inserted into the pcDNA3.1 (+) vector backbone (Life 
Technologies, Paisley, UK).  The ATF6(90) vector encodes the transcriptionally inactive, 
full ER membrane inserted form of the ATF6 protein (Ye et al., 2000; Haze et al., 1999).  
ATF6(50) encodes the cleaved, transcriptionally active form of the protein (Ye et al., 
2000; Haze et al., 1999).  XBP1µ encodes for un-spliced XBP1 mRNA which is translated 
into the transcriptionally un-active, shorter (33 kDa) form of the XBP1 protein (Yoshida 
et al., 2001a).  The XBP1s vector encodes for spliced XBP1 mRNA and this translates to 
the transcriptionally active and longer (54 kDa) form of the protein (Yoshida et al., 
2001a). 
6 different SEAP vectors were used in this chapter, SV40-SEAP (control), 1xERSE-SV40-
SEAP, 3xERSE-SV40-SEAP, 6xERSE-SV40-SEAP, 9xERSE-SV40-SEAP and CMV-SEAP.  The 
control vector SV40-SEAP is the Clonetech (Mountain View, CA, US) pSEAP2-control 
vector.  To create the ERSE vectors, oligonucleotides containing the ERSE sequence, 
were inserted upstream of the SV40 promoter in the SEAP control vector using a 
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method described by Jobbagy et al., (2002) for the unidirectional (same orientation) 
insertion of repeated DNA sequences.  To create the CMV-SEAP vector the SV40 
enhancer from the SV40-SEAP vector was first removed by restriction digest and the 
vector self-ligated.  The SV40 promoter was then also removed by restriction digest.  
The CMV promoter was PCR amplified from the ATF6(50) vector using primers with 
restriction site overhangs which matched those used to remove the SV40 promoter.  
After digesting the CMV PCR fragment with the correct restriction enzymes it was 
ligated into the linear SEAP vector. 
Six different GFP vectors were also used, SV40-GFP (control), 1xERSE-SV40-GFP, 
3xERSE-SV40-GFP, 6xERSE-SV40-GFP, 9xERSE-SV40-GFP and CMV-GFP.  These were 
created using the corresponding SEAP vector as a backbone for the insertion of a GFP 
CDS.  The SEAP CDS was removed from the SEAP vectors by restriction digest.  The GFP 
CDS was PCR amplified from the pTurboGFP-N vector (Evrogen, Moscow, Russia) using 
primers with restriction overhangs.  The GFP PCR fragments then underwent 
restriction digest before being ligated into the corresponding vector backbone. 
A negative control DNA vector containing no promoter or CDS was created by 
removing these elements by restriction digest from the SV40-SEAP vector and then 
ligating the sticky ends of the remaining vector backbone.  This vector was used as a 
control to maintain the same DNA loads in all transfection experiments as well acting 
as a negative control for transfection. 
Vector DNA was purified using both Miniprep and Maxiprep kits (Qiagen, Manchester, 
UK) according to the supplied protocol.  Vector DNA concentration was measured 
using the NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific, UK). 
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3.4.3 – Transient transfections 
Transfections were carried out on CHOK1SV cells which had been in culture for at least 
2-3 passages but no longer then 8 weeks.  The transfection reagent used was 
Lipofectamine® 2000 (Life Technologies, Paisley, UK). 
Cells on day 3 of culture were measured for cell concentration and viability.  1 mL of 
CHO cells at a concentration of 0.2 x 106 cells mL-1 were then plated on a 24 well plates 
(Nunclon™ Delta Surface microwell plates, Thermo Fisher Scientific, UK)  in DMEM 
medium (Gibco®, Life Technologies, Paisley, UK) containing 10% FCS (foetal calf serum) 
(Gibco®, Life Technologies, Paisley, UK) and 6 mM L-glutamine.  Plates were then 
placed in a static incubator at 37°C and 5% CO2. 
24 hours after plating the cells were transfected with vector DNA.  For every 
transfection 3 µg of DNA and 3 µl of Lipofectamine® 2000 was used per well.  The DNA 
and Lipofectamine® 2000 were diluted seperately in Opti-MEM media (Gibco®, Life 
Technologies, Paisley, UK) and were both prepared, mixed and added to the culture 
plates according to the manufactures supplied protocol and returned to the same 
incubator. 
For SEAP vector transfections the culture plates were incubated for 48 hours post 
transfection before spinning the plates down (5 minutes at 200 g) and carefully 
removing the cell media for further analysis. 
For GFP vector transfections the culture plates were analysed for GFP expression at 24 
and 48 hours post transfection. 
Transfection efficiency based on GFP expression was analysed using the Attune® 
Acoustic Focusing Cytometer and the Attune® Cytometric Software (Life Technologies, 
Paisley, UK). 
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3.4.4 – SEAP and GFP analysis 
The AnaSpec SensoLyte® pNPP Secreted Alkaline Phosphatase Reporter Gene Assay Kit 
(*Colorimetric*) (Cambridge Bioscience, Cambridge, UK) was used to quantify SEAP 
protein.  The assay was carried out according to the supplied protocol.  SEAP samples 
were incubated in a water bath at 65 °C for 20 minutes to inactivate endogenous non-
specific alkaline phosphatase. 
GFP expression was measured using the FluoroSkan Ascent™ FL Microplate 
Fluorometer (Themro Scientific, UK).  GFP was measured while the cells were still in 
their culture plates.  GFP was excited at 485 nm and emission measured at 510 nm. 
 
3.4.5 – Quantifying gene expression by real-time RT-qPCR 
Cells were centrifuged at 200 g for 5 minutes and the cell medium was carefully 
removed.  Extraction of mRNA was carried out using the RNeasy® Minikit in 
combination with the QIAShredder homogeniser according to the manufacturers’ 
protocol (Qiagen, Manchester, UK).  
mRNA concentration was measured using the NanoDrop 2000 UV-Vis 
Spectrophotometer (Thermo Scientific, UK). 
The TURBO DNA-freeTM Kit (Applied Biosystems®, Life Technologies) was used to 
remove any contaminating DNA from mRNA samples and was used according to the 
supplied protocol.  After removal of DNA, mRNA concentrations were measured again 
using the NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific, UK). 
mRNA was transcribed into DNA using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems®, Life Technologies) following the manufacturers protocol. 
SEAP mRNA expression was quantified by RT-qPCR using the Applied Biosystems 7500 
Fast Real-Time PCR system (Applied Biosystems®, Life Technologies) using an absolute 
quantification method (Pfaffl et al., 2002).  The SV40-SEAP vector was used as a 
standard. 
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SEAP primers were designed against the SEAP coding sequence and used at a 
concentration of 300 nM (SEAP FWD 5’ – CCATATGTGGCTCTGTCCAA – 3’, SEAP REV 5’ 
– GTCTGGAAGTTGCCCTTGAC – 3’). 
The Power SYBR® Green PCR Mastermix (Applied Biosystems®, Life Technologies) was 
used according to the manufacturer’s instructions.  1 µl of cDNA was added to each 
reaction.  The following PCR cycle program was used: 1. 50°C for 2 minutes; 2. 95°C for 
10 minutes; then 40 repeats of 3. 95°C for 15 seconds then 60°C for 1 minute.  A 
dissociation step was added to the end of procedure to check for the specificity of 
amplification. 
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3.5 – Results and Discussion 
3.5.1 – SEAP vector titrations 
The SEAP vectors CMV-SEAP, SV40-SEAP and 9xERSE-SV40-SEAP were transfected over 
a range of DNA concentrations (0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg, 1.0 
µg, 2.0 µg and 3.0 µg) to show the relative differences in their expression in CHOK1SV 
cells and whether the addition of ERSE alone had any significant impact on SEAP 
expression. 
From figure 3.2 it can be seen that the CMV-SEAP vector produced more SEAP protein 
across the whole range of transfected amounts of DNA compared to both the SV40-
SEAP and 9xERSE-SV40-SEAP vectors.  Over the range of 0.03125 µg to 1.0 µg SEAP 
vector DNA the CMV-SEAP vector produced ≥1.5-fold more SEAP protein compared 
with the other vectors.  SEAP expression from the CMV-SEAP vector plateaued at 1.0 
µg of DNA.  The SV40-SEAP and 9xERSE-SV40-SEAP vectors produced similar levels of 
SEAP protein for 0.03125 to 1.0 µg of transfected DNA.  The SV40-SEAP vector 
produced slightly more SEAP than the 9xERSE-SV40-SEAP vector when 2.0 µg and 3.0 
µg of SEAP DNA was transfected.  However, unlike the CMV-SEAP vector the SV40-
SEAP or 9xERSE-SV40-SEAP vectors protein expression did not plateau. 
In summary, the results show that SEAP production is higher when a CMV promoter is 
used to initiate transcription.  This was expected and it is already known that the CMV 
promoter is a stronger promoter in many cell lines when compared to the SV40 
promoter (Zarrin et al., 1999; Liu et al., 1997; Foecking & Hofstetter, 1986).  More 
importantly these results also showed that the addition of nine ERSE sequences 
upstream of the SV40 promoter alone had no positive effect on SEAP protein 
expression.  These results were used to help guide further experiments. 
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Figure 3.2 – Comparison of SEAP protein expression from three different SEAP DNA vectors over 
a range of transfected DNA amounts.  SEAP protein expression for eight differing amounts (0.03125 
µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg, 1.0 µg, 2.0 µg and 3.0 µg) of three SEAP expression vectors (● 
SV40-SEAP, ▲ 9xERSE-SV40-SEAP, ■ CMV-SEAP) transiently expressed in CHOK1SV cells in 24 
well plates.  The total amount of transfected DNA was kept consistent in all transfections by using an 
empty –ve control vector. Cell media was collected 48 hours post-transfection and analysed for SEAP 
protein expression.  N = 3, error bars represent ± 1 S.D. 
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3.5.2 – The effect of UPR activators on SEAP expression 
To test the effect of expressing UPR activators on SEAP expression the UPR vectors, 
ATF6(90), ATF6(50), XBP1µ and XBP1s were transiently co-expressed with three SEAP 
vectors, CMV-SEAP, SV40-SEAP and 9xERSE-SV40-SEAP (figure 3.3).  See chapter 2, 
figure 2.1 or chapter 3, section 3.2.2 for more information on these UPR components 
and the UPR vectors.  This experiment will help towards accomplishing the first aim set 
out in this chapter – can ATF6 transactivate vectors containing ERSE upstream of an 
SV40 promoter? 
All SEAP vectors were co-transfected with an equal mass of all four of the UPR vectors.  
From figure 3.3 we can see that the SV40-SEAP vector control produced a similar level 
of SEAP expression when compared with the results in figure 3.2 (0.5 µg DNA).  When 
the SV40-SEAP vector was co-transfected with the four UPR vectors no increase in 
SEAP expression was observed when compared to the control.  ATF6(90), ATF6(50) and 
XBP1µ co-expression resulted in a significant decrease in expression compared to the 
control.  The decrease was greater than 2-fold for the ATF6 vectors and around 1.6-
fold for XBP1µ.  Co-expression of XBP1s had no noticeable effect and SEAP expression 
was very similar to the control. 
The control for the CMV-SEAP vector also produced similar results to that seen in 
figure 3.2 (0.5 µg DNA).  When the UPR activator vectors were co-transfected with the 
CMV-SEAP vector, the effects were very similar and a roughly 1.3-fold decrease in SEAP 
expression was seen with all combinations. 
For the 9xERSE-SV40-SEAP vector, figure 3.3 shows that the control again produced 
similar levels of SEAP expression when compared with figure 3.2 (0.5 µg DNA).   Similar 
to results for SV40-SEAP there was a significant decrease in SEAP expression when 
ATF6(90) (-1.9-fold) and XBP1µ (-1.4-fold) were co-expressed.  XBP1s again had no 
effect on SEAP expression when compared to the control.  However, ATF6(50) caused a 
significant increase in SEAP expression (1.3-fold) when co-expressed with 9xERSE-
SV40-SEAP.  This shows that the ATF6(50) vector, which produces the transcriptionally 
active form of the ATF6 protein, is the only UPR activator that can increase SEAP 
expression from vectors containing ERSE sequences above that of its control.  
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The increase in SEAP expression seen when ATF6(50) was co-expressed with 9xERSE-
SV40-SEAP was the only increase seen in this experiment.  Although this was only a 
1.3-fold increase, this is only when compared to the expression of the 9xERSE-SV40-
SEAP vector under control conditions.  To further understand the effects of the 
combination of ATF6(50) expression and ERSE sequences being present upstream of an 
SV40 promoter, comparison between the results of the SV40-SEAP, 9xERSE-SV40-SEAP 
and CMV-SEAP vectors is needed.  SEAP expression was similar between CMV-SEAP 
and 9xERSE-SV40-SEAP when co-expressed with ATF6(50).  This shows that inserting 
ERSE sequences in a vector containing a weaker promoter (SV40), can produce similar 
levels of SEAP expression to that of a vector using a stronger promoter (CMV) when 
both are in the presence of ATF6(50).  When comparing the SEAP expression of 
ATF6(50) + 9xERSE-SV40-SEAP to the control CMV-SEAP the 9xERSE-SV40-SEAP vector 
produced less SEAP.   
Comparison of the control for both SV40-SEAP and 9xERSE-SV40-SEAP showed that 
their levels of SEAP expression were extremely similar.  This again shows that the 
presence of 9xERSE alone has no effect on SEAP expression from a vector using the 
SV40 promoter.  However, when comparing SEAP expression between the SV40-SEAP 
and 9xERSE-SV40-SEAP vectors when ATF6(50) is co-transfected there is a 5.9-fold 
difference.  This difference in SEAP protein expression is a better reflection on the 
effect of the insertion of 9xERSE sequences upstream of the SV40 promoter and the 
response to ATF6(50).  This is also evidence towards showing that recombinant 
ATF6(50) is capable of transactivating a vector containing ERSE upstream of a SV40 
promoter and completing the first aim set out in this chapter.  
As well as discussing the increases in expression seen in this experiment it is also worth 
discussing the results where there were decreases SEAP expression with certain 
combinations of SEAP vectors and UPR activators. 
It is expected when two DNA vectors are co-transfected that expression is reduced 
compared to if they were transfected alone.  This is seen when the SV40-SEAP vector 
was co-expressed with ATF6(90), ATF6(50) and XBP1µ and the 9xERSE-SV40-SEAP 
vector is co-expressed with ATF6(90) and XBP1µ.  The level of reduction in expression 
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can also be affected by the strength of the promoters in the different vectors.  For 
example the CMV promoter is expected to negatively affect the expression of a gene 
from a weaker SV40 promoter more so than co-expression with another CMV driven 
gene (Huliak et al., 2012).  The UPR activator vectors are driven by a CMV promoter 
and this pattern can be seen from results of the different SEAP vectors in figure 3.3.  
This effect could be termed ‘promoter interference’, although it is poorly defined in 
the literature and could also be termed ‘promoter competition’ and ‘transcriptional 
interference’ amongst other names and seems to depend on the context of the 
research and the researchers (Huliak et al., 2012; Curtin et al., 2008; Shearwin et al., 
2005; Conte et al., 2002; Eszterhas et al., 2002; Hirschman et al., 1988; Cullen et al., 
1984).  In brief, for the purpose of this chapter ‘promoter interference’ shall be defined 
as the negative effects promoters on different vectors have on each other and there 
resulting expression.  For a more detailed description of ‘promoter interference’ see 
chapter 4, section 4.2.1.  The results in chapters 4 & 5 of this thesis also investigate this 
phenomenon further, but there will be further references to it in the remainder of this 
chapter. 
‘Promoter interference’ did not occur for all combinations of SEAP and UPR activator 
vectors, e.g. - XBP1s co-transfection with SV40-SEAP or 9xERSE-SV40-SEAP.  This shows 
that the effect of the gene being expressed should also be considered.  The XBP1s 
vector produces the transcriptionally active form of the XBP1 protein.  This could 
potentially induce the expression of endogenous XBP1/UPR target genes which encode 
proteins which are important in protein folding and secretion and enhance the cells 
protein synthesis capability and this has been demonstrated previously by XBP1s over-
expression increasing recombinant protein production (Cain et al., 2013; Campos-da-
Paz et al., 2008; Tigges & Fussenegger, 2006). 
In summary, it was shown that out of the four UPR activators only ATF6(50) can 
increase the expression of a SEAP vector containing ERSEs upstream of an SV40 
promoter.  Therefore the remainder of this chapter will only involve co-expression of 
the ATF6(50) vector for further investigation of the potential of this tunable expression 
system. 
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Figure 3.3 – The effect of ATF6(90), ATF6(50), XBP1µ and XBP1 on SEAP protein expression from 
three different SEAP DNA vectors.   SEAP protein expression for 0.5 µg of SV40-SEAP, 9xERSE-
SV40-SEAP and CMV-SEAP vector DNA co-transfected with the 0.5 µg of UPR activator vectors 
(ATF6(90), ATF6(50), XBP1u and XBP1s) in CHOK1SV cells.  The total amount of transfected DNA 
was kept constant using the –ve control DNA vector.  For further information on the SEAP, UPR 
activator and -ve control DNA vectors please refer to section “4.2.2” in this chapter.  Cell media was 
collected 48 hours post-transfection and analysed for SEAP protein expression. For each SEAP vector, 
mean values significantly different (Dunnett’s test) from their control are indicated by asterisks (* p < 
0.05, ** p < 0.01, *** p < 0.001).   N = 3, error bars represent + 1 S.D. 
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3.5.3 – The effect of titrating ATF6(50) on SEAP expression 
The next experiment was carried out to investigate the effects of titrating the amount 
of ATF6(50) vector on SEAP expression.  To do this different amounts of the ATF6(50) 
vector (0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 µg, and 0.5 µg) were co-transfected with 
a constant amount of SEAP vector (0.5 µg).  This was carried out for SV40-SEAP, 
9xERSE-SV40-SEAP and CMV-SEAP.  This will aid in fulfilling the first and second part of 
the aims/objectives set at the beginning of this chapter. 
From figure 3.4 we can see that the controls for each SEAP vector again produced 
similar amounts of SEAP expression when compared to both figure 3.2 and 3.3.  
Increasing amounts of ATF6(50) had increasingly negative effects on SEAP expression 
from the SV40-SEAP vector.  When compared to the control the difference in 
expression was significant for all amounts of ATF6(50) vector DNA, except for the 
smallest amount (0.03125 µg).  For the CMV-SEAP vector, although some of the larger 
amounts of ATF6(50) did reduce the amount of SEAP expression, none of the 
decreases were statistically significant.  As in figure 3.3 we can see that ATF6(50) co-
expression with 9xERSE-SV40-SEAP again increased SEAP expression when compared 
to the control (figure 3.4).  For all amounts of ATF6(50) the increases in SEAP 
expression were significant.   
This again shows that a vector containing ERSE upstream of an SV40 promoter 
(9xERSE-SV40-SEAP) is capable of responding to the co-expression of the 
transcriptionally active form of ATF6 (ATF6(50)).  When only the SV40 promoter is 
present (SV40-SEAP) SEAP expression is reduced when co-expressed with the ATF6(50) 
vector.  Again this is likely to occur due to ‘promoter interference’. 
From table 3.1 we can see the fold differences when the amount of co-transfected 
ATF6(50) is adjusted.  For the 9xERSE-SV40-SEAP vector we can see that increasing the 
amount of ATF6(50) vector from 0.03125 µg to 0.5 µg does increase the amount of 
SEAP expression but this plateaus at 0.125 µg with a 1.26-fold increase.   In this 
instance this gives us only a very limited window in which to adjust the expression of 
SEAP and would make our system almost pointless for most applications.  However, 
when you look at the effects on the SV40-SEAP vector you can see a decreasing step-
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wise trend in SEAP expression when the amount of the ATF6(50) vector is increased.  
Overall there is a 3.81-fold decrease in SEAP expression when comparing the control 
and co-transfection of 0.5 µg of ATF6(50).  When you compare this with the highest 
level of SEAP expression achieved when ATF6(50) (0.25 µg) was co-expressed with 
9xERSE-SV40-SEAP there is a 5.35-fold increase from the lowest SEAP expression to the 
highest.  This gives a much broader range in which to control the expression of SEAP.  
Table 3.2 shows this range of SEAP expression. 
In summary, we have again shown that SEAP vectors containing ERSE upstream of an 
SV40 promoter are capable of responding to the co-transfection of ATF6(50). We can 
also see that by altering the amount of transfected ATF6(50) we change the level of 
SEAP expression.  This can be achieved for both the 9xERSE-SV40-SEAP and the SV40-
SEAP vector by using ATF6(50) and transactivation and ‘promoter interference’, 
respectively to improve the range of attainable SEAP expression.  This provides further 
evidence towards achieving both the first and second aims/objectives of this chapter. 
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Figure 3.4 – The effect of differing amounts of ATF6(50) vector DNA on SEAP protein expression 
from 0.5 µg of three different SEAP DNA vectors.  SEAP protein expression from 0.5 µg of SV40-
SEAP, 9xERSE-SV40-SEAP and CMV-SEAP  vector DNA when co-transfected with differing amounts 
of ATF6(50) vector DNA (0.0 µg (control), 0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg) in 
CHOK1SV cells.  Cell media was collected 48 hours post-transfection and analysed for SEAP protein 
expression.  For each SEAP vector, mean values significantly different (Dunnett’s test) from their control 
are indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).   N = 3, Error bars represent + 1 S.D. 
 
Table 3.1 – Fold change in SEAP expression for each SEAP vector when compared to their 
control from figure 3.4 
  SEAP vectors 
ATF6(50)  SV40-SEAP  9xERSE-SV40-SEAP  CMV-SEAP 
0.0 µg (Control)  1.00
a  1.00
a  1.00
a 
0.031255 µg  -1.10
a  1.10
a, b  -1.02
a
 
0.0625 µg  -1.30
b  1.16
b, c  -1.04
a
 
0.125 µg  -1.57
c  1.24
c  -1.01
a
 
0.25 µg  -2.26
d  1.26
c  -1.06
a
 
0.5 µg  -3.81
e  1.25
c  -1.13
a
 
The numbers in the table represent the fold change in SEAP protein expression from the control sample of 
the respective SEAP vectors.  Calculated using the data in figure 3.4.  For each SEAP vector, values with 
different letters differ significantly from each other (Tukey’s test, p < 0.05).  Comparisons between 
different SEAP vectors were not made. 
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Table 3.2 – Range of SEAP expression from figure 3.4 
SEAP vector  ATF6(50)  Fold change 
SV40-SEAP  0.5 µg  1.00
a 
SV40-SEAP  0.25 µg  1.68
b 
SV40-SEAP  0.125 µg  2.43
c 
SV40-SEAP  0.0625 µg  2.95
d 
SV40-SEAP  0.03125 µg  3.47
e 
SV40-SEAP  0.0 µg (Control)  3.81
e, f 
9xERSE-SV40-SEAP  0.0 µg (Control)  4.26
f, g 
9xERSE-SV40-SEAP  0.03125 µg  4.70
g, h 
9xERSE-SV40-SEAP  0.0625 µg  4.92
h, i 
9xERSE-SV40-SEAP  0.125 µg  5.29
i 
9xERSE-SV40-SEAP  0.25 µg  5.35
i
 
9xERSE-SV40-SEAP  0.5 µg  5.32
i
 
The numbers in the table represent the fold change in SEAP protein expression when compared to lowest 
expressing combination of SEAP vector and ATF6(50).  Calculated using the data in figure 3.4.  For each 
SEAP vector, values with different letters differ significantly from each other (Tukey’s test, p < 0.05). 
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3.5.4 – The effect of different numbers of ERSE on SEAP expression 
Along with the 9xERSE-SV40-SEAP vector, three other ERSE vectors were also 
engineered, 1xERSE-SV40-SEAP, 3xERSE-SV40-SEAP and 6xERSE-SV40-SEAP.  In this 
experiment, we investigated whether altering the number of ERSE while keeping the 
amount of ATF6(50) vector constant would alter the expression of SEAP.  As well as 
measuring SEAP protein expression, RNA samples were also taken to quantify the 
numbers of SEAP mRNA transcripts that were present.  Similar to the last section, this 
will aid in providing evidence for the first and second aims/objectives. 
From figure 3.5 – A. we can see that SV40-SEAP, 1xERSE-SV40-SEAP, 3xERSE-SV40-
SEAP, 6xERSE-SV40-SEAP and 9xERSE-SV40-SEAP all produced similar levels of SEAP 
protein expression when transfected under control conditions (no ATF6(50)).  The 
CMV-SEAP control again produced more SEAP protein when compared with vectors 
containing an SV40 promoter.  This shows again that the addition of ERSE sequences 
upstream of the SV40 promoter alone does not improve SEAP protein expression.   
The ERSE vectors all produced similar levels of SEAP mRNA under control conditions 
(figure 3.5 – B.).  The SV40-SEAP control on average produced less SEAP mRNA when 
compared to the ERSE vector controls, but this difference was only significant for 
6xERSE-SV40-SEAP.  From these results it could be possible that the addition of ERSE 
upstream of an SV40 promoter might increase the transcriptional capacity of this 
promoter slightly.  However, any difference seen at the mRNA level was not observed 
at the protein level (figure 3.5 – A.) and therefore the addition of ERSE alone does not 
seem to have a significant effect. 
The CMV-SEAP vector produced on average 3.39-fold (± 1.10 (SD)) more SEAP mRNA 
compared to all the other SEAP vectors under control conditions (figure 3.5 – B.).  This 
demonstrates the stronger transcriptional strength of the CMV promoter when 
compared to the SV40, but it also worth noting that mRNA stability and processing can 
be affected by the promoter used (Bregman et al., 2011; Trcek et al., 2011).  The same 
difference in mRNA is not observed at the protein level (figure 3.5 – A.).  The CMV-
SEAP vector only produced on average 1.74-fold (± 0.05 (SD)) more SEAP protein then 
the other SEAP vectors.  This shows that increases in SEAP mRNA and SEAP protein do 
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not necessarily correlate at a 1-to-1 ratio.  To understand this it is worth considering 
the differences in SEAP mRNA and protein.  SEAP protein is secreted into the cell 
media and will accumulate throughout culture.  Protein also tends to have a greater 
half-life than mRNA (Vogel & Marcotte, 2012).  The reported half-life of SEAP is ~500 
hours (Schlatter et al., 2002).  Therefore it is safe to assume that the SEAP 
measurement will represent the overwhelming majority of SEAP protein produced 
where as the mRNA measurement due to its much shorter half-life (estimated at 10.5 
hours (Weber et al., 2007)) will only represent a proportion of the total SEAP mRNA 
produced throughout the experiment.  It worth mentioning again that the different 
promoters used will also have an effect on the mRNA expression levels due to their 
transcriptional strength and the stability and processing of the mRNA produced 
(Bregman et al., 2011; Trcek et al., 2011). 
When looking at the effect that ATF6(50) co-transfection had on SEAP expression, 
figure 3.5 – A. shows again that it is capable of increasing the expression of SEAP 
protein from vectors containing ERSE upstream of an SV40 promoter.  The number of 
ERSE present in the vector also does have an effect as well.  As the number of ERSE 
increased from 1xERSE to 9xERSE there was an increase in SEAP protein expression.  
The 9xERSE-SV40-SEAP vector produced the largest amount of SEAP protein of all the 
ERSE vectors but was only significantly different from the 1xERSE-SV40-SEAP vector.  
Table 3.3 shows the fold change in SEAP protein expression relative to the SV40-SEAP 
control.  In this experiment it would seem that the difference between having 3xERSE, 
6xERSE and 9xERSE and co-transfection of 0.125 µg of ATF6(50) is not significant. 
When considering the amount of SEAP mRNA produced when the ERSE vectors were 
co-transfected with ATF6(50), similar to the protein results, there was an increase in 
SEAP mRNA compared to the SV40-SEAP control and from 1xERSE to 9xERSE.  The fold 
changes in SEAP mRNA expression were greater than that seen at the protein level 
(table 3.3) but similar to the protein data 9xERSE-SV40-SEAP produced the most mRNA 
but this was only significantly different from the 1xERSE-SV40-SEAP vector. 
From the data presented it would seem that increasing the numbers of ERSE present 
upstream of an SV40 promoter and the co-expression of ATF6(50) does lead to an 
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increase in SEAP mRNA and SEAP protein expression.  However, the differences in 
expression are only significant when comparing the results of the 1xERSE-SV40-SEAP 
vector to the other three ERSE vectors.  Although increases can be seen there was no 
significant difference in SEAP expression between the 3xERSE-SV40-SEAP, 6xERSE-
SV40-SEAP and 9xERSE-SV40-SEAP vectors.   
Although the range of control offered by changing the number of ERSE present in our 
vectors is limited, it has shown that increasing them does affect both SEAP mRNA and 
protein expression.  The work presented so far is evidence for achieving the first and 
second aims and objectives set out at the beginning of this chapter:- 
1. ATF6 is capable (ATF6(50)) of transactivating ERSE when placed upstream of an 
SV40 promoter.  This has been shown by increases in both SEAP mRNA and 
protein when comparing the ERSE vectors with the SV40-SEAP vector (figure 
3.3, 3.4 and 3.5). 
2. Changing the amount of co-transfected ATF6(50) does result in different levels 
of SEAP expression.  This is true for both an ERSE vector (9xERSE-SV40-SEAP - 
↑ATF6(50) = ↑SEAP) and the SV40-SEAP vector (↑ATF6(50) = ↓SEAP) (ﬁgure 
3.4).  Changing the number of ERSE present while co-expressing ATF6(50) also 
had an effect on SEAP expression.  An increase in both mRNA and protein was 
observed when increasing the number of ERSE from 1x to 3x to 6x and to 
9xERSE (figure 3.5).  9xERSE gave the highest expression but was only 
significantly different from the 1xERSE vector. 
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Figure 3.5 – The effect of different numbers of the ERSE sequence on SEAP protein and mRNA 
copy number when co-transfected with the ATF6(50) DNA vector.  A.
0.5 µg of SV40-SEAP, 1xERSE-SV40
SV40-SEAP and CMV-SEAP vectors when co
CHOK1SV cells.  B. SEAP mRNA copy numbers for the differe
samples as used in A.  Cell media was collected 48 hours post
expression.  For each SEAP vector, values with different letters differ significantly from each other 
(Tukey’s test, p < 0.05).  N = 3, Error bars represent + 1 S.D
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Table 3.3 –  Fold change in SEAP protein and mRNA relative to the SV40-SEAP vector under 
control conditions 
SEAP vector  SEAP protein fold change 
 
SEAP mRNA fold change 
SV40 SEAP (Control)  1.00
a  1.00
a 
1xERSE-SV40-SEAP + ATF6(50)  1.30
b  1.75
a, b 
3xERSE-SV40-SEAP + ATF6(50)  1.52
c  2.52
b, c, d 
6xERSE-SV40-SEAP + ATF6(50)  1.53
c, d  2.74
c, d 
9xERSE-SV40-SEAP + ATF6(50)  1.62
c, d  3.29
d 
The numbers in the table represent the fold change in SEAP protein and mRNA expression when 
compared to the SV40-SEAP vector under control conditions.  Calculated using the data in figure 3.5.  
For each SEAP vector, values with different letters differ significantly from each other (Tukey’s test, p < 
0.05). 
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3.5.5 – The effect of ATF6(50) and ERSE on GFP expression 
In the previous sections it was demonstrated that ATF6(50) and different numbers of 
ERSE upstream of an SV40 promoter could be used to achieve differing levels of SEAP 
expression.  Secreted proteins such as SEAP, as long as they have a long enough half 
life, will accumulate in the cell media, where as proteins which are not secreted and 
are only expressed intracellularly may accumulate to a lesser degree due to being 
retained within and degraded by the cell.  GFP is a commonly used intracellular 
reporter protein and has a reported half-life of ~26 hours but this can vary depending 
on the variant used (Corish & Tyler-Smith, 1999).  In this section investigation of 
whether the system can be used to control the expression of GFP in the same way as 
was shown with SEAP was carried out. 
Similar to the work carried out using SEAP, six different GFP expression vectors were 
created.  ERSE vectors containing 1x, 3x, 6x and 9xERSE upstream of an SV40 promoter 
and the GFP CDS were created to see the effect of differing numbers of ERSE.  An 
SV40-GFP and CMV-GFP vector were also created.  Both were used to compare the 
expression of the ERSE vectors, the former to show the effect of ERSE and the latter for 
comparison to a strong promoter.  All GFP vectors were transfected separately with 
and without the co-transfection of the ATF6(50) vector. 
From figure 3.6 (A. & B.) we can see that when the ERSE GFP vectors were transfected 
under control conditions there was no significant difference in GFP expression when 
compared to the SV40-GFP vector.  Like the work carried out with the SEAP vectors, 
this showed again that the addition of ERSE upstream of an SV40 promoter alone does 
not affect expression.  Likewise the CMV-GFP vector demonstrated the higher 
expression strength of the CMV promoter by producing significantly more GFP than 
the other vectors under control conditions at both time points.  
When the ERSE GFP vectors were co-transfected with the ATF6(50) vector the 3xERSE, 
6xERSE and 9xERSE-SV40-GFP vectors all showed increased expression compared to 
their controls at both 24 and 48 hours post-transfection (figure 3.6 – A. & B.).  The 
1xERSE-SV40-GFP vector produced the same amount of GFP when compared to its 
control.  However, for the SV40-GFP vector there was a decrease in expression 
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compared to the control when co-transfected with ATF6(50).  This was probably due to 
promoter interference from the strong CMV promoter in the ATF6(50) vector as 
mentioned earlier in this chapter.  This shows that even a vector containing 1xERSE 
upstream of an SV40 promoter can respond to co-expression of ATF6(50).  This is 
further evidence of ATF6(50) transactivating vectors containing ERSE upstream of an 
SV40 promoter. 
The CMV-GFP vector remained largely unaffected by co-expression of ATF6(50).  There 
were slight decreases in GFP expression when compared to the control, but this was 
only significant at 48 hours (figure 3.6 – A. & B.). 
Taking a closer look at the effect of differing numbers of ERSE on GFP expression in the 
presence of ATF6(50) table 3.4 shows the fold changes in GFP expression compared 
with the lowest GFP production (SV40-GFP + ATF6(50)) from figure 3.6 for both 24 and 
48 hours post transfection.  From this table we can see that between the lowest and 
highest GFP expression levels achieved, comparing only the GFP vectors containing 
either an SV40 promoter or both an SV40 promoter and ERSE, that there was a 4.80- 
and 4.31-fold difference in GFP expression at 24 and 48 hours, respectively.  The 
combination of SV40-GFP and ATF6(50) gave the lowest GFP expression while the 
9xERSE-SV40-SEAP + ATF6(50) gave the highest.  When increasing the number of ERSE 
from 1x to 9xERSE there were also increases in GFP expression when ATF6(50) was co-
expressed.  The differences in GFP expression were significant between the 1xERSE-
SV40-GFP vector and the rest of the ERSE GFP vectors, as well as between the 3xERSE-
SV40-GFP vector and the 6x and 9xERSE GFP vectors.  This again shows that increasing 
the number of ERSE does lead to increases in protein expression when ATF6(50) is also 
co-transfected. 
The results from the GFP vectors differed in two ways from the results seen in the 
similar experiment for the SEAP vectors (figure 3.5).  Firstly the range of GFP 
expression shown from the lowest to the highest is greater than for SEAP expression, 
4.31-fold and 1.62-fold, respectively at 48 hours.  Secondly there were greater 
significant differences between the different ERSE GFP vectors at 48 hours when co-
expressed with ATF6(50) (figure 3.5 – B.) than there was for the ERSE SEAP vectors 
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(figure 3.4 – A.).  One simple explanation why there was differences seen between the 
ERSE SEAP and ERSE GFP vectors might be due to the amount of ATF6(50) used in both 
experiments.  A lower amount of ATF6(50) DNA was used in the SEAP experiment then 
than the GFP experiment and we have already shown that increasing amounts of 
ATF6(50) can have a positive effect on expression from 9xERSE-SV40-SEAP vector 
(figure 3.4).  This is also likely to occur with ERSE GFP vectors.  Although this explains 
some of the difference it will not be the sole reason.   
Another explanation could be the differences in the synthesis of GFP and SEAP from 
transcription right through to the production and expression of the mature protein.  
Firstly, their final destinations differ significantly, SEAP is secreted and GFP is retained 
within cells.  Secondly, they have very different half-lives, ~500 and ~26 hours 
respectively for SEAP and GFP (Schlatter et al., 2002; Corish & Tyler-Smith, 1999).  
Thirdly, the SEAP protein is twice as large as a GFP monomer, ~65 kDa compared to 
~27 kDA, but GFP does normally exist as a dimer (Schlaeger et al., 2003; Desai & 
Person, 1998).  Fourthly, SEAP is a secreted glycoprotein (Schlatter et al., 2001) 
whereas GFP has a beta-barrel structure encasing a chromophore (Ormo et al., 1996; 
Yang et al., 1996).  Due to SEAP’s more complex structure and extra processing steps 
(i.e. – glycosylation and secretion) SEAP maybe more of burden or take longer for the 
cell to produce the mature protein than it does for GFP. 
In summary, we again showed that vectors containing ERSE upstream of an SV40 
promoter can be transactivated by ATF6(50) co-expression and that increasing 
numbers of ERSE result in increasing expression of a reporter protein.  We have now 
shown that this can be done for both SEAP and GFP expression and this fulfils the third 
aim/objective set out at the beginning of this chapter. 
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Figure 3.6 – The effect of ATF6(50) co
expression GFP.  0.5 µg of 6 different GFP expression vectors (SV40
3xERSE-SV40-GFP, 6xERSE
separately in CHOK1SV cells under two different conditions
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Table 3.4 – Fold change in GFP expression when compared to the lowest GFP expression 
achieved for both 24 and 48 hours post-transfection 
24 hours post-transfection  48 hours post-transfection 
GFP vector  Fold change  GFP vector  Fold change 
SV40-GFP  
+ ATF6(50) 
 1.00
a 
 SV40-GFP  
+ ATF6(50) 
 1.00
a 
SV40-GFP  
(Control) 
 2.08
b 
 1xERSE-SV40-GFP  
+ ATF6(50) 
 2.39
b 
1xERSE-SV40-GFP  
+ ATF6(50) 
 2.41
b 
 SV40-GFP  
(Control) 
 2.58
b, c 
3xERSE-SV40-GFP  
+ ATF6(50) 
 3.19
c 
 3xERSE-SV40-GFP  
+ ATF6(50) 
 3.03
c 
6xERSE-SV40-GFP  
+ ATF6(50) 
 4.39
d 
 6xERSE-SV40-GFP  
+ ATF6(50) 
 3.80
d 
9xERSE-SV40-GFP  
+ ATF6(50) 
 4.80
d 
 9xERSE-SV40-GFP  
+ ATF6(50) 
 4.31
d 
The numbers in the table represent the fold change in GFP expression when compared to the SV40-GFP 
vector co-transfected with the ATF6(50) vector.  Calculated using the data in figure 3.6.  For each SEAP 
vector, values with different letters differ significantly from each other (Tukey’s test, p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
Nathan West The University of Sheffield 
3.5.6 – Simultaneous and controllable expression of two proteins, SEAP 
and GFP, using ERSE and co-expression of ATF6(50) 
To see if ERSE upstream of an SV40 promoter and co-expression of ATF6(50) can be 
used to control the levels of expression of two genes simultaneously, different 
combinations of the SEAP and GFP vectors were co-transfected together with 
ATF6(50).  This involved nine different combinations of controlled SEAP and GFP 
expression.  This included:- 
• Low : low, low : medium, low : high, medium : low, medium : medium,  medium 
: high, high : low, high : medium and high : high expression of both GFP and 
SEAP expression, respectively 
From the work already presented in this chapter the following SEAP and GFP vectors 
were chosen:- 
• SV40-SEAP & SV40-GFP – these were chosen because co-expression with 
ATF6(50), and the resulting negative effects previously seen, will give lower 
levels of expression of both of these reporter proteins 
• 1xERSE-SV40-SEAP & 3xERSE-SV40-GFP – we expected that these vectors would 
give medium levels of expression for each reporter protein when co-expressed 
with ATF6(50).  Vectors containing different numbers of ERSE were chosen for 
expression of SEAP and GFP because the differences between the numbers of 
ERSE present effect SEAP and GFP expression slightly differently 
• 9xERSE-SV40-SEAP & 9xERSE-SV40-GFP – these two expression vectors gave the 
highest levels of SEAP  and GFP expression when co-transfected with ATF6(50) 
Initially every combination of these six SEAP and GFP vectors were co-transfected 
together (9 different combinations).  1 µg of SEAP and 1 µg of GFP was co-transfected 
along with three different amounts of ATF6(50) DNA (0.5, 0.75 and 1.0 µg). In total, 27 
different combinations of SEAP and GFP vectors and ATF6(50) DNA amounts were 
tested.  48 hours post transfection the results were collected and analysed (data not 
shown).  From this data, we could see that the ranges of expression of both SEAP and 
GFP were very different.  SEAP expression from lowest to highest had a 3.77-fold range 
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while GFP expression had a 26.50-fold range.  The highest levels of SEAP and GFP 
expression were similar to those seen earlier in this chapter.  The results of both SEAP 
and GFP were compared together for every combination and combinations of SEAP 
and GFP vectors and the amount of ATF6(50) DNA were selected (see table 3.5) 
according to levels of expression we hoped to achieve and previously stated in this 
section.  These combinations were then transfected again.  Control transfections 
without ATF6(50) were also carried out for every combination of SEAP and GFP vector 
to show that both ATF6(50) was having an effect on the expression of both reporter 
proteins and show any effects these combinations of SEAP and GFP vectors had on 
each other’s expression in the absence of ATF6(50).  
Figure 3.7 – A. shows the results of the controls.  We can see that SEAP expression 
from all the different combinations of SEAP and GFP vectors was roughly the same and 
it was also similar to SEAP expression shown previously in this chapter when the SV40-
SEAP and ERSE SEAP vectors were transfected alone and without ATF6(50) DNA.  The 
presence or absence of ERSEs and the presence of any of GFP vectors did not seem to 
effect SEAP expression, whereas for GFP there were clear differences in expression.  
There were both differences in expression between the three different GFP vectors 
and also differences for the same GFP vector depending on the co-transfected SEAP 
vector.  Considering the average amount of GFP expression for each different GFP 
vector the SV40-GFP vector performed the worst under control conditions followed by 
the 3xERSE-SV40-SEAP vector while the 9xERSE-SV40-GFP vector produced the highest 
GFP expression.  However, for each GFP vector the co-expressed SEAP vector also had 
an effect on GFP expression.  When they were co-expressed with 9xERSE-SV40-SEAP, 
GFP expression was the lowest for each individual GFP vector.  For both SV40-GFP and 
3xERSE-SV40-GFP, GFP expression was highest when co-expressed with SV40-SEAP and 
slightly lower when co-expressed with 1xERSE-SV40-SEAP.  The results for 9xERSE-
SV40-GFP were different with co-expression of SV40-SEAP and 1xERSE-SV40-SEAP 
giving similar results, but this was still significantly higher compared to GFP expression 
when 9xERSE-SV40-SEAP was co-transfected and the highest GFP expression of all the 
GFP vectors.  Only when the 9xERSE-SV40-GFP vector was co-transfected with SV40-
SEAP and 1xERSE-SV40-SEAP was GFP expression at a similar level to that seen earlier 
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in this chapter when not co-expressed with a SEAP vector or ATF6(50).  Both the SV40-
GFP and 3xERSE-SV40-GFP vectors underperformed compared to early results. 
These control results with the three different GFP vectors were unexpected and this 
was because from figure 3.6 we saw that in the absence of ATF6(50) there was very 
little difference in GFP expression between the SV40-GFP vector and the ERSE GFP 
vectors, which we had also seen with the SV40-SEAP and ERSE SEAP vectors (figure 
3.5).  We did not expect the presence of a SEAP vector to effect GFP expression so 
significantly, due to all vectors containing an SV40 promoter and the fact that the 
presence of ERSE alone did not seem to effect GFP expression previously.  This shows 
that the ERSE present in the GFP vectors must have some effect when there is a co-
transfected SEAP vector and even in the absence of ATF6(50) expression.  The 
differences seen between the three GFP vectors and also the effects of the different 
SEAP vectors might be able to be explained by the number of ERSE present or their 
absence having an effect on expression from the GFP vectors when a SEAP vector is co-
expressed.  Having 9xERSE in the GFP vector did seem to benefit GFP expression when 
co-expressed with a SEAP vector and even 3xERSE was better for GFP expression than 
having none in this instance.  GFP expression was also greater when the competing 
SEAP vector had less or a similar number of ERSE.  Exactly why this is the case is 
unknown and why this only occurs for the GFP vectors and not the SEAP vectors is 
even harder to answer.  Is it the differences between SEAP and GFP protein in terms of 
structure, processing, half-life and their final destinations that cause this major 
difference?  Is SEAP selectively produced over GFP?  Does the simultaneous expression 
of SEAP and GFP induce a UPR?  If so, why does it not affect SEAP expression the same 
as GFP expression?  Whatever the reason for this it is beyond the scope of this chapter 
and this thesis but is interesting none the less. 
Table 3.5 shows the different combinations of GFP and SEAP vectors and also the 
amount of co-transfected ATF6(50) DNA used for the results in figure 3.7 – B..  From 
figure 3.7 – B. we can see the different levels of simultaneous GFP and SEAP 
expression.  For GFP expression we can see that using either the absence or presence 
of ERSEs in these vectors and co-transfection of ATF6(50) we achieved three distinct 
levels of expression, namely low, medium and high expression.  For all three levels of 
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expression the results within each group (low, medium and high) did not differ 
significantly while between groups they were significantly different.  There were clear 
distinct differences in the GFP expression achieved between the low, medium and high 
expression groups.  The highest levels of GFP expression were similar to those seen 
before for the 9xERSE-SV40-GFP vector when co-expressed with ATF6(50) but without 
a SEAP vector.   
For SEAP expression we also saw differences between the low, medium and high 
expression groups (figure 3.7 – B.).  The highest levels of SEAP expression were slightly 
higher than previous experiments when ERSE SEAP vectors were co-transfected with 
ATF6(50) and no GFP DNA was present.  Within the low group, all SEAP expression was 
shown to be similar but significantly different from the medium and high groups.  
There were less clear differences between medium and high SEAP expression groups.  
Within each of these groups, there were no significant differences in SEAP expression, 
which is what we were aiming to achieve.  However, between groups for some pairs of 
GFP and SEAP vectors, there was no significant difference between some medium and 
high SEAP expression conditions, which is not what we expected and we had aimed to 
achieve results similar to that seen for GFP expression.  Ideally, SEAP expression for the 
medium group would be lower or the high group higher then it was or indeed both. 
This lack of difference between high and medium SEAP expression conditions may be 
due to the range of SEAP that we managed to achieve being much smaller than the 
range of GFP expression.  As mentioned earlier, the range in SEAP and GFP expression 
in the preliminary work for this section was 3.77-fold and 26.50-fold respectively.  The 
ranges of expression from lowest to highest in figure 3.7 – B. were similar but slightly 
lower, 3.22-fold for SEAP and 24.21-fold for GFP expression.  This means there was a 
much bigger window to work with for GFP expression then we did for SEAP.  Also from 
the control results (figure 3.7 – A.), we saw how just the presence of different numbers 
of ERSE effected GFP expression when co-expressed with a SEAP vector which was not 
the case for SEAP expression.  Both these differences would point to GFP expression 
being easier to affect and manipulate than SEAP expression.  Work from earlier in this 
chapter also shows this. 
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Although the differences between the medium and high SEAP expression was not as 
great as we had aimed to achieve we have still shown how we can use different 
numbers of ERSE and different amounts of ATF6(50) to manipulate expression in a 
controllable fashion for two reporter proteins simultaneously.  We set out to achieve 
nine different combinations of simultaneous SEAP and GFP expression and this was 
very nearly achieved.   
In summary, ERSEs and ATF6(50) can be used to help control the level of two reporter 
proteins simultaneously, although GFP expression was more successfully manipulated 
then SEAP expression.  This goes some way to fulfilling the final aim/objective we set 
out at the beginning of this chapter, but more work is needed to make this a more 
useful system for controlled mammalian expression. 
 
Table 3.5 – The combinations of co-transfected GFP and SEAP vectors and the amounts of co-
expressed  ATF6(50) used to achieve the nine different levels of simultaneous  and controlled 
GFP and SEAP expression in figure 3.7 – B. 
Level of expression  GFP vector  SEAP vector  ATF6(50) 
Low GFP : Low SEAP  SV40-GFP  SV40-SEAP  1.0 µg 
Low GFP : Medium SEAP  SV40-GFP  1xERSE-SV40-SEAP  0.5 µg 
Low GFP : High SEAP  SV40-GFP  9xERSE-SV40-SEAP  1.0 µg 
Medium GFP : Low SEAP  3xERSE-SV40-GFP  SV40-SEAP  0.75 µg 
Medium GFP : Medium SEAP  3xERSE-SV40-GFP  1xERSE-SV40-SEAP  0.75 µg 
Medium GFP : High SEAP  3xERSE-SV40-GFP  9xERSE-SV40-SEAP  1.0 µg 
High GFP : Low SEAP  9xERSE-SV40-GFP  SV40-SEAP  1.0 µg 
High GFP : Medium SEAP  9xERSE-SV40-GFP  1xERSE-SV40-SEAP  1.0 µg 
High GFP : High SEAP  9xERSE-SV40-GFP  1xERSE-SV40-SEAP  0.5 µg 
The table shows the different combinations of co-transfected GFP and SEAP vectors (1.0 µg of each GFP 
and SEAP DNA were co-transfected) and the amount of co-expressed ATF6(50) DNA used in figure 3.7 
– B. to achieve the nine different combinations of simultaneous GFP and SEAP expression. 
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Figure 3.7 – Controllable and simultaneous expression of SEAP and GFP.  
and 1.0 µg of GFP vector DNA were co
CHOK1SV cells.  Table 3.5 shows the different combinations of SEAP and GFP vectors used in each co
transfected pair as well as the amount of co
taken 48 hours post-transfection.  A. Shows the results of the controls were no ATF6(50) DN
present and transfection load was normalised using 
normalised separately to the average of all nine conditions
the GFP and SEAP vectors used for each pair
Different amounts of ATF6(50) (see table 3
–ve control DNA.  SEAP and GFP expression were normalised separately to the lowest results see
each reporter protein to show the range of expression.  The 
SEAP expression for each pair.  For SEAP and GFP results, values with different letters differ 
significantly from each other (Tukey’s test, 
compared).  N = 3, Error bars represent + 1 S.D
The University of Sheffield 
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3.6 – Further Discussion, Final conclusions and Future 
Directions 
3.6.1 – Further discussion 
At the beginning of this chapter we set out to produce a system where we used the 
number of ERSE and expression of its binding factor, ATF6(50), to control the 
expression of initially a single reporter protein and then two reporter proteins 
simultaneously.  We showed how co-expression of ATF6(50) could transactivate both 
SEAP and GFP vectors which had ERSE sequences upstream of an SV40 promoter and 
increase expression above that of a control (no ATF6(50)).  Due to the ATF6(50) vector 
containing the strong CMV promoter it had negative effects on expression from both 
SEAP and GFP vectors lacking ERSE and just containing the weaker SV40 promoter.  
This was thought to occur due to promoter interference which will be studied later in 
this thesis (chapter 4).  Although a negative effect on expression, we took advantage of 
this and used it to increase the range of expression for both SEAP and GFP.  The 
amount of ATF6(50) had an effect on either the increase or decrease in expression.  
We also showed how the number of ERSE had an effect on expression when ATF6(50) 
was present.  Expression increased when the numbers of ERSE was increased although 
this was shown to work better when expressing GFP.  When expressing SEAP and GFP 
ERSE vectors separately, the number of ERSE sequences had no effect when ATF6(50) 
was not co-transfected.  At the end of the chapter we also showed how we could use 
ERSE and ATF6(50) to control expression of both SEAP and GFP simultaneously.  This 
was for only nine different combinations of SEAP and GFP and the results for different 
levels of GFP expression were more distinct and significant.  The number of different 
combinations of SEAP and GFP will need to be increased in the future as we develop 
this system further for tunable/controlled expression of one or more genes. 
This was our first attempt at constructing a system for the tunable/controlled 
expression of genes in mammalian cells.  However, this system still needs further 
development.  The results for different levels of GFP expression were significantly 
different in the final results section (section 3.5.6 & figure 3.7 – B.) but the results for 
SEAP were not as significantly different as initially expected.  The aim was for the high 
and medium levels of SEAP expression to be more distinct from each other.  This may 
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have occurred because the range of SEAP expression was much lower than for GFP 
(3.22-fold and 24.21-fold respectively).  Other experiments had also showed that SEAP 
expression was less amenable to the effect of different numbers of ERSE then GFP 
(figure 3.6 & 3.7) when ATF6(50) was co-expressed even though increases in 
expression were observed.  It would seem that GFP expression was easier to 
manipulate then SEAP.  It cannot be said with any certainty why there were such 
differences in controlling SEAP and GFP expression, although this was briefly discussed 
in a previous results section, but we will discuss it further in the next paragraph. 
SEAP and GFP expression in terms of range and ease to control differed when 
expressed either separately or simultaneously when co-expressed with ATF6(50).  
Another major difference between them was their expression when the ERSE SEAP and 
SV40-SEAP vectors were co-transfected with ERSE GFP vectors and SV40-GFP in the 
absence of ATF6(50) (figure 3.7 – B.).  We saw that all the SEAP vectors used in this 
experiment gave similar levels of SEAP expression regardless of the co-transfected GFP 
vector.  However this was not the case for GFP, were both the number and absence of 
ERSE as well as the co-transfected SEAP vectors did have an effect.  We already stated 
that SEAP and GFP are very different kinds of reporter proteins, but it was still an 
unexpected result.  The presence of ERSE alone when GFP vectors were transfected by 
themselves showed them not to have an effect, so why did it seem they did once they 
were co-expressed with a SEAP vector but still in the absence of ATF6(50)?  Surely this 
means there are very significant differences in the way both SEAP and GFP are 
produced in our cells. 
One explanation could be that the dual expression of SEAP and GFP actually induces a 
UPR.  If this is the case, then it would be expected that both SEAP and GFP vectors 
containing ERSE might be capable of responding to endogenous UPR activators such as 
endogenous XBP1s and more prominently ATF6(50).  This is turn might result in 
increased transcription from vectors containing ERSE and therefore more mRNA 
available for translation.  If this were true then it might be expected that both SEAP 
and GFP vectors containing ERSE should respond with increased SEAP and GFP protein 
expression.  However, this might be where the differences between the proteins may 
affect their expression when in this context.  SEAP is a secreted glyco-protein and 
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could be said to be a more complex protein to produce than GFP given the extra steps 
involving glycosylation and secretion.  We have already shown that SEAP protein does 
not correlate at a one-to-one ratio with SEAP mRNA (figure 3.6).  Increasing the 
amount of SEAP mRNA did not proportionally increase SEAP protein and this may be 
because the cells cannot handle or completely process this increase in SEAP mRNA.  It 
could also be due to the secretary machinery of the cell being unable to process 
further increases in SEAP protein.  This is known as ‘secretion saturation’ and it has 
been shown to occur in CHO cells previously (Schroder et al., 1999; Schroder & Friedl, 
1997) and in microbial systems as well (Smith & Robinson, 2002; Parekh et al., 1995).   
This may be different for GFP, since it is not secreted extracellularly, the cells may be 
better able to handle increases in GFP mRNA and so increase GFP protein.  This would 
mean that the correlation of GFP mRNA to GFP protein is closer to a one-to-one ratio 
and that even a small increase in GFP mRNA can be translated and reflected in the 
amount of protein expressed.  This is just a hypothesis and further work such as 
measuring the amount of GFP mRNA present would need to be done to start to have a 
clearer understanding of the differences seen between SEAP and GFP protein 
expression.  Although this does not completely answer why there were differences 
seen between the two proteins, and there are also other possible explanations, the 
fact that the work with SEAP seems less successful, SEAP is a secreted protein and 
future directions of the system being controlled expression of multiple genes for cell 
engineering it is likely that SEAP is not the right reporter protein to use to further 
develop this system.  Another intracellularly expressed protein might be a better 
candidate. 
In hindsight, SEAP is not the correct reporter protein to continue using for the future 
development of this system and alternatives will be mentioned later in this chapter 
along with how it can be improved and expanded into a more viable 
tunable/controllable system for the expression of one or multiple genes in mammalian 
cells.  However, we have still showed it is possible using recombinant ATF6(50) 
expression and differing numbers ERSE upstream of an SV40 promoter driving 
expression of a reporter protein that we can control the level of expression and that 
this can also be done with two reporter proteins simultaneously.  
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3.6.2 – Final conclusions 
The insertion of ERSE upstream of an SV40 promoter without co-transfection of 
ATF6(50) had no effect on either SEAP or GFP expression when these were expressed 
by themselves and compared to a vector just containing an SV40 promoter and no 
ERSE. 
Vectors containing ERSE were transactivated and expression was increased by co-
transfection of ATF6(50).  Expression from vectors containing only the SV40 promoter 
was reduced by ATF6(50) expression.  The amount of ATF6(50) DNA transfected had an 
effect, increased ATF6(50) DNA caused increased expression from ERSE vectors and 
decreased expression from SV40 only vectors.  These positive and negative effects can 
both be used to increase the range of expression for our proposed system. 
The number of ERSE also had an effect on the levels of expression when ATF6(50) was 
co-expressed.  Increasing numbers of ERSE gave increasing levels of expression.  This 
was shown better for GFP expression then it was for SEAP expression.  The number of 
ERSE had no effect when ATF6(50) was not co-transfected and when SEAP and GFP 
vectors were transfected alone. 
The same system of differing numbers of ERSE and ATF6(50) can used for manipulating 
the levels of both a secreted glycoprotein, SEAP, and an intracellular protein, GFP.  Our 
system seemed to perform better for GFP compared to SEAP expression. 
This same system for controlled expression can be used to control expression of SEAP 
and GFP simultaneously.  However, GFP again performed better having a greater range 
of expression and more distinction between the three levels of expression we set out 
to attain which we simply termed low, medium and high. 
These are the first steps towards developing a mammalian tunable/controlled 
expression system for one or multiple genes and although we achieved the majority of 
the goals we set out to achieve there is still much room for improvement, expansion 
and refinement of our system to be a valuable tool for not only the biopharmaceutical 
industry but many areas of biological research and biotechnology.  This will be 
discussed in the next section.   
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3.6.3 – Future directions 
Although this chapter has shown what can be achieved using a activating transcription 
factor and its binding sequence to control expression of either a single reporter protein 
or two reporter proteins simultaneously further work needs to be done to develop our 
system into a viable one for tunable/controlled expression. 
Firstly, we should consider applications for this kind of system.  Improved 
biopharmaceutical production is a vast research area studied by both academic and 
industrial researchers.  Within this research area there have been a vast number of 
strategies that have been studied to help increase or lower the cost of production from 
bioreactor design, media formulation, cell line selection, and improved DNA 
production vectors etc.  Cell line engineering has also been attempted to improve the 
productivity of CHO cells and other cell lines important in this area.  Most basic 
strategies involve the over-expression of a single protein and although some have 
been successful many more have failed.  Although the ideas behind these strategies 
may be rational, the complexity of biological systems means that manipulating the 
expression of a single protein is unlikely to have a dramatic effect.  There will be a 
need in the future for strategies were more than one protein is expressed, two/three 
or probably even greater numbers.  It is also likely that the different proteins will need 
to be expressed at different levels which are quite difficult to achieve with completely 
constitutive promoters.  This is what we hope to achieve with further development of 
this system.  We want to be able to discretely control or tune the expression of 
multiple proteins simultaneously in mammalian cells.  Firstly this would be done in 
CHO cells and used to improve performance of an industrially important cell line and 
most likely for a so called ‘difficult to express’ biopharmaceutical.  This system can also 
be classed as mammalian synthetic biology and we expect that it could be used for 
applications outside of the biopharmaceutical area.  For this to happen, though, we 
need to further develop, expand and improve our system. 
The work in this chapter used the reporter proteins, SEAP and GFP, although we did 
show we can manipulate the expression of both simultaneously, in hindsight and also 
thinking about the future development of our system this is not the ideal combination 
to show the full potential of this system.  The limitations showed when manipulating 
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SEAP expression, mostly the range of its expression, and the fact it is a secreted glyco-
protein means it is unlikely to reflect the type of protein that this system will be used 
for controlling expression.  GFP being an intracellular protein is more suited and future 
work should initially involve the expression of other fluorescent proteins (RFP and YFP) 
and other intracellular reporter proteins.  Using both RFP and YFP along with GFP 
would make the initial further development of the system easier, in terms of being 
able to easily measure their expression, and also expanding the number of controlled 
proteins.  Eventually proteins that actually have more of a direct effect on cells would 
need to be tested, but this would be a good starting point for a proof of concept. 
To further expand this system the number of ERSE placed upstream of an SV40 
promoter should also be increased past nine copies until we reach a point where 
additional copies no longer have an additive effect.  Further titrations of ATF6(50) with 
both GFP and other fluorescent proteins also needs to be carried out to better 
understand the effects when different numbers of ERSE are present in these vectors. 
Optimizing this system for the expression of multiple proteins may be benefitted by 
using a DOE approach.  As long as we fully understand the limits or boundaries of the 
design space correctly and the interactions and the expressions of multiple proteins 
can be modelled sufficiently using this approach, this will reduce the number of 
experiments required to show our system works along with giving some predictive 
power.  In turn this will reduce the timeframe of development.  However DOE is not 
simple and we would have to make sure we approached it in the right manner. 
Further development might also include the use of a synthetic transcription factor to 
replace ATF6(50) which does not bind endogenous transcription factor binding sites 
but a novel binding site instead of the ERSE.  This would add orthogonality and remove 
any off system effects that may currently occur with ATF6(50) which are presently 
unknown.  However this is something that would not be done initially and it may even 
be the case that over-expression of ATF6(50) might not affect the cell too greatly when 
there are vectors containing ERSE for it to bind, acting as transcription factor sponges, 
and thus reducing the available ATF6(50) to affect endogenous targets. 
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If the vision of our system is achieved it would be a novel method of controlling the 
expression of multiple genes in mammalian cells in cell engineering strategies and 
would be an extremely useful tool for not only the biopharmaceutical industry but also 
for biotechnology and biological research in general. 
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Chapter 4 – A Study of Promoter 
Interference between Three Commonly 
used Constitutive Promoters for 
Biopharmaceutical Production in CHO 
Cells 
4.1 – Abstract 
The SV40 early, human CMV major immediate-early and the human EF1α promoters 
are all commonly used in the production and research of therapeutic proteins.  
However, when more than one promoter is expressed in a system as will occur in many 
cell engineering strategies, there is competition between promoters which can have 
negative effects on the expression from the promoters involved.  This phenomenon 
can be termed promoter interference and this can occur between even physically 
unlinked promoters. 
The expression of these three promoters in CHO-S cells along with their abilities to 
negatively affect the expression of another competing promoter was compared.  SEAP 
was used as a model glycoprotein and GFP in place of an active intracellular effector 
protein.  Vectors containing CMV and EF1α promoters produced similar and higher 
levels of SEAP expression compared to an SV40 containing vector.  Co-expression of 
SEAP and GFP vectors utilizing different promoters showed that a SV40 containing 
SEAP vector was most negatively affected by the presence of a competing GFP vector.  
This depended on the competing promoter and a SV40 had the least, effect while the 
CMV had the greatest negative effect closely followed by the EF1α promoter.  
Expression from a CMV-SEAP vector was the least affected by a competing promoter.  
The level of interference of a competing promoter seemed to be related to its 
transcriptional strength since the CMV promoter was the most transcriptionally active 
it was also the most interfering followed by the EF1α promoter with SV40 promoter 
being the least. 
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These promoters are poorly suited for use in cell engineering strategies were multiple 
genes are needed to be expressed and that the development of independent 
promoters which do not overly interfere with each other’s expression will be needed in 
the future.  For the development of such promoters a more in depth understanding of 
why even physically unlinked promoters either interfere or compete for expression is 
needed. 
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4.2 – Introduction 
In chapter three a phenomenon termed “promoter interference” was discussed briefly 
due to its effects on the expression of co-expressed proteins.  From this work it could 
be seen that when an expression vector using a weaker promoter such as the SV40 
was co-transfected with another containing the stronger CMV promoter, the amount 
of expression from the latter was reduced (figure 3.3 & 3.4).  Although this effect is not 
a new discovery and rather just an accepted consequence when mixing more than one 
promoter in a system there are only a limited number of published studies on it, 
especially in terms of the context we encountered it. 
There is great interest in biopharmaceutical research in understanding CHO cells and 
the processes surrounding recombinant therapeutic protein production in mammalian 
cells.  A large proportion of the work involves the expression of recombinant proteins 
which might include therapeutic proteins, reporter proteins (SEAP, luciferase and GFP), 
and effector proteins for potential cell engineering strategies (e.g. – over-expression of 
UPR proteins and molecular chaperones (Pybus et al., 2013)).  Sometimes this will 
involve the co-expression of a single protein, but when a new cell engineering strategy 
is being tested then two or more recombinant proteins maybe over-expressed 
simultaneously (e.g. – reporter and effector protein).  Initially this will likely involve the 
over-expression of a reporter protein such as SEAP, which is often used in this area of 
academic research due it being an easily expressed model glycoprotein and the ease 
and low cost of measuring its expression compared to therapeutic glycoproteins.  An 
effector protein will also be co-expressed with the reporter protein.  This would likely 
be done first in a transient manner due to the time consuming nature of creating 
stable cell lines.  The effect of the cell engineering strategy on the expression of the 
reporter protein will then be measured after a given amount of time post-transfection.  
Depending on the effects of the effector protein further studies may be carried out to 
understand and develop the approach further.  Sometimes however, some strategies 
do not work or are unviable and this can happen for many reasons.  This could include 
incorrect expression of the recombinant proteins (meaning either too high/low or not 
optimal expression) and negligible, non-target or negative effects of recombinant 
proteins on the cell expression system. 
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Another point to consider is that when co-expressing two proteins this will probably 
involve, at least initially, the co-transfection of two DNA vectors.  As well as the two 
recombinant proteins competing at the translational level there will also be prior 
competition at the transcriptional level.  If two strong DNA promoters are used, this 
may not become a problem if high level expression of each protein is acceptable.  
However, if different strength promoters are used because there is a need for different 
levels of expression, negative interactions may occur between them resulting in the 
reduction in expression of either one of them or both.  This may make it very difficult 
to get the optimum levels of expression required for certain cell engineering strategies 
to work.  Changing the ratios of transfected DNA may help overcome this problem but 
some promoters such as the CMV have been shown to negatively affect expression 
from other promoters even when present in small amounts (Huliak et al., 2012). 
In chapter four it was shown that the strong CMV promoter reduced expression from a 
DNA vector containing the weaker SV40 promoter.  This was thought to occur through 
‘promoter interference’.  The research on this phenomenon has studied it in a few 
different scenarios but never from a cell engineering for biopharmaceutical production 
perspective.  In this chapter we aim to investigate this phenomenon from this 
perspective by comparing the expression of three promoters commonly used in 
biopharmaceutical research and production (SV40, CMV and EF1α) and how there 
expression changes when two are present in the same system.  This will be done by co-
transfecting SEAP vectors with GFP vectors.  An explanation of why these reporter 
proteins were chosen is given in the aims and objectives of this chapter (section 4.3). 
The next two sub sections give a brief description of what promoter interference is and 
the origins, structure and uses of the SV40, CMV and EF1α promoters. 
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4.2.1 – Brief Background – ‘Promoter interference’ 
Promoter interference is basically defined as the “perturbation of one transcriptional 
unit by another” (Huliak et al., 2012; Curtin et al., 2008; Eszterhas et al., 2002).  
Promoter interference can also be called transcriptional interference or promoter 
competition (Curtin et al., 2008; Shearwin et al., 2005; Conte et al., 2002; Eszterhas et 
al., 2002; Hirschman et al., 1988; Cullen et al., 1984).  The different names used to 
describe this perturbation of one transcriptional unit by another can reflect the 
context or the area of the research.  The definition at the beginning of this paragraph 
and repeated in the previous sentence is very broad because there is more than one 
way to perturb transcription from a promoter and this can occur in many different 
scenarios.  This could occur in the context where a DNA enhancer could activate 
multiple genes but only selectively activates the promoter of a single gene (Conte et 
al., 2002; Choi & Engel, 1988; Hirschman et al., 1988).  Other examples involve either 
the blocking of the binding of RNA polymerase (RNAP) or its progression along DNA 
and this can occur when promoters are in close proximity or the sequences of genes 
overlap (Shearwin et al., 2005; Callen et al., 2004; Prescott & Proudfoot, 2002; Wang et 
al., 1998; Adhya & Gottesman, 1982).  It could also occur through a process called 
transcriptional squelching, where there is competition for limited amount of a 
transcriptional regulator/s (Huliak et al., 2012; Cahill et al., 1994a; Prywes & Zhu, 
1992).  These occurrences can occur naturally in chromosomes and in integrated and 
non-integrated transgene DNA expression vectors (Curtin et al., 2008; Shearwin et al., 
2005; Conte et al., 2002; Eszterhas et al., 2002; Choi & Engel, 1988; Hirschman et al., 
1988; Cullen et al., 1984).  Although the term ‘interference’ may make this 
phenomenon sound somewhat of a negative and unwanted effect, and in some cases 
it such as certain examples of controlled expression of multiple transgenes (Curtin et 
al., 2008; Thompson & Myatt, 1997; Ingelbrecht et al., 1991), it can actually be used 
for gene regulation (Shearwin et al., 2005; Callen et al., 2004; Nasser et al., 2002; 
Wang et al., 1998). 
The overwhelming majority of the research published on promoter interference 
describes cases when this occurs for promoters or transcriptional regulatory sequences 
which are in cis, meaning that they are either on the same chromosome or the same 
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DNA expression vector.  Very little work has been carried out on promoter interference 
on promoters which are physically unlinked or in trans.  In chapter 4 we encountered 
promoter interference and this occurred in trans when two different expression 
vectors were co-transfected. 
The only research carried out on physically unlinked promoters, which is in the same 
context, as the interference we encountered was conducted by Huliak et al., (2012).  
They were interested in the interpretation of transiently expressed reporter gene 
experiments that are frequently used to analyse promoters and transcriptional 
regulators.  Most of these experiments involve the expression of a reporter protein, an 
internal control (e.g. - GFP) and/or trans-acting factor such as transcriptional 
activator/repressor.  Generally it is thought that the expression of the reporter protein 
is a good relative indicator of the strength of the transcriptional units involved in the 
assay.  In many cases it is, but there is known inherent limitations with this kind of 
experiment and situations when the reporter protein does not accurately reflect the 
strength of a promoter/regulator.  This could occur when the reporter protein itself is 
toxic to the cell or when the internal control and/or trans-acting factor interfere with 
reporter protein activity (Huliak et al., 2012; Liu et al., 1999).  Alternatively, negative 
interactions may occur between two physically unlinked promoters and could be 
another reason why reporter protein expression might not reflect the true 
transcriptional capacity of given regulatory element, or in other words promoter 
interference.  Huliak et al., (2012) showed that when the often utilized CMV promoter 
was present, even in only small amounts, it had a severe negative impact on 
expression from other promoters.  This negative impact was seen for both basal and 
activated promoter activities and even when a CMV promoter was present in a vector 
lacking a recombinant gene to express it still had a negative effect.  The take home 
message was that because the CMV is so commonly utilised in many vectors that are 
used in transient reporter gene assays that its impact on promoters when co-
expressed should be taken into account when interpreting the results.  A hypothetical 
example would be when a GFP vector with a CMV promoter is used as an internal 
control in such an assay.  A newly designed synthetic promoter which is driving 
expression of a reporter protein may seem according to reporter protein activity to be 
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performing disappointingly poorly.  However, if the internal control is removed from 
the experiment the promoter performs better due to the removal of the negative 
interference of the CMV promoter.  
In the study Huliak et al., (2012) co-expressed the CMV promoter with the human 
immunodeficiency virus (HIV), human T-cell leukaemia virus type-I (HTLV-T), NF-κB-
responsive and p53-responsive promoters.  However, apart from the CMV none of 
these promoters are routinely used in vectors for recombinant therapeutic protein 
production.  The work in this chapter will investigate the negative interactions of three 
promoters (SV40, CMV and EF1α) which are routinely used in biopharmaceutical 
production.  The next section will give a brief description of the three promoters 
studied in this chapter. 
 
4.2.2 – Brief Background – SV40, CMV and EF1α promoter 
4.2.2.1 – SV40 early promoter 
The SV40 (Simian virus 40) early promoter originally came from the polyomavirus, 
SV40, which was initially found in Rhesus monkey cells (Eddy et al., 1961; Sweet & 
Hilleman, 1960).  It is responsible for the transcription of so called early genes which 
are expressed soon after productive viral infection and before viral genome replication 
(Wildeman, 1988).  Research on the promoter has been very important in 
understanding eukaryotic transcription (Cooper, 2000; Banerji et al., 1981; Benoist & 
Chambon, 1981) 
The promoter is composed of a TATA box with three 21 bp repeats (GC boxes) and two 
72 bp repeats (also known as the SV40 enhancer) upstream (Byrne et al., 1983).  
However, it has been shown that although the enhancer is essential for good 
transcription from the promoter its position relative to it is not important and can still 
enhance transcription when placed downstream of the promoter and gene CDS 
(Cooper, 2000; Kadesch & Berg, 1986; Berg et al., 1984). 
The SV40 promoter/enhancer has been used for recombinant gene expression in many 
different areas of biological research.  It can function in many different cell lines, gives 
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constitutive expression and although not overall the strongest promoter in terms of 
transcription it still gives relatively good expression.  In the biopharmaceutical industry 
the SV40 promoter is not commonly used to drive expression of a therapeutic protein 
because stronger/better alternatives are available, but it is still used for expression of 
selection genes for the creation of stable cell lines.  For example the GS (glutamate 
synthetase) expression system (Bebbington et al., 1992) (Lonza Biologics, Slough, UK)  
and the MTX (methotrexate) DHFR (dihydrofolate reductase) expression system 
(Kaufman & Sharp, 1982) use the SV40 promoter. 
The SV40 promoter used in this chapter and the rest of this thesis is slightly different 
to the wild-type promoter (figure 4.1 – A. & table 4.1).  It is composed of the three 21 
bp repeats and a TATA box which are upstream of the CDS.  Downstream of the CDS 
there are two 72 bp repeats and another three 21 bp repeats.  The downstream 
elements are in the opposite orientation to the upstream elements of the SV40 
promoter.  This promoter originally came from the pSEAP2-Control vector (Clontech, 
Mountain View, CA, US).   
 
4.2.2.2 – Human CMV major immediate-early promoter 
The human CMV major immediate-early promoter is another commonly used viral 
promoter.  It originates from the human CMV (cytomegalovirus), which is part of the 
herpesviruses family (Jordan, 1983).  In vivo the promoter controls the transcription of 
immediate-early genes of the virus (Stenberg et al., 1985).   
In the virus as well as the core promoter other DNA regulatory sequences exist, such as 
the upstream regulatory sequence, a unique region and a strong enhancer upstream of 
the core promoter followed by the first exon and then intron A downstream (Chapman 
et al., 1991; Nelson et al., 1987; Hennighausen & Fleckenstein, 1986; Boshart et al., 
1985; Stinski & Roehr, 1985). 
The CMV is the most commonly used promoter in the biopharmaceutical industry and 
in customized and commercial vectors due to its constitutive and high expression in 
many cell lines.  In nearly all DNA vectors containing the CMV promoter, they compose 
of at least the strong enhancer upstream of the core promoter which contains a TATA 
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box.  However, different companies and researchers use CMV promoters which also 
contain different combinations of all the other CMV DNA regulatory sequences.  The 
majority of studies using these different combinations only used one or two of the 
sequences as well as different vector backbones, cell lines and reporter proteins and 
therefore the effects are probably cell type specific and also possibly reporter protein 
specific (Mariati et al., 2010; Lee et al., 2007; Xia et al., 2006; Xu et al., 2002; Simari et 
al., 1998; Ghazal & Nelson, 1991; Nelson et al., 1987; Foecking & Hofstetter, 1986). 
The CMV promoter used in this chapter and in the rest of this thesis consists of the 
core promoter and enhancer (figure 4.1 – B. & table 4.1) and this was mainly due to 
the vector where this promoter originated (pcDNA3.1 (+), Life Technologies, Paisley, 
UK).   
 
4.2.2.3 – Human EF1α promoter 
The EF1α promoter is a mammalian promoter and controls the transcription of the 
ubiquitously expressed EF1α (eukaryotic translation elongation factor 1 alpha) (Locus 
tag: RP11-505P4.2) gene which encodes the alpha sub-unit of the elongation factor-1 
complex which delivers aminoacyl tRNAs to ribosomes (Wakabayashiito & Nagata, 
1994; Kim et al., 1990; Mizushima & Nagata, 1990; Uetsuki et al., 1989). 
The EF1α promoter is composed of a TATA box, a 200 bp upstream 5’ flank containing 
two regulatory elements (EFP1 and EFP2) and the downstream first exon and intron of 
the EF1α gene (Wakabayashiito & Nagata, 1994; Mizushima & Nagata, 1990).  These 
elements were found to be essential for promoter activity (Wakabayashiito & Nagata, 
1994).  Another characteristic of this promoter is that it contains a 5’ TOP (5’ terminal 
oligopyrimidine tract) element (Shibui-Nihei et al., 2003; Avni et al., 1997) and it is 
found at the transcriptional start site (beginning of exon 1) (Shibui-Nihei et al., 2003; 
Uetsuki et al., 1989).  A 5’ TOP starts with a cytidine residue, and then between 4 and 
14 pyrimidine residues (Meyuhas, 2000; Avni et al., 1997; Biberman & Meyuhas, 1997).  
The EF1a promoter has a C residue followed by five T’s (Uetsuki et al., 1989).  The 5’ 
TOP forms part of the 5’ cap of the resulting mRNA and it has been shown to be 
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important in translational regulation in a positive cell growth dependent manner 
(Hamilton et al., 2006; Meyuhas, 2000; Biberman & Meyuhas, 1997). 
This promoter, like the CMV, has been shown to give high levels of constitutive 
expression across many mammalian cell lines (Qin et al., 2010; Gopalkrishnan et al., 
1999; Goldman et al., 1996; Mizushima & Nagata, 1990; Uetsuki et al., 1989) and it has 
been used for high level expression of recombinant therapeutic proteins and other 
biotechnology applications.  It is an alternative to the CMV due to its ability to 
maintain its expression for longer time durations in some cell lines were the CMV can 
become silenced (Ramezani et al., 2000; Gopalkrishnan et al., 1999; Nakai et al., 1998; 
Song et al., 1998; Ye et al., 1998; Guo et al., 1996). 
The EF1α promoter (figure 4.1 – C. & table 4.1) was taken from the pEF-GFP vector 
(Plasmid – 11154, http://www.addgene.org/11154/) which was originally constructed 
in the lab of Dr. S. Sugano (University of Tokyo) (Kim et al., 1990). 
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Figure 4.1 – Basic structure of the three promoters used in this chapter.  A. SV40 early promoter – 
The SV40 (Simian virus 40) early promoter is composed of a promoter region (209 bp) downstream of 
the CDS and an upstream enhancer region (246 bp).  The promoter region contains three 21 bp repeats 
followed by a TATA box.  The enhancer region also consists of three 21 bp repeats as well as two 72 bp 
repeats.  The arrows indicate the orientation (5’ → 3’) of the different elements.  This promoter originated 
from the pSEAP2-control vector (Clontech, Mountain View, CA, US).  B. Human CMV major 
immediate-early promoter – The human CMV (Cytomegalovirus) major immediate early promoter (589 
bp) is composed of the strong CMV enhancer region and a TATA box.  This promoter originates from the 
pcDNA3.1 (+) vector (Life Technologies, Paisley, UK).  C. Human EF1α promoter – The human EF1α 
(eukaryotic translation elongation factor 1 alpha) promoter (1189 bp) is composed of a 5’ flank consisting 
of the EFP1 and EFP2 regions, then a TATA box followed by the first exon and the first intron.  At the 
start of exon 1 is a 5’ TOP (5’ terminal oligopyrimidine tract) element.  This promoter originated from the 
pEF1-GFP vector (Plasmid – 11154, http://www.addgene.org/11154/), which was originally constructed 
in the lab of Dr. S. Sugano (University of Tokyo), (Kim et al., 1990). 
 
Table 4.1 – Length and origin of the three promoters studied in this chapter 
Promoter  Length (bp)  Origin 
SV40 early promoter + enhancer  209 + 246 = 455  Viral 
CMV major immediate-early  589  Viral (human) 
EF1α  1189  Mammalian (human) 
Table shows the lengths and origins of the three promoters studied in this chapter.  The SV40 (Simian 
virus 40) early promoter originally came from the pSEAP2-control vector (Clontech, Mountain View, 
CA, US).  The human CMV (Cytomegalovirus) major immediate-early promoter originally came from 
pcDNA3.1(+) vector (Life Technologies, Paisley, UK).  The human EF1α (eukaryotic translation 
elongation factor 1 alpha) promoter originally came from the pEF1-GFP vector (Plasmid – 11154, 
http://www.addgene.org/11154/), which was originally constructed in the lab of Dr. S. Sugano 
(University of Tokyo), (Kim et al., 1990). 
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4.3 – Aims and Objectives 
The expression and interactions of three promoters (SV40, CMV and EF1α) that are 
commonly used in both biotechnology and biopharmaceutical research and production 
are compared.  This was done using two reporter proteins, SEAP and GFP.  These were 
chosen due the main research interest of our lab being biopharmaceutical production.  
Most simple engineering strategies implemented to increase therapeutic recombinant 
protein production involve the expression of a secreted recombinant glycoprotein and 
an intracellular expressed effector protein.  SEAP acts as our model glycoprotein while 
GFP will act as our effector protein.  Although GFP is not actually an effector protein 
per se it is being used because it should not have a dramatic effect on the cellular 
pathways downstream of protein synthesis.  Therefore it should allow us to look more 
directly at the interactions of two promoters in the same system while still being 
relevant to a cell engineering strategy. 
The aims/objectives of this chapter are as follows: 
1. Compare the relative expression of the SV40, CMV and EF1α promoters in CHO-
S cells to see if the results are comparable with those from the literature.  This 
will be done at both the protein and mRNA level 
2. Compare the expression when more than one promoter is co-expressed in the 
same system in different scenarios:-  
a. When SEAP DNA is kept constant but the amount of GFP DNA is titrated 
b. When GFP DNA is kept constant but the amount of SEAP DNA is titrated 
c. When SEAP and GFP DNA are co-expressed at a one-to-one ratio in 
terms of DNA vector copy number.  Comparisons will be made at both 
the protein and mRNA level 
We hope understanding how these promoters effect each other will help us make 
better rational decisions for selecting promoters when the expression of more than 
one recombinant protein is required. 
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4.4 – Materials and Methods 
4.4.1 – Cell line and cell culture 
CHO-S cells (Life Technologies, Paisley, UK) were cultured in Erlenmeyer shake flasks 
(Corning, Surrey, UK) using CD-CHO medium (Gibco®, Life Technologies, Paisley, UK) 
supplemented with 8 mM L-glutamine (Gibco®, Life Technologies, Paisley, UK).  Cells 
were cultured in 125 or 250 mL cap-vented Erlenmeyer flasks in a shaking incubator 
set at 37°C, 5% CO2 and 140 rpm.  Cells were passaged every 3-4 days.  Viability (%) 
and viable cell concentration (cells mL-1) were measured using the Vi-Cell automated 
cell counter (Beckman Coulter, Brea, CA, USA).  The required amount of cells for a 
concentration of 0.2 x106 cells mL-1 in the new culture were centrifuged at 200 g for 5 
minutes.  The old medium was removed and the cells were resuspended in fresh 
medium and added to a new flask.   
 
4.4.2 – DNA vectors used and vector engineering 
Six different reporter vectors were used in this chapter, SV40-SEAP, CMV-SEAP, EF1α-
SEAP, SV40-GFP, CMV-GFP and EF1α-GFP.  The origin and construction of SV40-SEAP, 
CMV-SEAP, SV40-GFP and CMV-GFP were described earlier in chapter 3, section 3.4.2.  
The EF1α-SEAP and EF1α-GFP vectors were created using the respective SV40 vectors.  
The SV40 promoter and enhancer were removed via restriction digest.  The EF1α 
promoter was cloned by PCR from the pEF-GFP vector (Plasmid – 11154, 
http://www.addgene.org/11154/) (Kim et al., 1990) using primers containing 
overhanging restriction digest sites that matched those in the acceptor vector.  After 
restriction digest the PCR fragments were ligated into the SEAP and GFP vectors. 
A control vector was also used for normalising DNA concentrations in all transfections 
as well as acting as a negative control for transfection.  The construction of this vector 
was also described in chapter 3, section 3.4.2. 
Vector DNA was purified using both Miniprep and Maxiprep kits (Qiagen, Manchester, 
UK) according to the supplied protocol.  Vector DNA concentration was measured 
using the NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific, UK). 
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4.4.3 – Transient transfections 
Transfections were carried out on CHO-S cells which had been in culture for at least 2-
3 passages but no longer then 8 weeks.  Transfection was carried out using PEI 
(Polyethylenimine) as the transfection reagent. 
Cells on day 3 of culture were measured for cell concentration and viability.  0.5 mL of 
CHO-S cells at a concentration of 1.0 x 106 cells mL-1 were then plated on a 24 well 
plates (Nunclon™ microwell plates, Thermo Fisher Scientific, UK) in CD-CHO medium 
with 8 mM L-gluatmine.  Plates were then placed in a static incubator at 37°C and 5% 
CO2. 
One to two hours after plating the cells were transfected with vector DNA.  In total 2.0 
µg of DNA was transfected in each well.  The PEI protocol used for transfection was 
developed and optimised in our lab for CHO-S cells by Dr. B. Thompson and Dr. O. 
Mozley.  For each well two tubes were set up.  One containing 6.5 µl of 150 mM NaCl, 
2.35 µl of 300 mM NaCl and 2.35 µl of stock PEI solution (1 mg mL-1 in nuclease-free 
water) (11.2 µl in total).  The other containing 2.0 µg of vector DNA and then made up 
to 22.2 µl using 150 mM NaCl.  The two tubes where then added together and the DNA 
and PEI allowed to complex for one minute before being added to the cells in the 
culture plate.  After DNA addition the plates were gently shook for around one minute 
before returning to the same incubator.  Master mixes were prepared when PEI 
transfections were scaled up for triplicate samples. 
For SEAP vector transfections the culture plates were incubated for 48 hours post 
transfection before removing the samples from the plate and spinning them down (5 
minutes at 200 g) and carefully removing the cell media for further analysis. 
Transfection efficiency based on GFP expression was analysed using the Attune® 
Acoustic Focusing Cytometer and the Attune® Cytometric Software (Life Technologies, 
Paisley, UK). 
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4.4.4 – SEAP analysis 
The AnaSpec SensoLyte® pNPP Secreted Alkaline Phosphatase Reporter Gene Assay Kit 
(*Colorimetric*) (Cambridge Bioscience, Cambridge, UK) was used to quantify SEAP 
protein.  The assay was carried out according to the supplied protocol.  SEAP samples 
were incubated in a water bath at 65 °C for 20 minutes to inactivate endogenous non-
specific alkaline phosphatase. 
 
4.4.5 – Quantifying gene expression by real-time RT-PCR 
Cells were centrifuged at 200 g for 5 minutes and the cell medium was carefully 
removed.  Extraction of mRNA was carried out using the RNeasy® Minikit in 
combination with the QIAShredder homogeniser according to the manufacturers’ 
protocol (Qiagen, Manchester, UK).  
mRNA concentration was measured using the NanoDrop 2000 UV-Vis 
Spectrophotometer (Thermo Scientific, UK). 
The TURBO DNA-freeTM Kit (Applied Biosystems®, Life Technologies) was used to 
remove any contaminating DNA from mRNA samples and was used according to the 
supplied protocol.  After removal of DNA, mRNA concentrations were measured again 
using the NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific, UK). 
mRNA was transcribed into DNA using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems®, Life Technologies) following the manufacturers protocol. 
SEAP mRNA expression was quantified by RT-qPCR using the Applied Biosystems 7500 
Fast Real-Time PCR system (Applied Biosystems®, Life Technologies) using an absolute 
quantification method (Pfaffl et al., 2002).  The SV40-SEAP vector was used as a 
standard. 
SEAP primers were designed against the SEAP coding sequence and used at a 
concentration of 300 nM (SEAP FWD 5’ – CCATATGTGGCTCTGTCCAA – 3’, SEAP REV 5’ 
– GTCTGGAAGTTGCCCTTGAC – 3’). 
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The Power SYBR® Green PCR Mastermix (Applied Biosystems®, Life Technologies) was 
used according to the manufacturer’s instructions.  1 µl of cDNA was added to each 
reaction.  The following PCR cycle program was used: 1. 50°C for 2 minutes; 2. 95°C for 
10 minutes; then 40 repeats of 3. 95°C for 15 seconds then 60°C for 1 minute.  A 
dissociation step was added to the end of procedure to check for the specificity of 
amplification. 
 
4.4.6 – Fitted SEAP inhibition curves 
In section 4.5.3, SEAP titrations are carried out with a fixed amount of a competing GFP 
vector.  The raw data was then used to produce fitted curves using the Michaelis-
Menten equation as a model:- 
V =	
V	[S]
K +	[S]
 
Where V equals the concentration of SEAP protein produced (ng mL-1), S equals the 
amount of SEAP DNA transfected (µg), Vmax is the maximum concentration of SEAP 
protein produced and Km is the amount of transfected SEAP DNA (S) required to 
produce half of the maximum concentration of SEAP protein (half Vmax). 
This was done in Excel using the Solver Add-in program through iterations of changing 
the predicted values of Km and Vmax until the sum of the square differences between 
the calculated and actual SEAP concentrations was at a minimum.  The quality of the fit 
was then analysed by working out the R-squared value between actual and calculated 
SEAP concentrations.  All fits had an R-squared value of ≥ 0.99. 
The predicted Vmax and Km were then used to draw curves in Excel. 
Ki values were calculated from the predicted Km values using the follow equation:- 
K =
K	[I]
K	 − K	
 
Km control is the Km value under control conditions, [I] is the concentration of the 
inhibitor (or competing vector) present and Km inhibitor is the Km value when in the 
presence of the inhibitor (or competing vector). 
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4.5 – Results and Discussion 
4.5.1 – Relative expression of the SV40, CMV and EF1α promoters 
To show the relative strengths of the SV40, CMV and EF1α promoters their 
corresponding SEAP DNA vectors were transfected into CHO-S cells over a range of 
eight different DNA concentrations (0.015625 µg, 0.03125 µg, 0.0625 µg, 0.125 µg, 
0.25 µg, 0.5 µg, 1.0 µg and 2.0 µg) and SEAP protein and mRNA expression measured 
48 hours post-transfection. 
From figure 4.2 and table 4.1 it can be seen that the SV40-SEAP vector produced less 
SEAP protein and mRNA then both the other two vectors across the whole range of 
transfected DNA amounts.  This was expected due the SV40 promoter being known to 
be a weaker promoter then both the CMV and EF1α promoters in many cell lines (Qin 
et al., 2010; Zarrin et al., 1999; Liu et al., 1997; Thompson et al., 1990; Foecking & 
Hofstetter, 1986).  Similar titrations in chapter 3 (figure 3.2) also showed the SV40-
SEAP vector to produce less SEAP protein over a range of transfected DNA amounts 
then the CMV-SEAP vector.  However, the differences seen in expression in this 
chapter were not as large as those seen chapter 3.  This is probably due to both the 
different transfection protocols and the different CHO cell lines used. 
The CMV-SEAP and EF1α-SEAP vectors produced very similar amounts of SEAP protein 
for the majority of DNA concentrations (figure 4.2 – A. & table 4.2).  Only at the lowest 
two DNA amounts did the CMV-SEAP vector produce slightly more than the EF1α-SEAP 
vector.  When looking at the amount of SEAP mRNA produced from vectors containing 
either the CMV or EF1α promoter it can be seen that the CMV produced more mRNA 
at all amounts of transfected DNA then the EF1α (figure 4.2 – B. & table 4.2).  The 
differences in mRNA expression were larger over the range of 0.015625 – 0.125 µg of 
DNA.  For the larger amounts of transfected DNA (≥ 0.25 µg) the differences in SEAP 
mRNA expression became increasingly smaller.  The different patterns seen in mRNA 
expression between CMV-SEAP and EF1α-SEAP compared to SEAP protein expression 
(figure 4.2 – A. & B.) might be due to the differences in mRNA stability or processing 
and this could be caused by the presence of the 5’ TOP element within the EF1α 
promoter (Shibui-Nihei et al., 2003; Avni et al., 1997).   
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These results confirm that the SV40 promoter, as expected, was indeed the weakest of 
the three promoters tested.  It produced the least protein and mRNA across all 
amounts of transfected DNA.  The SEAP protein results for both the CMV and EF1α 
promoter’s vectors were very similar but the CMV promoter did produce more SEAP 
mRNA for most of the transfected amounts of DNA.  Both the CMV and EF1α 
promoters are known to be high expressing promoters so their similarities was not 
unexpected and the differences seen between their SEAP mRNA and protein 
expression may be due to the stability or the processing of the transcripts that each 
promoter produces. 
From this data the three different promoters can be ranked accordingly:- 
• Overall SEAP protein expression – CMV = eEF1a > SV40 
• SEAP mRNA expression – CMV > eEF1a > SV40 
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Figure 4.2 – Comparison of SEAP protein and mRNA expression from SEAP DNA vectors utilising 
three different promoters.
0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg, 1.0 µg and 2.0 µg) of SEAP 
SEAP vectors (● SV40
transiently expressed in CHO
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post-transfection and analysed for SEAP protein
S.D. 
The University of Sheffield 
  A. SEAP protein expression for eight differing amounts (0.015625 µg, 
-SEAP, ▲ EF1α-SEAP, ■ CMV-SEAP) utilising three different promoters 
-S cells.  SEAP protein expression was normalised to the average SEAP 
-SEAP.  B. SEAP mRNA expression for the different SEAP vectors 
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Table 4.2 – SEAP protein and mRNA expression represented as a percentage of the 
measurements for 2.0 µg of transfected CMV-SEAP DNA 
  SEAP DNA vectors 
  SV40-SEAP  EF1α-SEAP  CMV-SEAP 
Amount of DNA  Protein  mRNA  Protein  mRNA  Protein  mRNA 
0.015625 µg  7.9%  1.4%  16.2%  3.6%  19.2%  5.2% 
0.03125 µg  17.3%  3.0%  32.0%  6.3%  41.7%  18.05 
0.0625 µg  31.2%  5.5%  54.4%  12.7%  55.9%  26.6% 
0.125 µg  50.7%  9.5%  71.5%  23.3%  73.3%  43.5% 
0.25 µg  70.3%  13.8%  85.4%  40.4%  85.5%  58.4% 
0.5 µg  82.0%  24.0%  93.7%  58.1%  92.8%  75.1% 
1.0 µg  88.5%  32.8%  97.9%  79.5%  97.6%  91.7% 
2.0 µg  93.1%  53.7%  100.7%  95.7%  100.0%  100.0% 
The numbers in the table represent the percentage of SEAP protein and mRNA expression when 
compared to 2.0 µg of transfected CMV-SEAP DNA.  Calculated using the data in figure 4.2.   
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4.5.2 – Promoter interference between the SV40, CMV and EF1α 
promoters: The effect of titrating GFP vectors utilizing different 
promoters on SEAP protein expression from constant amounts of SEAP 
vectors also utilizing different promoters 
To investigate the effects on expression when more than one promoter is used in the 
same system all combinations of the SEAP and GFP vectors using the different 
promoters were transfected into CHO-S cells.  The amount of SEAP DNA was kept 
constant (0.0625 µg) while the amount of GFP DNA was titrated (0.015625 µg, 0.03125 
µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg, 1.0 µg).  SEAP expression was then measured 
48 hours post-transfection to see the effects of different levels of GFP expression 
driven by different promoters had on SEAP expression.  
 
4.5.2.1 – SV40 promoter 
The SV40-SEAP vector was co-transfected with the SV40-GFP, CMV-GFP and EF1α-GFP 
vectors.  SV40-SEAP was also transfected alone to determine the control level of 
expression in this experiment.  All SEAP measurements where then compared to this 
control. 
Figure 4.3 shows that for all GFP vectors co-transfected with the SV40-SEAP vector 
there were decreases in SEAP expression from the control.  The decreases in SEAP 
protein expression increased with increasing amounts of co-transfected GFP DNA.  GFP 
vectors containing the CMV or EF1α promoters caused the biggest decreases in SEAP 
expression.  For all amounts of co-transfected GFP DNA the CMV and EF1α GFP vectors 
had roughly similar effects.  When these vectors were at a one-to-one ratio to the 
SV40-SEAP vector (in terms of µg’s of DNA) SEAP expression was reduced to about 60% 
of the control.  SEAP had been reduced to around 50% when 0.125 µg of CMV-GFP and 
EF1α-GFP were co-transfected.  For the largest amount of co-transfected GFP (1.0 µg) 
SEAP expression had reduced to around 10-15%. 
Co-expression of the SV40-GFP vector with SV40-SEAP also caused a reduction in SEAP 
protein expression but not to the same extent as that seen for the other two 
promoters (figure 4.3).  SEAP expression was reduced to 90% of the control when 
122 
Nathan West The University of Sheffield 
these vectors were co-transfected at a one-to-one ratio.  A near 50% reduction was 
only seen when 1.0 µg of SV40-GFP DNA was co-transfected.    
From this data we can see that GFP vectors containing either the CMV or EF1α 
promoters had a much greater negative effect on SEAP expression from SV40-SEAP 
vector then the SV40-GFP vector. 
 
 
 Figure 4.3 – The effect of a competing promoter from another vector on the expression of SEAP 
protein from the SV40-SEAP vector.  SEAP expression for a fixed amount of SV40-SEAP DNA 
(0.0625 µg) co-transfected with differing amounts (0.015625 µg, 0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 
µg, 0.5 µg, 1.0 µg) of GFP expressing vectors utilising three different promoters (● SV40-GFP, ▲ EF1α-
GFP, ■ CMV-GFP) in CHO-S cells.  The total amount of transfected DNA was kept consistent in all 
transfections by using the empty –ve control vector.  Cell media was collected 48 hours post-transfection 
and analysed for SEAP protein expression.  All results were normalised to a control sample (0.0625 µg of 
SV40-SEAP co-transfected with –ve control DNA only).  The ratios in grey represent the ratio of SEAP 
DNA to GFP DNA (µg).  N = 3, error bars represent ± 1 S.D. 
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4.5.2.2 – EF1α promoter 
The EF1α-SEAP vector was also co-transfected with the SV40-GFP, CMV-GFP and EF1α-
GFP vectors.  EF1α-SEAP was also transfected alone to determine the control level of 
expression in this experiment.  All SEAP measurements where then compared to this 
control. 
Figure 4.4 shows the effects of co-transfecting different amounts of SV40-GFP, CMV-
GFP and EF1α-GFP on SEAP expression from the EF1α-SEAP vector.  Co-transfection of 
SV40-GFP mostly had no effect on SEAP expression.  For the largest amount of co-
transfected SV40-GFP DNA (1.0 µg), which was 16 times the amount of EF1α-SEAP, 
there was only a reduction to around 90% of the control. 
The results were much more significant when the EF1α-SEAP vector was co-
transfected with GFP vectors utilizing the CMV or EF1α promoter (figure 4.4).  Both the 
CMV-GFP and EF1α-GFP vectors had a similar effect on reducing SEAP expression but 
the CMV-GFP reduced the level of SEAP to a slightly greater extent for every amount of 
co-transfected GFP DNA.  When the CMV-GFP and EF1α-GFP vectors were co-
transfected at a one-to-one ratio with the SEAP vector, SEAP protein expression was 
reduced to around ~78% and ~88%, respectively.  SEAP protein expression was 
reduced to below 50% when 0.5 µg of these two GFP vectors were co-transfected.  
When 1.0 µg of CMV-GFP and EF1α-GFP was co-transfected with EF1α-SEAP, SEAP 
expression dropped to between 20-30%.   
This data shows that a GFP vector containing an SV40 promoter negligible effect on 
SEAP expression from a vector containing an EF1α promoter.  Only when there was 16 
times more GFP DNA then SEAP DNA was there a reduction seen and this was to only 
to around 90% of the control.  GFP vectors utilizing either the CMV or EF1α promoters 
had a much greater effect and were a much more negative influence on SEAP 
expression.  Although CMV and EF1α GFP vectors showed a similar pattern in reducing 
SEAP expression the CMV-GFP vector generally affected SEAP slightly more for all co-
transfected amounts of GFP DNA.   
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The results in figure 4.4 and 4.3 have similar patterns in so much as the SV40 promoter 
had the least negative effects while the CMV and EF1α promoters had similar effects 
with the CMV-GFP reducing SEAP expression slightly more than EF1α-GFP. 
 
 
Figure 4.4 – The effect of a competing promoter from another vector on the expression of SEAP 
protein from the EF1α-SEAP vector.  SEAP expression for a fixed amount of EF1α-SEAP DNA 
(0.0625 µg) co-transfected with differing amounts (0.015625 µg, 0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 
µg, 0.5 µg, 1.0 µg) of GFP expressing vectors utilising three different promoters (● SV40-GFP, ▲ EF1α-
GFP, ■ CMV-GFP) in CHO-S cells.  The total amount of transfected DNA was kept consistent in all 
transfections by using the empty –ve control vector.  Cell media was collected 48 hours post-transfection 
and analysed for SEAP protein expression.  All results were normalised to a control sample (0.0625 µg of 
EF1α-SEAP co-transfected with –ve control DNA only).  The ratios in grey represent the ratio of SEAP 
DNA to GFP DNA (µg).  N = 3, error bars represent ± 1 S.D. 
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4.5.2.3 – CMV promoter 
The SV40-GFP, CMV-GFP and EF1α-GFP vectors were co-transfected with the CMV-
SEAP vector.  CMV-SEAP was also transfected alone to determine the control level of 
expression in this experiment.  All SEAP measurements where then compared to this 
control. 
Figure 4.5 shows the effects of co-transfecting the three GFP vectors on SEAP 
expression from CMV-SEAP.  Similar to the EF1α-SEAP vector (figure 4.4) the SV40-GFP 
vector had no negative effect on SEAP expression from CMV-SEAP across the whole 
range of DNA amounts co-transfected.   
Co-transfection of CMV-GFP and EF1α-GFP vectors again had negative effects on SEAP 
expression (figure 4.5).  Both GFP vectors had similar effects on SEAP expression from 
the CMV-SEAP vector from the lowest amount of co-transfected DNA to 0.0625 µg 
DNA.  At this one-to-one ratio SEAP expression was around 90% of the control.  After 
this, although both the CMV and EF1α GFP vectors still had negative effects, the levels 
of reduction in SEAP expression significantly diverged between these two vectors.  A 
~50% reduction in SEAP was achieved when 0.5 µg of CMV-GFP DNA was co-
transfected and this decreased to around 25% when 1.0 µg was co-transfected.  The 
results of CMV-GFP co-transfection with CMV-SEAP were quite similar to the results for 
EF1α-SEAP and CMV-GFP in figure 4.4.  When more than 0.0625 µg of EF1α-GFP DNA 
was co-transfected with CMV-SEAP (figure 4.5) there was less negative effect when 
compared to CMV-GFP.  SEAP expression did not drop below 50% for any amount of 
co-transfected EF1α-GFP.  When the largest amount of EF1α-GFP (1.0 µg) was co-
expressed SEAP expression was around 60% of the control. 
In summary the results from figure 4.5 showed that SV40-GFP had no effect on SEAP 
expression while EF1α-GFP did it was not to the same extent as the GFP vector utilizing 
the CMV promoter. 
In comparison to results in figures 4.3 and 4.4 the SV40-GFP vector again had the least 
negative effects on SEAP expression.  GFP vectors containing CMV and EF1α promoters 
had more of negative effects but this time the CMV-GFP vector decreased SEAP 
expression more significantly then EF1α-GFP. 
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Figure 4.5 – The effect of a competing promoter from another vector on the expression of SEAP 
protein from the CMV-SEAP vector.  SEAP expression for a fixed amount of CMV-SEAP DNA 
(0.0625 µg) co-transfected with differing amounts (0.015625 µg, 0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 
µg, 0.5 µg, 1.0 µg) of GFP expressing vectors utilising three different promoters (● SV40-GFP, ▲ EF1α-
GFP, ■ CMV-GFP) in CHO-S cells.  The total amount of transfected DNA was kept consistent in all 
transfections by using the empty –ve control vector.  Cell media was collected 48 hours post-transfection 
and analysed for SEAP protein expression.  All results were normalised to a control sample (0.0625 µg of 
CMV-SEAP co-transfected with –ve control DNA only).  The ratios in grey represent the ratio of SEAP 
DNA to GFP DNA (µg).  N = 3, error bars represent ± 1 S.D. 
 
4.5.2.4 – Comparisons and conclusions 
Table 4.3 shows the collated results from figure 4.3, 4.4 and 4.5 in terms of fold change 
from their control.  From these set of experiments we can see that expression of SEAP 
was most negatively affected by a competing vector/promoter when it was under the 
control of the SV40 promoter.  All three GFP vectors significantly affected SEAP 
expression but there was a clear difference between the effects of SV40-GFP and both 
CMV-GFP and EF1α-GFP across the whole range of co-transfected DNA amounts.  
When the GFP vectors were titrated against the EF1α-SEAP and CMV-SEAP vectors only 
the CMV and EF1α GFP vectors caused a significant reduction in SEAP expression.  The 
SV40-GFP had very little negative effects on SEAP expression from the EF1α vector and 
no negative effects on the CMV-SEAP vector.  Both the CMV-GFP and EF1α-GFP vectors 
negatively affected SEAP in similar ways for both SV40-SEAP and EF1α-SEAP but this 
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was not the case when co-transfected with CMV-SEAP.  The CMV-GFP vector had 
greater negative effects on CMV-SEAP expression with increasing amounts of GFP DNA 
when compared to EF1α-GFP. 
This fits in with the strengths of the promoters used.  In figure 4.2 it was shown that 
for the same amount of DNA (0.0625 µg) the SV40 vector produced around half the 
amount of SEAP protein (~57%) then that of the CMV and EF1α SEAP vectors which 
had very similar expression.  Greater differences were seen when the levels of mRNA 
were measured with SV40 producing around 20% and EF1α producing ~50% of that 
produced from the CMV-SEAP vector. 
The different results seen when co-transfecting the GFP vectors utilizing different 
promoters is the interesting result, but when the amount of SEAP DNA is kept constant 
it is not unexpected that increasing the amount of a competing vector has a negative 
effect on SEAP expression.  However, to show that these results are not simply due to 
increasing the amount of co-transfected GFP DNA we also need to look at the effects 
of a constant amount of co-transfected GFP DNA on a range of SEAP DNA amounts.  
This is carried out in the next section. 
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4.5.3 – Promoter interference between the SV40, CMV and EF1α 
promoters: The effect of a fixed amount of GFP DNA from vectors 
utilizing different promoters on SEAP titration curves 
In the last set of experiments it was seen that with increasing the amount of a 
competing vector/promoter that SEAP expression would decrease.  Although this 
result was not unexpected, it was the different responses seen depending on the two 
promoters present that was the interesting result.  To further investigate the effects of 
two competing promoters and to show it is not just an effect of increasing the amount 
of GFP vector present we kept GFP DNA constant (0.25 µg) while titrating the amount 
of SEAP DNA (0.015625 µg, 0.03125 µg, 0.0625 µg, 0.125 µg, 0.25 µg, 0.5 µg, 1.0 µg 
and 1.75 µg) similar to section 4.5.1, figure 4.2.  The same combinations of co-
transfected GFP and SEAP vectors as in section 4.5.2 were used. 
The results in section 4.5.1 (figure 4.2) seemed to resemble curves for enzymatic 
reactions.  Due to this similarity, the new curves produced in this section were treated 
as such and the competing GFP vectors considered inhibitors.  The raw data generated 
was used to produce fitted curves using the Michaelis-Menten equation as a model 
(see section 4.4.6 for a description of this was done).  This allowed us to make 
estimates for Km (concentration required for half the maximum expression) values and 
allow us to compare the effect of different GFP vectors with different competing 
promoters on SEAP expression.  Lineweaver-Burk (LB) plots were also made (by 
plotting the reciprocals of both DNA concentration and SEAP expression against each 
other) for further graphical representation of the effects of GFP vectors and the 
different promoters utilized.  Ki values were also calculated and these reflect the level 
of inhibition a GFP vector has on a SEAP vector allowing for further comparison of the 
effects of the different promoters. 
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4.5.3.1 – SV40 promoter 
Figure 4.6 shows the effects of co-transfecting a fixed amount (0.25 µg) of SV40-GFP, 
CMV-GFP and EF1α-GFP on titrations of SV40-SEAP DNA.  All three GFP vectors caused 
a change in the shape of the fitted curves when compared to the control (figure 4.6 – 
A.).  Co-expression of the CMV-GFP vector caused the biggest shift in the curve by 
reducing the amount of SEAP produced for all transfected amounts when compared to 
the control.  EF1α-GFP also caused a shift in the curve but not to the same extent as 
CMV-GFP while SV40-GFP had the least effect of all of the GFP vectors.   
These results correlate with those in the previous section (4.5.2.1) that GFP vectors 
containing CMV and EF1α promoters had the greatest negative impact on SEAP 
expression from a vector utilizing the SV40 promoter.  The LB plots (figure 4.6 – B.) also 
show that co-transfection of CMV-GFP caused the greatest inhibition on SEAP 
expression from the SV40-SEAP vector, EF1α-GFP the second greatest level of 
inhibition and SV40-GFP the least.  This plot also suggests that competitive inhibition 
between the vectors/promoters is occurring due to the fact that lines differ in their 
steepness but all cross the y axis at the same point.  However, the LB plot has 
limitations and it cannot be used as proof of competitive inhibition. 
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Figure 4.6 – Fitted plots showing the effect of competing promoters on SEAP protein expression 
from the SV40-SEAP vector.
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4.5.3.2 – EF1α promoter 
As with the SV40-SEAP vector the three GFP vectors were then co-transfected with the 
EF1α-SEAP vector.  Figure 4.7 shows the results and it can be seen that the CMV-GFP 
again had biggest effect of inhibiting SEAP expression, EF1α-GFP the second and SV40-
GFP has the least effect on SEAP expression.  The shifts in the curves (figure 4.7 – A.) 
were not as pronounced as those seen for the SEAP vector utilizing the weaker SV40 
promoter (figure 4.6 – A.). 
Again the levels of reduction in SEAP expression for the GFP vectors using the three 
different promoters match what has previously been shown in this chapter.  The LB 
plot (figure 4.7 – B.), presents the data in another graphical form to show that the CMV 
driven GFP vector had the greatest effect of inhibiting SEAP expression followed by the 
EF1α driven GFP vector and then the SV40.  The changes in steepness of the lines in 
the LB plot (figure 4.6 – B.) were not as great as those seen for the SV40-SEAP vector 
(figure 4.6 – B.). 
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Figure 4.7 – Fitted plots showing the effect of competing promoters on SEA
from the EF1α-SEAP vector.
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4.5.3.3 – CMV promoter 
Figure 4.8 shows the effects of co-transfecting a fixed amount (0.25 µg) of SV40-GFP, 
CMV-GFP and EF1α-GFP on titrations of CMV-SEAP DNA.  Again the CMV-GFP vector 
had the greatest negative impact on SEAP expression, but this time both the GFP 
vectors using the EF1α and SV40 promoter had little to no effect (figure 4.8).  The shift 
in the curve caused by co-transfection of CMV-GFP (figure 4.8 – A.) was to a smaller 
extent when compared to the effect of CMV-GFP on the other two SEAP vectors (figure 
4.6 & 4.7). 
As for both the other two SEAP plasmids the results for this experiment using CMV-
SEAP match what has been previously been shown in this chapter.  Namely, that a 
larger negative effect on SEAP expression is seen when a GFP vector utilizing a CMV 
promoter is co-transfected then with the SV40 and EF1α promoters.  The LB plot for 
CMV-SEAP shows this as well (figure 4.8 – B.).  Conversely, this data also shows that a 
SEAP vector utilizing a CMV promoter is less prone to having its expression effected 
then the SV40 and EF1α promoters.  Which makes sense since any interaction between 
the SEAP and GFP vectors will occur in both directions, i.e. – CMV-SEAP will also be 
effecting the expression of competing GFP vectors. 
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Figure 4.8 – Fitted plots showing the effect of competing promoters on SEA
from the CMV-SEAP vector.
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4.5.3.4 – Comparisons and conclusions 
Table 4.4 shows the fold changes, when compared to their respective controls, in the 
estimated Km values from the fitted data presented in figures 4.6, 4.7 and 4.8.  The Km 
in this situation is the amount of SEAP DNA required to produce half the maximum 
SEAP protein expression (Vmax) for each individual SEAP expression vector.  This is 
another way to show how the SEAP titration curves changed when a competing GFP 
vector was co-transfected.  From table 4.4, we can see that the presence of CMV-GFP 
brought about the biggest fold changes in Km for all three SEAP vectors used while 
SV40-GFP had the least effect. 
Estimated Ki values were also calculated from the fitted data presented in figures 4.6, 
4.7 and 4.8 and are shown in table 4.5.  The Ki value reflects the level of inhibition that 
a competing GFP vector has on a SEAP vector.  The lower the Ki value the greater the 
level of inhibition.  For both the SV40-SEAP and EF1α-SEAP vectors the Ki values for 
each respective competing GFP vector were roughly similar with the SV40-GFP vector 
having the highest Ki value and CMV-GFP having the lowest.  For the CMV-SEAP vector 
the Ki values for all GFP vectors were higher than for the other two SEAP vectors but 
again the SV40-GFP vector had the highest Ki while the CMV-GFP vector had the 
lowest. 
The work so far suggests that a vector containing a CMV promoter has a greater 
negative influence on the expression of a competing vector when compared to both 
the EF1α and SV40 promoter.  In turn, the EF1α promoter has a greater negative 
influence when compared to the SV40 promoter.  The level of this negative 
interference could be due to the strengths of the promoters.  From figure 4.2 – B., it 
was shown that the CMV-SEAP vector generally produced more mRNA then EF1α-SEAP 
which produced more than the SV40-SEAP vector.  Since it is the promoters in these 
vectors that control transcription and therefore mRNA production from the vectors the 
CMV can be seen as the strongest in terms of transcriptional activity.  Therefore, it is 
likely to out-compete transcriptionally weaker promoters for important factors which 
are needed for transcription.  These include things such as general transcription 
factors, shared activating transcription factors and RNAP II (RNA polymerase II).  Some 
of these factors may only be present in limited amounts and if a stronger promoter is 
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better at recruiting these then there will be less left for a weaker promoter and 
transcription from this promoter may be lower than it would be when it is present by 
itself. 
Although all the evidence so far points to the CMV promoter being the most 
interfering promoter of the three promoters used in this chapter we should also 
consider that all the vectors are not the same length (in bp), meaning that although 
the same amount in micrograms of each vector has been used in all related 
experiments if the co-expressed SEAP and GFP vectors differ in size there will not be 
equal numbers in terms of DNA vector copy number.  This will have an effect on 
competition between two vector/promoters.  In the next section this is taken into 
account and the GFP and SEAP vectors are co-transfected at a 1:1 ratio in terms of DNA 
vector copy number. 
Table 4.4 – Summary of the fold change in the estimated Km values from the results in 
figures 4.6, 4.7 and 4.8 
  SEAP vectors 
GFP vectors  SV40-SEAP  eEF1a-SEAP  CMV-SEAP 
SV40-GFP 
 
+1.35 
 
+1.33 
 
+1.02 
eEF1a-GFP 
 
+2.59 
 
+2.39 
 
+1.20 
CMV-GFP 
 
+3.19 
 
+3.08 
 
+1.77 
The numbers in the table represent the fold change in estimated Km values compared to the control sample 
of the respective SEAP vectors.  The fold changes come from the data for figures 4.6 (SV40-SEAP), 4.7 
(EF1α-SEAP) and 4.8 (CMV-SEAP). 
 
 
Table 4.5 – Estimated Ki values from the results in figures 4.6, 4.7 and 4.8 
  SEAP vectors 
GFP vectors  SV40-SEAP  eEF1a-SEAP  CMV-SEAP 
SV40-GFP 
 
0.71 
 
0.75 
 
10.35 
eEF1a-GFP 
 
0.16 
 
0.18 
 
1.27 
CMV-GFP 
 
0.11 
 
0.12 
 
0.32 
Estimated Ki values from the results presented in figures 4.6 (SV40-SEAP), 4.7 (EF1α-SEAP) and 4.8 
(CMV-SEAP). 
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4.5.4 – Promoter interference between the SV40, CMV and EF1α 
promoters: The effect on SEAP expression of a competing promoter 
when SEAP and GFP vectors utilizing different promoter combinations 
are co-expressed at a one-to-one ratio in terms of vector copy number 
Table 4.6 shows the lengths of the different SEAP and GFP vectors used in this chapter.  
From the table we can see that the longest GFP and SEAP vectors both contain the 
EF1α promoter and the shortest both contain the CMV promoter.  At the end of the 
last section, we mentioned that the lengths of the vectors may have an impact in 
terms of the number of copies of each vector being transfected and how this could 
have an effect on competition between two vectors in the same system.  In this 
section, we account for this and transfect SEAP and GFP vectors at a one-to-one ratio 
in terms of DNA vector copy number.   
The amount in micrograms for 1.66 x 1011 copies of each SEAP and GFP vector was 
worked out by rearranging the following equation :- 
Equation 5.1 
 
Number	of	DNA	vector	copies =
(amount	of	vector	(ng+ × (6.022 × 1023++
(length	of	vector	(bp+ × (1 × 106+ × 650+
	 
 
6.022 x 1023 = Avogadro’s number, 1 x 109 = conversion to ng and 650 = one mole of bp equals 650 g 
(the average weight of a single bp equals 650 Daltons) 
 
Using the amounts that were calculated for 1.66 x 1011 copies of each vector all the 
SEAP vectors were co-transfected with every GFP vector as in the previous sections.  
48 hours post-transfection media and cell samples were collected for analysis of SEAP 
protein and mRNA expression.  SEAP mRNA was also analysed during this experiment 
to see what effect a competing vector/promoter had on transcription and not just 
solely on SEAP protein expression. 
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Table 4.6 – Length in base pairs (bp) of the SEAP and GFP vectors used in this chapter 
SEAP expression vectors  GFP expression vectors 
Vector  Length in bp  Vector  Length in bp 
CMV-SEAP  5045  CMV-GFP  4347 
SV40-SEAP  5115  SV40-GFP  4409 
EF1α-SEAP  5596  EF1α-GFP  4898 
Numbers in the table represent the length in base pairs (bp) of the different DNA expression vectors. 
4.5.4.1 – SV40 promoter 
Figure 4.9 shows the effect on SEAP protein and mRNA expression from the SV40-SEAP 
vector when co-expressed at a 1:1 ratio, in terms of vector copy number, with SV40-
GFP, CMV-GFP and EF1α-GFP.  Co-transfection of SV40-GFP had no effect on SEAP 
protein, while both EF1α-GFP and CMV-GFP had both significantly reduced it 
compared to the control.  CMV-GFP reduced SEAP protein expression slightly more 
than EF1α-GFP, about ~67% and ~77% compared to the control respectively. 
All three GFP vectors significantly reduced SEAP mRNA expression when compared to 
the control.  SV40-GFP reduced it to ~77% of the control, EF1α-GFP reduced it to ~27% 
and CMV-GFP reduced it to ~19% (figure 4.9).  From this we can see that the 
reductions in SEAP mRNA are much greater but that this is not translated directly to 
the amount SEAP protein produced. 
In comparisons to the previous work in this chapter SEAP expression from the SV40-
SEAP vector was again most negatively affected by the co-transfection of the CMV-GFP 
vector, closely followed by the EF1α-GFP vector and least affected by the SV40-GFP. 
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Figure 4.9 – Graph showing the effect on SEAP protein and mRNA expression from the SV40-
SEAP vector when co-transfected at a 1:1 ratio (vector copy number) with three different GFP 
vectors.  The effects of co-transfection of SV40, EF1α and CMV-GFP with the SV40-SEAP vector at a 
1:1 ratio in CHO-S cells.  The 1:1 ratio is in terms of DNA vector copy number rather than total amount 
of DNA in µg’s.  1.66 x 1011 copies of the SEAP and GFP DNA vectors were used.  The total amount of 
transfected DNA was still, however, kept consistent in all transfections by using the empty –ve control 
vector.  Cell media was collected 48 hours post-transfection and analysed for SEAP protein expression.  
All results were normalised to the control sample.  Mean values significantly different (Dunnett’s test) 
from their control are indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).    N = 3, error bars 
represent + 1 S.D. 
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4.5.4.2 – EF1α promoter 
The SV40-GFP, CMV-GFP and EF1α-GFP vectors were this time co-transfected at a one-
to-one ratio with EF1α-SEAP.  Figure 4.10 shows the effects of these GFP vectors on 
SEAP protein and mRNA expression.  Only the CMV-GFP vector caused a significant 
decrease in SEAP protein expression but this was only a ~8% decrease from the 
control.  Neither GFP vector containing the SV40 or EF1α promoter had any significant 
effect on SEAP protein expression from the EF1α-SEAP vector. 
The results for SEAP mRNA were quite different from the protein results (figure 4.10).  
This time all three GFP vectors caused a significant and large reduction relative to the 
protein results.  The CMV-GFP vector reduced mRNA expression the most too around 
34% of the control.  SEAP mRNA was reduced to ~45% by the EF1α-GFP vector and to 
around 77% of the control for SV40-GFP.  This correlates with the results for SV40-
SEAP (figure 4.9) in that the order of GFP vectors effecting SEAP mRNA expression the 
greatest was the CMV then EF1α and then the SV40-GFP vector.  Also it showed again 
that the effects on SEAP mRNA are not necessarily translated to the protein expression 
level. 
Compared to the SV40-SEAP vector (figure 4.9) all GFP vectors had a less negative 
effect on SEAP protein/mRNA expression from the EF1α-SEAP vector.  This correlates 
with the rest of the work carried out previously in this chapter. 
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Figure 4.10 – Graph showing the effect on SEAP protein and mRNA expression from the EF1α-
SEAP vector when co-transfected at a 1:1 ratio (vector copy number) with three different GFP 
vectors.  The effects of co-transfection of SV40, EF1α and CMV-GFP with the EF1α-SEAP vector at a 
1:1 ratio in CHO-S cells.  The 1:1 ratio is in terms of DNA vector copy number rather than total amount 
of DNA in µg’s.  1.66 x 1011 copies of the SEAP and GFP DNA vectors were used.  The total amount of 
transfected DNA was still, however, kept consistent in all transfections by using the empty –ve control 
vector.  Cell media was collected 48 hours post-transfection and analysed for SEAP protein expression.  
All results were normalised to the control sample.  Mean values significantly different (Dunnett’s test) 
from their control are indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).    N = 3, error bars 
represent + 1 S.D. 
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4.5.4.3 – CMV promoter 
Again the three GFP vectors utilizing the SV40, CMV and EF1α promoters were co-
transfected at a one-to-one ratio but this time with the CMV-SEAP DNA vector.  The 
results are shown in figure 4.11.  We can see that none of the GFP vectors had any 
significant effect on SEAP protein expression. 
When looking at the results for SEAP mRNA, the SV40-GFP vector had no negative 
effect on mRNA expression from the CMV-SEAP vector (figure 4.11).  The CMV-GFP 
vector did cause a significant decrease in SEAP mRNA and reduced it to ~66% of the 
control.  When the EF1α-GFP vector was co-transfected SEAP mRNA was reduced, 
although it was not found to be statistically significant, to around 87% of the control.  
Again this is similar to the results for the other two SEAP vector in so much as the 
SV40-GFP vector has the least negative effect on SEAP mRNA expression and the CMV-
GFP vector the most.  We can also see once again that reductions in SEAP mRNA were 
not translated to the protein level. 
When compared to the results for both SV40-SEAP (figure 4.9) and EF1α-SEAP (figure 
4.10) we can see that the effects of a co-transfected GFP vector had less of a negative 
impact on SEAP expression from the CMV-SEAP vector especially in regards to SEAP 
mRNA (figure 4.11).  
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Figure 4.11 – Graph showing the effect on SEAP protein and mRNA expression from the CMV-
SEAP vector when co-transfected at a 1:1 ratio (vector copy number) with three different GFP 
vectors.  The effects of co-transfection of SV40, EF1α and CMV-GFP with the CMV-SEAP vector at a 
1:1 ratio in CHO-S cells.  The 1:1 ratio is in terms of DNA vector copy number rather than total amount 
of DNA in µg’s.  1.66 x 1011 copies of the SEAP and GFP DNA vectors were used.  The total amount of 
transfected DNA was still, however, kept consistent in all transfections by using the empty –ve control 
vector.  Cell media was collected 48 hours post-transfection and analysed for SEAP protein expression.  
All results were normalised to the control sample.  Mean values significantly different (Dunnett’s test) 
from their control are indicated by asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).    N = 3, error bars 
represent + 1 S.D. 
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4.5.4.4 – Comparisons and conclusions 
Table 4.7 collates the results of figure 4.9, 4.10 and 4.11 and shows them as a fold 
decrease from their respective control.  This again shows how in this experiment that 
the GFP vector containing the CMV promoter had the most negative effect on both 
SEAP protein and mRNA expression from all the SEAP vectors while the SV40-GFP 
vector had the least effect.  The CMV-GFP vector also had a much greater effect on 
expression from the SV40-SEAP vector then on the other two SEAP vectors as well as 
having a greater effect than the other two GFP vectors.  This pattern of negative 
interference has been seen in the other sections of this chapter. 
Interestingly, apart from the SV40-SEAP vector the effects on SEAP protein expression 
were not as great as was expected.  Figure 4.12 and table 4.8 show side-by-side 
comparisons of SEAP protein expression from figures 4.3-4.5 when SEAP and GFP 
vectors were co-transfected in equal amounts of DNA in terms of mass compared with 
those from figures 4.9-4.11 when they were co-transfected in equal amounts 
(equimolar) in terms of vector copy number.  When the SEAP vectors were co-
transfected with an equal mass of GFP vectors there was a greater decrease in SEAP 
expression across all combinations then when compared with the results for equal 
vector copy numbers.  The most probable explanation for this is that for all equal mass 
co-transfections there was more GFP vector present in terms of vector copy number 
than SEAP vector (see numbers in the brackets in table 4.8).  This is due to all the GFP 
vectors being smaller in terms of the number of bp’s than all SEAP vectors (table 4.6).  
It would be expected that having more copies of a vector present, it would compete 
more and have a greater effect on SEAP protein expression.  This fits in with the full 
results from figures 4.3-4.5 and table 4.3, were increasing masses of GFP DNA had 
increasing effects on SEAP expression.  It would be expected that as you change the 
amount in terms of mass of both SEAP and GFP vectors and also there ratio in terms of 
vector copy number that the effects of a competing GFP vector on SEAP expression 
would change.  Although we would still expect that a CMV promoter would have a 
greater negative impact than the other two promoters under comparable conditions. 
Even though in figures 4.9-4.11 there were smaller or no decreases in SEAP protein 
expression compared with figures 4.3-4.5, there were significant decreases in SEAP 
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mRNA expression.  Possible explanations why these decreases in mRNA were not 
translated into decreases in protein could be that for both the CMV and EF1α 
promoters there is an excess production of mRNA which is not being actively 
translated or produces an excess of nascent protein and that the post-translational 
machinery is limiting the quantity of fully mature protein being produced.  Even when 
the amount of mRNA production from the SEAP vectors utilizing these promoters is 
reduced it may reduce the amount of excess mRNA rather than the mRNA that is being 
actively translated or reduce the amount of excess nascent protein.  It is has been 
shown previously that translational/post-translational mechanisms can be become 
limiting in a transient expression system (Mason et al., 2012) but from our data we 
cannot say for certain whether this occurred in this case. 
Alternatively the SV40 promoter is weaker and produces less mRNA and possibly 
produces either no excess or a smaller amount of excess mRNA or nascent protein 
then the other promoters.  Its SEAP mRNA expression is also more negatively affected 
by the competing GFP vectors and therefore, it is more likely that the amount of SEAP 
mRNA available for translation is decreased and becomes a limiting factor for SEAP 
protein expression when compared to the other promoters.   
In summary, from this section we can see that once again, as in other sections in this 
chapter that the GFP vectors containing the CMV promoter has the most negative 
effects on a competing vector and that SV40-GFP had the least.  Expression from the 
SV40-SEAP was the most negatively affected by all GFP vectors and CMV-SEAP the 
least affected.  Changes in SEAP protein expression were not as large as those seen in 
other sections in this chapter however decreases in SEAP mRNA expression did follow 
a similar pattern to the previous SEAP protein results. 
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Table 4.7 – Fold decrease in SEAP protein and mRNA expression when SEAP and GFP 
vectors are co-transfected at a one-to-one ratio in terms of DNA vector copy number 
  SV40-SEAP  EF1α-SEAP  CMV-SEAP 
GFP vector  Protein  mRNA  Protein  mRNA  Protein  mRNA 
SV40  -  -1.31  -  -1.30  -  - 
EF1α  -1.31  -3.71  -  -2.21  -  -1.15 
CMV  -1.49  -5.15  -1.08  -2.98  -  -1.52 
The numbers in the table represent the fold decrease in SEAP protein and mRNA expression when 
compared to the control for the respective SEAP vector.  SEAP and GFP vectors were co-transfected at a 
one-to-one ratio in terms of DNA vector copy number (1.66 x 1011 copies of each vector).  Fold changes 
come from the data in figures 4.9 (SV40-SEAP), 4.10 (EF1α-SEAP) and 4.11 (CMV-SEAP).. 
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Table 4.8 – Side-by-side comparison of the fold change in SEAP expression when the three 
SEAP vectors are each co-transfected at a one-to-one ratio with the three GFP vectors in terms 
of both the amount of DNA in mass and vector copy number 
  SV40-SEAP  EF1α-SEAP  CMV-SEAP 
GFP 
vector 
 Equal mass  
Equi-
molar 
 Equal mass  
Equi-
molar 
 Equal mass  
Equi-
molar 
SV40  -1.12 (1.16)  -  - (1.27)  -  - (1.14)  - 
EF1α  -1.53 (1.04)  -1.31  -1.14 (1.14)  -  -1.11 (1.03)  - 
CMV  -1.76 (1.18)  -1.49  -1.29 (1.29)  -1.08  -1.10 (1.16)  - 
The numbers in the table represent the fold decrease in SEAP protein expression when compared to the 
control for the respective SEAP vector.  Fold changes come from the data collated in figure 4.12 and from 
figures 4.3 & 4.9 (SV40-SEAP), 4.4 & 4.10 (EF1α-SEAP) and 4.5 & 4.11 (CMV-SEAP).  SEAP and 
GFP vectors were co-transfected at a one-to-one ratio in terms of both DNA mass (0.0625 µg – equal 
mass)) and vector copy number (1.66 x 1011 copies of each vector - equimolar).  For equal mass the 
numbers in the brackets represent how much extra GFP vector was co-transfected in terms of DNA vector 
copy number.  In all equal mass instances more GFP vector was transfected than SEAP vector due to the 
all GFP vectors being smaller in terms of the number of bp’s than the all the SEAP vectors. 
 
 
 
 
 
 
 
 
 
150 
Nathan West The University Of Sheffield 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
151 
Nathan West The University Of Sheffield 
4.6 – Further Discussion, Final Conclusions and Future 
Directions 
4.6.1 – Further discussion 
The results at the beginning of this chapter (figure 4.2 & table 4.2) looked at the 
relative strengths of the three promoters used.  We saw that both SEAP vectors 
utilizing the CMV and EF1α promoters produce similar amounts of SEAP protein across 
a range of transfected DNA amounts.  This was greater than was seen for a SEAP vector 
using the SV40 promoter.  The SEAP mRNA expression for the same range of 
transfected DNA amounts painted a slightly different picture in so much that the SEAP 
vectors using the CMV and EF1α promoters were not as equal anymore with the vector 
containing a CMV promoter producing more SEAP mRNA for the majority of 
transfected DNA amounts. The SV40 promoter vector produced lower amounts of 
SEAP mRNA then both the other two promoters.  SEAP mRNA expression had a much 
more linear relationship across the whole range of increasing DNA amounts then SEAP 
vectors using the CMV and EF1α promoters.  The differences in SEAP mRNA expression 
seen between the three different promoters are not reflected completely by the levels 
of SEAP protein expression.  This shows that increases in mRNA are not always 
followed by equal increases in expression of the protein.  This could possibly be due to 
the capacity of these CHO-S cells to produce more mRNA being greater than their 
capacity to produce more protein when both systems are pushed to their functional 
limits. 
Another possible reason that the differences in SEAP mRNA between the different 
promoters were not reflected at the protein level could be differences in the mRNA 
transcripts that they each produce.  While each promoter produces mRNA that is 
translated into SEAP protein and all three mRNAs will have the same Kozak sequence 
(important in initiation of translation) and polyadenylation signal (3’ end of the mRNA), 
all of which are important for further processing of mRNA, their 5’ ends do differ.  The 
5’ end of eukaryotic mRNA usually has a 5’ cap (RNAP II transcripts) which is important 
for creating mature mRNA as well as nuclear export, prevention of mRNA degradation, 
5’ proximal intron excision and promotion of translation (Cowling, 2010; Shuman, 
2002; Shatkin & Manley, 2000).  As mentioned earlier the EF1α promoter produces 
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mRNA with a 5’ TOP element at the 5’ cap and therefore can be called a TOP mRNA 
(Shibui-Nihei et al., 2003; Avni et al., 1997; Uetsuki et al., 1989).  The translation of 
TOP mRNA is thought to be somewhat dependent on the growth state of the cell.  TOP 
mRNA, unlike non-TOP mRNA, show an association with sub-polysomes in non-growing 
cells and polysomes in growing cells, meaning TOP mRNA is more actively translated in 
growing cells (Hamilton et al., 2006).  Therefore SEAP mRNA from the EF1α-SEAP 
vector will be processed differently by the cell when compared to SEAP mRNA from 
the SV40 and CMV-SEAP vectors.  This may possibly explain why the CMV-SEAP and 
EF1α-SEAP vectors produced similar levels of SEAP protein even though their levels of 
SEAP mRNA expression differed.   
Even though both the SV40 and CMV promoters do not produce TOP mRNA the 5’ 
ends of the SEAP mRNA they produce will still differ from each other.  The information 
sheet for pSEAP2-Control (Clontech, Mountain View, CA, US) states there are four 
major transcriptional start points for the SV40 promoter (Khalili et al., 1986) in this 
vector while information for the CMV promoter (GenBank: X03922.1) only suggests 
one major transcriptional start point.  This will have an effect on the mRNA produced 
with the SV40 promoter possibly producing multiple mRNA with slightly different 5’ 
sequences and the CMV promoter possibly producing SEAP mRNA with a more 
consistent 5’ sequence.  This might have an effect on both transcription and processing 
of the mRNA produced from the SV40 and CMV promoters and why the larger 
differences in SEAP mRNA expression between the two promoters is not reflected in 
differences in SEAP protein expression.   
Looking at the data from figure 4.2, it can said that the CMV promoter is the most 
transcriptionally active promoter due to producing more SEAP mRNA across the whole 
range of transfected SEAP vector amounts then the other promoters.  However, its 
mRNA might be said to be less translationally active then the others.  To clarify, both 
the SEAP vectors utilizing the SV40 and EF1α promoters, produced more SEAP protein 
compared to the amount of SEAP mRNA they produced when compared to the CMV-
SEAP vector.  This can be seen in table 4.2 were differences in SEAP mRNA expression 
for both SV40 and EF1α compared to CMV are much greater than the respective SEAP 
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protein expression.  Again this could be down to differences in the 5’ structure of their 
respective SEAP mRNA. 
In summary the three different promoters could be ranked accordingly:- 
• SEAP protein expression – CMV = EF1α > SV40 
• SEAP mRNA expression – CMV > EF1α > SV40 
This work is in agreement with previously published literature that both the CMV and 
EFα promoters are stronger than the SV40 promoter in many cell lines (Qin et al., 
2010; Zarrin et al., 1999; Liu et al., 1997; Thompson et al., 1990; Foecking & Hofstetter, 
1986).  However, a comparison of these three specific promoters expression in the 
industrially relevant CHO-S cell line has not been published before. 
The rest of the chapter looked at the influence of having two expression vectors and 
therefore two promoters in the same system, potential interference between the two 
promoters and the effects on SEAP expression.  Interestingly, a similar pattern to that 
seen for the transcriptional strength of the promoters emerged when looking at the 
negative effects each promoter had on the expression of a competing promoter.  This 
pattern was that the GFP vector containing the CMV promoter had the bigger negative 
influence on SEAP expression then any of the other GFP vectors and this influence was 
seen for all three of the SEAP vectors tested.  The EF1α-GFP vector had the second 
biggest negative influence while the SV40-GFP the least.  This was shown at both the 
SEAP protein and mRNA level. 
Looking at the results of all the promoter interference experiments (figures 4.3 – 4.12 
& table 4.3 – 4.8) together the SEAP expression from the vector containing the SV40 
promoter was the most affected by the co-expression of a GFP vector and a competing 
promoter in all the experiments.  The EF1α-SEAP was the second most effected and 
the CMV-SEAP vector was the least affected by a competing vector/promoter.  This 
would suggest that the strength of a promoter in our case also had an effect on how 
much it is affected by the presence of another promoter.   
However, it is impossible to separate the effects of a certain promoter driving SEAP 
expression being affected by the presence of a certain promoter driving GFP 
154 
Nathan West The University Of Sheffield 
expression whose expression will also be affected.  The interference that will occur 
between different promoters is not unidirectional as has already been said early during 
this chapter.  Interference between the SEAP and GFP vectors will occur both ways.  So 
although the CMV-SEAP vector may seem to be less affected by co-expression of 
competing GFP vector it might be more correct to say that the CMV-SEAP is better at 
competing with any GFP vector containing any promoter for its own expression but 
that this does vary depending on the competing promoter.  In fact in our case it may 
be more appropriate to call this “perturbation of one transcriptional unit by another” 
(Huliak et al., 2012; Curtin et al., 2008; Eszterhas et al., 2002) “promoter competition” 
rather than promoter interference.  Promoter competition suggests more of a bi-
directional effect then promoter interference does. 
In terms of the effects seen with the different promoters it was not unexpected or 
surprising that the SV40 promoter was the worst promoter at competing for its own 
expression and negatively affecting expression from another promoter due to being 
clearly the weakest of the three studied.  What was interesting was the difference 
seen between the CMV and EF1α promoters which were shown to be more clearly 
matched in terms of strength shown by both SEAP protein and mRNA expression.  
When these promoters were used to drive GFP expression they had similar effects on 
SEAP expression from both the SV40-SEAP and EF1α-SEAP vector, although the CMV-
GFP vector always had a slightly greater effect, but when co-expressed with the CMV-
SEAP vector there affects differed significantly.  The GFP vector containing the EF1α 
promoter had less of negative impact then CMV-GFP in all the 
interference/competition experiments.  This suggests that although their differences in 
transcriptional strength may not be great, there is something about the CMV promoter 
that does allow it to out-compete other promoters and maintain higher levels of 
expression.  This is best shown in section 4.5.4 were the changes in SEAP mRNA were 
also shown alongside the changes in SEAP protein expression.  Although changes in 
SEAP protein were not as great as expected, this will discussed again later, for both the 
SV40-SEAP and EF1α-SEAP vectors there were significant reductions in SEAP mRNA 
when co-expressed with any competing GFP vector.  Even the SV40-GFP vector 
reduced SEAP mRNA compared to the controls for both these SEAP vectors.  However 
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when looking at the results for the CMV-SEAP vector the SV40-GFP had no negative 
effect while the EF1α-GFP vector only caused a small decrease in SEAP mRNA 
expression.  Only another CMV promoter significantly reduced the mRNA expression 
from the CMV-SEAP vector.  There must be something about the regulation of the 
CMV promoter and its structure in terms of binding sites for factors involved in 
transcription which makes it capable of out competing the other two promoters for 
expression.  The fact that the CMV promoter has the ability to compete well with other 
promoters makes sense when you consider its origin is viral.  It would be advantageous 
of a virus to be able to out-compete not only endogenous promoters such as the EF1α 
for expression but also other viruses such as the SV40.  Exactly what would give it this 
ability can only be hypothesized in terms of the results in this chapter.  It could be 
through a direct competition for general transcription factors and transcriptional 
machinery or competition for other transcription factors that can bind more than one 
of these promoters (this includes competition for factors that positively affect 
expression from a CMV promoter as well as sequestering transcription factors which 
may not directly enhance CMV expression but are required by other the promoters).   
So in terms of the level of potential promoter interference/competition the promoters 
can be ranked accordingly:- 
• Promoter interference/competition – CMV > EF1α > SV40 
In section 4.5.4 all combinations of SEAP and GFP vectors were co-transfected together 
but at roughly a one-to-one ratio in terms of DNA vector copy number.  This was done 
to help normalise for the effects of the different sizes of the vectors and potentially 
make competition between two vectors and therefore two promoters initially more 
equal.  As well as measuring SEAP protein expression SEAP mRNA was also quantified 
to see what effects a competing promoter had on SEAP mRNA expression.  As in 
previous sections in this chapter we expected to see reductions in SEAP protein 
expression especially in the presence of the CMV and EF1α-GFP vectors.  Although this 
was observed for the SV40-SEAP vector (figure 4.9), little to no effect on SEAP protein 
expression was observed for the EF1α-SEAP (figure 4.10) and CMV-SEAP (figure 4.11).  
Fortunately mRNA samples were also taken which did show when quantified for SEAP 
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mRNA expression that although levels of SEAP protein did not change significantly the 
levels of SEAP mRNA did decrease significantly.  This matched what we had previously 
shown (Promoter interference/competition – CMV > EF1α > SV40) and also that 
competition between promoters occurs at the level of transcription.   
Another thing this showed was that the cells in our experiments were capable of 
producing similar levels of SEAP from the same vector even when the amount of SEAP 
mRNA was reduced by a competing promoter (figure 4.9 – SV40-SEAP + SV40-GFP, 
figure 4.10 – EF1α-SEAP + SV40-GFP or EF1α+GFP and figure 4.11 – CMV-SEAP + CMV-
GFP).  This would seem to suggest that there is an excess or surplus of SEAP mRNA 
compared to how much mRNA can be actively translated into fully mature SEAP 
protein.  This seems best demonstrated by the difference seen between the SV40-
SEAP and the other two SEAP vectors.  The SV40-SEAP vector was already shown to 
produce significantly less SEAP mRNA compared to the other two SEAP vectors and 
between 0.9 – 1.0 µg of SEAP DNA was transfected depending on the size of vector in 
section 4.5.4.  In figure 4.2 – B. we saw that for 1.0 µg of SV40-SEAP DNA the 
expression of SEAP mRNA was significantly less than 50% of that produced from the 
other two SEAP vectors but SEAP protein expression was ~90%.  This shows that extra 
SEAP mRNA is not all translated into SEAP protein and that possibly there is in fact 
quite a substantial excess.  Only when the amount of SEAP mRNA was significantly 
reduced compared to its control did the level of SEAP protein begin to drop.  For the 
SV40-SEAP vector this occurred when the amount of SEAP mRNA was reduced to 20 – 
30% of the control by the CMV and EF1α-GFP vectors.  This is likely to also be 
dependent on the promoter used.  Although CMV-GFP reduced EF1α-SEAP mRNA 
expression to ~30% of the control and only a small but significant drop in SEAP protein 
was observed and this is probably because of the large amounts SEAP mRNA produced 
by the EF1α promoter meant even a reduction of this size did not significantly affect 
the amount of SEAP protein it was capable of producing. 
An interesting final point to make is that this promoter interference/competition may 
already be occurring unwittingly and to the benefit of stable CHO cell lines which have 
already been and are still being created to produce a therapeutic protein.  The CMV 
and EF1α promoters are routinely used to drive the expression of a therapeutic protein 
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while the SV40 promoter is utilized in the same vector to drive the expression of a 
selection gene.  If promoter interference/competition is occurring between promoters 
in this situation, which it is likely that will, then it is adding further selection pressure 
and possibly contributing to the selection of high producing CHO cell clones. 
 
4.6.2 – Final conclusions 
In this chapter the relative strengths of three different promoters, SV40, CMV and 
EF1α, to produce SEAP mRNA and protein over range of transfected DNA amounts in 
CHO-S cells were shown.  In terms of the relative amounts of SEAP protein and mRNA 
these promoters were ranked accordingly:- 
• SEAP mRNA expression – CMV > EF1α > SV40 
• SEAP protein expression – CMV = EF1α > SV40 
This is in agreement with previously published work for other cell lines (Qin et al., 
2010; Zarrin et al., 1999; Liu et al., 1997; Thompson et al., 1990; Foecking & Hofstetter, 
1986).  This also shows that both the CMV and EF1α promoters can be used for 
similarly high levels of recombinant protein expression in CHO-S cells. 
It was also showed via co-transfections of SEAP and GFP vectors that promoter 
interference/competition can occur between two physically unlinked promoters.  The 
level of competition or interference seemed to be related to the strengths of the two 
promoters present.  SEAP protein expression was most negatively affected when a GFP 
vector containing a CMV promoter was co-transfected and least negatively affected by 
co-transfection of an SV40-GFP vector.  Reductions in SEAP expression were greater for 
the SV40-SEAP vector and the least for the CMV-SEAP vector. 
• Level of promoter interference/competition inflicted – CMV-GFP > EF1α-GFP > 
SV40-GFP 
• Level of reduction in SEAP protein seen – SV40-SEAP > EF1α-SEAP > CMV-SEAP 
Reductions in SEAP mRNA were also seen which showed the same pattern of promoter 
competition and showed that some competition must be occurring at the 
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transcriptional stage.  However, this does not rule out competition at other stages of 
SEAP production as well. 
Although the strengths of the EF1α and CMV promoters did not differ greatly the 
promoter competition effects did.  The CMV was shown to be stronger at competing 
with another promoter but the reasons for this still need to be further investigated 
(more information on this is provided in the next section and the next chapter). 
Finally these results show why the CMV and EF1α promoters and the SV40 promoter 
are used for the expression of therapeutic proteins and selection genes respectively 
but also why they might not be ideally suited for expression in cell engineering 
strategies.  All three promoters are constitutively expressed but their expression can 
be effected by not only the presence of different promoters but also by the presence 
of the same promoter and this will affect our ability to tightly control the expression of 
multiple genes in the same system.  For future progress of cell line engineering 
strategies which could be used for the improvement of not only CHO cells lines 
producing therapeutic proteins but also in other areas of biological research there will 
be a need for promoters which can produce differing levels of expression and which 
function somewhat independently and do not overly interfere with each other’s 
expression.  To be able to achieve this we will first need a better understanding of why 
two physically unlinked promoters interfere or compete for expression. 
 
4.6.3 – Future directions 
Future directions should include further investigation into what gives promoters their 
strength and why promoters interfere and compete with each other.  In the next 
chapter this will be investigated by taking a bioinformatics approach to studying the 
promoters used in this chapter.  A collection of programs will be used (Genomatix 
Software Suite, Genomatix Software, Munich, Germany) to analyse the potential 
transcription factor binding sites (TFBS) present in the promoters.  A comparison 
between the promoters may give clues to the regulation of the different promoters 
and why they interfere with expression of a competing promoter.   
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It is also possible that this information can be used to help design promoters which not 
only differ in terms of strength but that can possibly act independently and not overly 
effect the expression of another competing promoter.  This would not only be 
extremely useful for future cell line engineering strategies in biopharmaceutical 
production were control of multiple genes may be necessary but also for other 
applications and also in many other areas of biotechnology and biology. 
Further research also needs to be done to investigate how promoter 
interference/competition actually occurs.  Is it just competition for general 
transcription factors, other more specific transcription factors, and transcriptional 
machinery or is it more complex then this?  Promoter interference can occur between 
promoters that are physically unlinked and this suggests that there is some kind of 
competition for shared transcriptional resources but without further research this 
cannot be said for certain and other possible explanations cannot be ruled out.  The 
design of synthetic promoters as well as the use of decoy DNAs (Brown et al., 2013) 
will be useful for gaining a further understanding of how this interference/competition 
occurs. 
Another area of research which future developments in would help us to be better 
able to investigate and understand this phenomenon would be how vector DNA is 
processed and regulated once it reaches the nucleus.  Although a large amount of 
research has been done on gene expression from chromosomes little has been done 
on the nuclear localisation and expression of DNA vectors which are not integrated 
into the genome (Mearini et al., 2004).  Understanding this would be extremely useful 
for many applications of transient gene expression. 
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Chapter 5 – Transcription Factor Binding 
Site Analysis of Three Commonly used 
Constitutive Promoters for 
Biopharmaceutical Production in CHO 
Cells 
5.1 – Abstract 
Previously we have shown how the three promoters, SV40 early, CMV major 
immediate-early and the human EF1α promoters interact when co-expressed and the 
difference in promoter interference/competition observed.  The level of promoter 
interference was reflected in the strengths of the promoters. 
The strengths of the promoters will reflect the transcriptional activators (transcription 
factors (TFs)) which can bind each promoter and one hypothesis for a potential cause 
of promoter interference is the competition for shared TFs. 
The promoter sequences were analysed using the programs MatInspector and 
ModelInspector.  Both programs showed the SV40 to have less potential transcription 
factor binding sites (TFBSs) and also potentially less variety in the families of TFs which 
it could bind when compared to the CMV and EF1α promoters.  The SV40 promoter 
also shared a greater proportion of these TFBSs with both the CMV and EF1α 
promoters.  Results from the ModelInspector search of the CMV promoter showed it 
to have less potentially functional TFBSs in common with the other two promoters. 
TFBSs identified by ModelInspector imply more potential functionality then those 
identified by MatInspector.  These differences might be a reflection of both their 
transcriptional strengths and their ability to interfere with expression from another 
promoter. 
Potentially functional TFBSs binding sites from the SP1 family were found to be 
overrepresented in all three promoters and were thought to be one potential source 
of promoter interference/competition.  Over-expression of the TF SP1 from a vector 
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utilizing the CMV promoter rescued expression from SV40, CMV and EF1α-SEAP 
vectors and from SV40 and CMV-GFP vectors compared to co-expression of CMV-GFP 
and CMV-SEAP respectively. 
The presence of high numbers of potential TFBSs in each promoter, although a large 
proportion will not be functional, highlighted that promoter interference is unlikely to 
occur due to competition for single TF or even just TFs alone and also the potential 
complexity in the regulation of expression from each promoter.  Trying to discretely 
control expression of multiple genes using these promoters is unlikely to be viable 
option without modification of their sequences which could result in unexpected 
effects.  A ‘bottom up’ approach for the creation of synthetic promoters is likely to be 
a better strategy for in attempts to control expression of multiple genes. 
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5.2 - Introduction 
In the last chapter it was seen that the SV40 early, the CMV major immediate-early and 
the human EF1α promoters not only differed in expression, but also how they 
differentially affected the expression of a competing promoter when present in the 
same system.  The negative effect of a competing promoter is termed promoter 
interference/competition.  The CMV promoter had the greatest negative effects when 
competing with itself, the EF1α and the SV40 promoter.  A GFP vector utilizing a CMV 
promoter was shown to reduce the expression of SEAP from a competing vector more 
when compared to an EF1α and SV40 promoter.  The magnitude of this reduction was 
dependent on the promoter present in the co-transfected SEAP vector.  SEAP 
expression from the SV40-SEAP vector was reduced the most, followed by the EF1α-
SEAP vector and the least from the CMV-SEAP vector.  The presence of a GFP vector 
containing an EF1α promoter had similar effects on SEAP expression from the SV40 
and EF1α-SEAP vectors when compared to CMV-GFP, but did not affect SEAP 
expression from CMV-SEAP to the same extent.  The SV40-GFP vector had the least 
competitive effect and only reduced SEAP expression from the SV40-SEAP vector to 
any significant extent.  This showed that in terms of promoter 
interference/competition the CMV promoter was the most interfering while the SV40 
promoter was the least.  This pattern of competition matched the strengths of the 
promoters used and suggests that the strength of the different promoters used plays a 
role.   
From work in chapter 4 it is not possible to say exactly why the different promoters 
differed in both strength and in terms of interference/competition.  Was it competition 
for general transcription factors (TF) and transcriptional machinery (RNAPII etc) or was 
it competition for more specific TFs for which the promoter’s share common binding 
sites?  The second hypothesis is investigated in this chapter. 
In this chapter the Genomatix Software Suite (Genomatix Software, Munich, Germany) 
was used to analyse the promoter sequences of these three commonly used 
constitutive promoters.  Although the individual promoters have been studied to some 
extent in terms of some selected specific transcription factor binding sites (TFBSs) a 
more detailed analysis and a comparison between the three promoters has not be 
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carried out previously.  Comparison of the results for the promoters is also done to see 
which common factors they might potentially share.  The presence of common TFBSs 
amongst the three promoters should give clues as to which, if any, TFs the promoters 
compete with each other for.  A TF is also over-expressed which can potentially bind all 
three promoters to help alleviate promoter interference/competition and show that 
competition for a possibly limited supply of a shared factor is one of the causes of 
promoter interference/competition seen in the last chapter. 
This might also provide evidence or guidance for how to rationally design promoters 
which can produce different levels of expression but which do not significantly 
interact, interfere or compete with each other.  In future cell engineering strategies 
involving the expression of more than one gene being able to somewhat 
independently and reliably control the expression of multiple genes will be advantage 
for their successful development. 
 
5.2.1 – The Genomatix Software Suite 
The Genomatix Software Suite is a collection of online programs for the analysis of 
genomic data as well as gene expression and gene regulation.  For the purposes of this 
chapter, a set of sequence analysis programs which analysed the promoters used in 
the previous chapter for potential TFBSs, TFBS modules, over-represented TFBSs and 
also common TFBSs shared between the three different promoters studied.  The next 
sections we briefly describe the programs that were used but it should be pointed out 
that although these programs can be quite powerful, the TFBSs they identify are only 
potential TFBSs and they do not prove any functionality.  The program ModelInspector 
is better at identifying functional modules but still has its limitations.  However, the 
results of such searches can be used and are used to help guide further experiments. 
 
5.2.1.1 – MatInspector 
MatInspector was the main analysis program that was used for identifying potential 
TFBSs and it also forms the basis for the analysis carried out by the other programs 
that will be described shortly.  MatInspector uses a large library of matrix descriptions 
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for TFBSs to identify matches in DNA sequences (Cartharius et al., 2005; Quandt et al., 
1995).  It identifies TFBSs using nucleotide or position weight matrices (NWM or PWM) 
rather than simple IUPAC consensus strings.  They have the advantage in that for each 
single position in a PWM the entire nucleotide distribution can be considered.  They 
also allow for quantification of a similarity score between the potential TFBS and the 
PWM.  Alternative programs also use PWM for identifying potential TFBSs in 
sequences, but most of these programs have greater limitations then MatInspector.  
Some are based on old matrix libraries which are no longer updated such as Signal 
Scan (Prestridge, 1996, 1991).  Other programs such as MATCH (Kel et al., 2003) 
perform searches similar to MatInspector.  However, MATCH has two drawbacks.  The 
first being the freely available version only contains 398 matrices due to using the 
publically available TRANSFAC matrix library.  A commercial version using the updated 
TRANSFAC library is available and is more than six years ahead of the public one and 
contains >2000 entries, but this is not freely available to academic users.  Although the 
public version of MATCH has a much bigger library than programs such as Signal Scan 
and ConSite (Sandelin et al., 2004; Prestridge, 1996, 1991) it is still much smaller than 
the matrix library for MatInspector, 1381 weight matrices (Matrix Family Library 
Version 9.0 (August 2012)), which is also freely available for public/academic use.  The 
second drawback of the public version of MATCH is that it does not group matrices 
into matrix families like MatInspector.  Although this is not a significantly major 
problem, it does mean that MATCH can produce redundant matches when the same 
part of a sequence is identified for having overlapping matches to more than one 
similar or related matrix.  MatInspector overcomes this problem by grouping similar 
individual matrices into so called matrix families and then when more than one 
overlapping match from the same matrix family occurs in a sequence only the highest 
scoring match is returned.  This greatly reduces the number of redundant matches 
returned and gives a more condensed and comprehensive output. 
Another advantage of the MatInspector program is its use of optimized matrix 
thresholds (Cartharius et al., 2005).  Rather than having the same matrix similarity 
threshold for all matrices, which would greatly affect the number of matches returned 
depending on the matrix length and sequence conservation, each individual matrix has 
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its own threshold which helps reduce the number of false positives.  The optimized 
threshold of a weight matrix for MatInspector was defined as the matrix similarity 
score which resulted in only a maximum of three matches per 10,000 bp of non-
regulatory test sequences (Cartharius et al., 2005). 
As mentioned earlier MatInspector forms a major part of all the following programs we 
used and each will be briefly described. 
 
5.2.1.2 – Overrepresented TFBSs 
This program uses MatInspector to search sequences to identify TFBSs which are 
overrepresented compared to a defined background.  Overrepresentation of a TFBS 
can sometimes be a sign that it is functionally important.  It generates statistics for 
matrix families including overrepresentation values and Z-scores.  This is achieved by 
comparing the occurrence of the matches in a given sequence to the occurrences seen 
in a selected background.  This can either be the occurrence of matches in the whole 
genome sequence of a selected species, the occurrence of matches in promoter 
sequences of a selected species which were annotated by Genomatix or to user a 
defined background. 
The overrepresentation value is calculated from the number of matches found in a 
sequence compared to the number seen in an equally sized sample from the selected 
background.  Put simply, the overrepresentation value is basically found versus 
expected. 
The Z-score is another way of showing overrepresentation compared to a selected 
background.  It is the number of standard deviations that a given data point is from the 
population mean.  In this case the number of matches found compared to the mean 
and standard deviation of a given background.  This program uses continuity correction 
to calculate the Z-score using the following formula:- 
Z = 	
(x − E − 0.5+
SD
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Where x equals the number of matches found in a sequence, E equals the mean 
number of expected matches and SD is the standard deviation of E.  This formula was 
described previously in a paper identifying overrepresented TFBS in co-expressed 
genes (Ho Sui et al., 2005).  The Z-score has the advantage over the overrepresentation 
value given that it can be used to calculate statistical significance.  A Z-score value 
equal or greater than 1.96 shows a TFBS is overrepresented with a corresponding p 
value which is equal or less than 0.05.  A Z-score equal to or less than -1.96 shows a 
TFBS is underrepresented with a p value equal or less than 0.05.  As with all of these 
programs it must be remembered that a p value represents statistical significance and 
not necessarily biological significance. 
 
5.2.1.3 – ModelInspector 
ModelInspector is used to search sequences for so called pre-defined modules 
(Klingenhoff et al., 1999; Frech et al., 1997).  A model consists of two or more TFBSs 
which have been shown in the literature to be important in gene regulation from a 
given promoter/enhancer.  Information for a certain model consists of not only the 
appropriate TFBSs but also the distance these sites are expected to be from each other 
in terms of bp’s and also the orientation of the site (on either the + or – strand).   
Like the TFBS matrices the modules also have their own library which is currently 
version 5.6 and because ModelInspector uses matrices for identifying individual TFBSs 
this model library is linked with version 9.0 of the matrix family library. 
Model matches are only returned if the individual TFBSs present satisfy the 
requirements of the model.  This includes having a sufficient core and matrix similarity 
score (note that the similarity score required for a model may be different than the 
score for the optimized matrix threshold), being within the correct distance of each 
other and also on the correct DNA strands. 
Unlike MatInspector and the other programs mentioned in this section ModelInspector 
is better at giving potential functional information about a given sequence.  The other 
programs just give potential individual TFBSs whose presence alone can mean very 
little since it is known that TF often work co-operatively to modulate gene expression.  
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ModelInspector not only identifies possible TFBSs that could interact together but 
because it is also based on examples taken from the literature were these interactions 
have been shown to occur and have an effect on gene expression a greater 
functionality can be inferred.  Again caution should be taken with results as they still 
have major limitations since not all modules can be expected to function the same in 
not only different species but within different tissues and cells of the same species.  
However, the results from ModelInspector are still much more functionally informative 
then the results from MatInspector. 
 
5.2.1.4 – Common TF sites 
This program uses MatInspector to simultaneously search multiple sequences for 
matches for TFBSs which are found to be common to all or a certain percentage of the 
selected sequences.  Results are presented in both a graphical and a summary table 
form.  The summary table lists the name of the TFBS matrix families identified, the 
number of times it was found in total, the numbers times it was found in each 
sequence and the number of the sequences it was found in. 
It also gives a p value for each matrix family identified.  This p values represents the 
probability of getting an equal or greater number of sequences with matches when 
compared a random sample which is the same size as the input sequences.  These p 
values were based on already pre-defined promoter matches.  These promoter 
matches are for known promoter sequences which were extracted from Genomatix’s 
ElDorado (http://www.genomatix.de/online_help/help_eldorado/introduction.html) 
database.  P values are only correct if the average length of the sequences analysed is 
around 600 bp and optimized matrix thresholds are used. 
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5.3 – Aims and Objectives 
In this chapter the programs created by Genomatix and described in the previous 
section are used to analyse the sequences of the three promoters studied in the last 
chapter (SV40, CMV and EF1α) for potential TFBSs.  The results for each promoter will 
be used to give an idea of the TFs that are potentially important for their regulation.  
They will also be compared with each other to see if they share TFBSs and this should 
give clues to why these promoters can negatively affect the expression of a competing 
promoter with one hypothesis for the promoter interference/competition being there 
is a competition for shared TFs. 
It was also tested whether a TF whose binding site is present in all three promoters can 
rescue SEAP/GFP expression from three SEAP/GFP vectors even in the presence of a 
competing CMV promoter which was shown to most negatively affect/decrease 
expression from another promoter. 
The aims and objectives of this chapter are as follows:- 
1. Use MatchInspector to analyse the potential TFBSs present in the SV40, CMV 
and EF1α promoters 
a. Do the total numbers of TFBSs identified in each promoter differ from a 
random sample of 30 sequences who match each promoter in terms of 
both size and ACGT content? 
b. Analyse the results for each promoter in more depth including the 
results for MatInspector and also the identification of overrepresented 
TFBSs 
2. Use ModelInspector to identify potentially functional TFBS modules present in 
the promoters 
a. This kind of search is more functionally informative then MatInspector 
3. Compare the potential TFBSs present in each promoter from the MatInspector 
and ModelInspector searches to see if they share common sites for TFs as this 
could be a source of promoter interference/competition 
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4. Express a TF which each promoter contains a binding site for and which is 
potentially functional to see the effect on SEAP/GFP expression when a 
competing promoter is present 
a. This TF will be SP1, more information and why this was selected will 
become clearer later in this chapter 
b. A vector containing the CDS for SP1 and utilizing a CMV promoter for 
expression will be co-expressed with the three SEAP and GFP vectors at 
a one-to-one ratio in terms of vector copy number similar to the 
experiment in chapter 4, section 4.5.4 
c. SEAP proteins and mRNA expression will both be measured as well as 
GFP expression 
By comparing the potential TFBSs found in each of the SV40, CMV and EF1α promoters 
it will give a better understanding of the regulation of expression from each and also 
how/why these promoters interact and compete with each other.  This information 
may also help guide the design of novel synthetic promoters which can function 
somewhat independently of each other even in the same system. 
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5.4 – Materials and Methods 
5.4.1 – Using the Genomatix Software Suite 
All four programs mentioned earlier form part of an extensive collection of online 
programs for genomic data and gene expression and gene regulation analysis.  The 
homepage can be found at the following web address 
http://www.genomatix.de/solutions/genomatix-software-suite.html.  For the different 
programs MatInspector, Overrepresented TFBS, ModelInspector and Common TFs, all 
three promoter sequences are presented to the programs in a FASTA format with the 
first line denoting the specific promoter (see CD appendix for promoter sequences in 
FASTA format).  Other common formats are also accepted. 
On the first page of the MatInspector program you add your sequence. The 
transcription factor binding sites (weight matrices) option was selected under library 
selection (this is the default option) before proceeding to the next page.  On the next 
page under matrix search parameters the latest version of the matrix library (Matrix 
Library 9.0), the vertebrate and general core promoter elements and the use all 
matrices from selected groups option (you can also select subsets to customise your 
search) were selected.  Under the matrix families parameter, you can select to search 
using either matrix families or individual matrices.  Searches of the promoter 
sequences were carried out using both options.  Core similarity was left at the default 
0.75 and for matrix similarity optimized thresholds were used.  Further options are 
available to customise the output given from the search. 
For the Overrepresented TFBS program sequences were inputted on the first page 
along with selecting the following parameters – overrepresentation of single TF (using 
MatBase), matches to matrix families and both genomic and promoter background.  
For comparison against a background an organism also needs to be selected and while 
this should be the organism your sequences came from or are being expressed in the 
lack of a single sequence origin and the fact Cricetulus griseus (Chinese hamster) was 
not an option Mus musculus was selected. 
ModelInspector, the first page was simply for inputting your sequences.  On the 
second page the following parameters were used.  The latest module library was 
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selected (Module Library 5.6) as well as vertebrate modules and use all selected 
modules from this group (again you can also customise this by selecting subsets).  
Under search parameters, the options were left as the defaults while in the next 
section the output parameters could be adjusted to customise the final output of your 
result. 
When using the Common TFs program sequences were inputted on the first page as 
well as selecting transcription factor binding sites (weight matrices) under library 
selection.  The next page was very similar to the second page for MatInspector.  The 
same options were chosen with this time only searches for matrix families being 
carried out.  An extra parameter was also available and this was to select for the 
percentage of sequences a match had to appear in to be returned in the results. 
For all programs the full results or just summaries could be downloaded in different 
formats.  Files were downloaded as Excel or PDF files and all the raw search results can 
be found in the attached CD appendix in this format. 
 
5.4.2 – Over-expression of the TF SP1 and its effects on promoter 
interference/competition 
This set of experiments were carried out in the exact same manner as those in chapter 
4, section 4.5.4.  The cell line used, culture method, transfection protocol were all the 
same as those used in chapter 4 and described in section 4.4.  SEAP protein and mRNA 
as well as GFP expression were analysed as already described in chapter 3 & 4.  The 
SEAP, GFP and negative control DNA vectors used have already been described in 
chapter 4, section 4.4.2. 
The CMV-SP1 vector (SC101137) was purchased from OriGene (Rockville, MD, US).  
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5.5 – Results and Discussion 
5.5.1 – Identification of potential TFBS in the SV40, CMV and EF1α 
promoters by MatInspector 
The program MatInspector was used to analyse the SV40 early, CMV major-immediate 
early and the human EF1α promoters for the presence of potential TFBSs.  All three 
promoters were analysed using the search parameter matrix families (identifies the 
best match from a matrix family at a given position in a sequence) and individual 
matrices (gives all possible matches for a given position in a sequence).  Although it is 
recommended that the matrix family option is used to help prevent the presence of 
redundant matches, it was thought it would be more informative to first look at the 
results of searches using both options. 
The reasoning being that although the removal of redundant results is helpful at giving 
a result which is more condensed, presentable and potentially more accurate in terms 
of the actual potential numbers of TFBSs, the extra information would actually help us 
study the results better by understanding which potential binding sites had a greater 
selection in terms of potential TFs to bind to them.  Most TFBSs are capable of binding 
more than a single TF, but by looking at the results for individual matrices this would 
be shown to some extent by the program and not only just an assumption made by the 
user.  Although it should be mentioned that just because a site for a TF with a similar 
binding sequence at the same location was not identified using the individual matrices 
option does not mean a related TF cannot bind there.  Some TFs can be quite 
promiscuous and will sometimes bind to similar sequences even if that particular 
sequence does not quite meet the optimized matrix threshold for a given TF but the 
strength of the binding or interaction might differ from a TF whose binding site is 
present and more conserved.  Remember that the individual TF matrices and 
optimized thresholds have not been defined for all possible biological interactions. 
After running the promoter sequences of SV40, CMV and EF1α through MatInspector 
the raw numbers given by the program in terms of the number of potential TFBSs were 
studied.  Table 5.1 shows the results for each promoter and also the numbers of TFBSs 
identified using both matrix families and individual matrices.  The SV40 promoter had 
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the least number of potential TFBSs when searching using the matrix family or the 
individual matrices option, 163 and 335, respectively.  The difference in number seen 
when analysing sequences using either the matrix families or individual matrices 
options demonstrates how selecting the matrix families reduces the number of TFBSs 
returned by removing so called redundant matches.  For the CMV and EF1α promoters, 
EF1α had more potential TFBSs (274) when using matrix families compared to the CMV 
(225).  When using individual matrices the CMV promoter had a greater number of 
hits, 457, than the EF1α promoter, 422. 
Studying this and considering what was shown in the previous chapter, it could be true 
that the number of potential TFBSs identified in a promoter might be a reflection of 
their relative strengths.  The SV40 promoter was the weakest promoter in terms of the 
strength of expression and from this search, was also shown to have the least number 
of potential TFBSs.  The SV40 promoter had 62 and 111 fewer sites then both CMV and 
EF1α, respectively, when the matrix families option was selected and 122 and 87 fewer 
sites when individual matrices was used.  For both the CMV and EF1α promoters the 
numbers of potential sites identified were different but there were less differences 
than seen for the SV40 promoter.  For matrix families, the CMV had 49 fewer sites 
then the EF1α promoter.  Given this and what was said at the start of this paragraph, it 
could be expected that the EF1α promoter would have stronger expression then the 
CMV.  In chapter 4 this was shown to not be the case.  In terms of individual matrices 
the opposite was seen with the CMV promoter having 35 more sites then EF1α.  This 
might potentially mean that although the EF1α may possibly have more binding sites 
for a greater number of TFs from different families the TF families that could 
potentially bind the CMV have a greater number of individual but related TFs within 
each or in certain families which could bind the CMV.  Alternatively some of the TFBS 
identified for the EF1α promoter might either not be functional or their TF might not 
be expressed to a significant degree in CHO-S cells.  However, the same could be said 
of any of the promoters and a more in depth look at the TFBSs identified in each 
promoter is done later in this chapter. 
The number of TFBSs identified was compared to the length of the promoters.  
Interestingly even though the EF1α promoter is 734 (2.6-fold) and 600 (2.0-fold) bp 
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longer then the SV40 and CMV promoters, it did not have two times or greater 
numbers of potential TFBSs.  This suggests that there are differences in the 
sequence/structures between viral and endogenous mammalian promoters.  Indeed in 
this case there is.  As mentioned in the last chapter when describing the promoters 
(chapter 4, section 4.2.2) a large part of the EF1α promoter which has been shown to 
be essential for high expression is the first intron (Wakabayashiito & Nagata, 1994).  
The first intron is 943 bp and makes up most of the EF1α sequence (79% of 1189 bp).  
Although it is essential for strong expression it be might expected that an intron 
contains less TFBS than a core promoter or enhancer might.  The SV40 and CMV 
promoters are mostly made up of a core promoter and enhancer sequences.  It might 
also be expected that viral promoters contain higher numbers of TFBSs in a given 
length of sequence due to their much smaller genome and, like some mammalian 
promoters in vivo, they can also be used for controlling multiple genes.  There is also a 
need for some viruses to be capable of infecting and thriving in multiple related 
species and in different cell types which may differ in their TF profiles.  On this last 
point on viral promoters it should also be pointed out that the EF1α gene is expressed 
in all cell types, except neurons and skeletal and cardiac muscle (Soares & Abbott, 
2013), and therefore its promoter, like the viral ones, is capable of functioning in many 
different cell types with different TF profiles.  Alternatively, this could also mean that 
all three of these promoters rely heavily on ubiquitously expressed TFs. 
To look whether these differences between the number of TFBSs found in each 
promoter and length could be due to their different origin or structures the number of 
TFBSs for each promoter were compared to the average number of TFBSs found by 
MatInspector in 30 randomly generated DNA sequences which were matched in both 
length and ACGT content for each promoter (http://users-
birc.au.dk/biopv/php/fabox/random_sequence_generator.php).  Figure 5.1 shows for 
both the SV40 and CMV promoters that in comparison to 30 random DNA sequences 
they each had more predicted TFBSs sites.  On average the SV40 and CMV had ~64 and 
~77 more TFBSs for matrix families (figure 5.1 – A.) and ~170 and ~174 more TFBSs for 
individual matrices (figure 5.1 – B.) when compared to their respective 30 random 
sequences.  Comparison of the EF1α promoter showed that it had roughly the same 
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number of predicted TFBSs for both matrix families and individual matrices when 
compared to random sequences which match it in length and ACGT content. 
It is interesting that the viral promoters have a greater number of potential TFBS then 
a representative random sample of DNA sequences while the mammalian EF1α 
promoter did not show any difference.  This would suggest differences in the structure 
between these two viral and this mammalian promoter.  One obvious difference 
between the viral promoters compared to EF1α is the fact that these promoters are 
composed of repeated sequences to a greater or lesser extent.  The SV40 promoter is 
almost entirely made up of two copies of three 21 bp repeats and a single copy of two 
72 bp repeats (Byrne et al., 1983).  While the enhancer of the CMV contains multiple 
copies (between three and five) of four different repeats (17, 18, 19 and 21 bp repeats) 
(Fickenscher et al., 1989).  This repeated structure could be one reason why the two 
viral promoters had greater numbers of TFBS then their comparable random 
sequences while the EF1α was more comparable to its random set of sequences.  This 
is interesting in terms of the design of synthetic promoters because it shows that you 
can achieve get high and comparable levels of expression from smaller promoters 
which contain repeated sequences (Schlabach et al., 2010).  Although this is interesting 
the fact that the CMV and EF1α promoters produce similar levels of expression shows 
there is multiple ways of achieving high levels of recombinant gene expression but the 
use of smaller promoters may be an advantage when constructing large DNA vectors 
which contain multiple recombinant genes. 
Looking at the results of the MatInspector searches for each promoter in more detail 
the SV40 promoter had 163 TFBSs identified which was composed of 50 different 
matrix families (table 5.1).  For individual matrices of the 335 TFBSs found this was 
made up of 129 separate matrices.  For the CMV promoter out of the 225 potential 
TFBSs found this was made up of 77 different matrix families and out of the 457 found 
searching using individual matrices there were 244 different individual matrices (table 
5.1).  274 TFBSs were identified for the EF1α promoter and this was composed of 112 
different matrix families (table 5.1).  For individual matrices out of the 422 TFBSs 
identified there were 276 separate individual matrices.  This showed that in terms of 
the number of potential TFs that the EF1α promoter may have a larger selection.  
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Although, as was shown in figure 5.1, these larger numbers might be a reflection of the 
EF1α promoters longer sequence rather than actually on functional TFBSs.  For any of 
these promoters, all of the different matrix families or individual matrices identified 
are only potential TFBSs and it is extremely unlikely that they are all functional.  For 
both the SV40 and CMV promoters the numbers of different matrix families and 
individual matrices were of a higher proportion of the total numbers of potential TFBSs 
than for the EF1α promoter (table 5.1).  This suggested that the CMV and SV40 
promoters rely on some matrix families or individual matrices more than others and 
also potentially more than the EF1α promoter. 
Table 5.1 – Number of potential TFBSs identified by MatInspector for the SV40, CMV and 
EF1α promoters  
  Number of potential TFBSs 
Promoter  Matrix families  Individual matrices 
SV40  163 (50 diff matrix families)  335 (129 diff individual matrices) 
CMV  225 (77 diff matrix families)  457 (244 diff individual matrices) 
EF1α  274 (122 diff matrix families)  422 (276 diff individual matrices) 
The numbers in the table represent the number of potential TFBSs identified by MatInspector for each 
promoter.  The numbers in the brackets represent the number of different matrix families or individual 
matrices found in each search.  This was done searching the sequences selecting both the matrix family 
and individual matrices options in the search parameters of the program.  See text in this section for their 
differences or section 5.2.1.1.  
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Figure 5.1 – Number of potential TFBSs in the SV40, CMV and EF1
30 randomly generated DNA sequences.  
for SV40, CMV and EF1α promoters were each compared to the average number of TFBS identified by 
searches of 30 randomly generated DNA sequences which matched each promoter in terms of both length 
and ACGT content. A. Shows the results when matrix families were selected in the search parameters.  
Shows the results when individual matrices were selected in the search parameters.  Error bars represent + 
1 S.D. 
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Table 5.2 shows the top 20 hits in terms of number of sites found for both matrix 
families and individual matrices found by MatInspector for the SV40 promoter.  The 
most prevalent matrix family identified was V$KLFS with 13 potential TFBSs.  This 
matrix family is composed of KLF (Kruppel-like factors) TFs.  The KLFs are a set of 17 
(KLF1-KLF17) zinc finger DNA binding proteins which have a variety of diverse functions 
from differentiation, proliferation, apoptosis, growth and responding to external 
stimuli (McConnell & Yang, 2010).  Unsurprisingly the next most prevalent matrix 
family was the V$SP1F which contains SP (specificity protein) TFs.  These proteins 
share homology with the KLFs and are in fact considered as a closely related family, the 
SP1/KLF family (McConnell & Yang, 2010; Waby et al., 2008). Nine SP factors have 
been identified so far (SP1-SP9) (Suske et al., 2005) and like the KLFs have a wide range 
of roles from cell cycle regulation, growth, apoptosis and angiogenesis etc (Archer, 
2011).  Due to their homology many members of the SP1/KLF family bind GC rich 
elements and therefore also share similar binding sites (Archer, 2011; McConnell & 
Yang, 2010).   
The third most prevalent matrix families are V$OCT1 and V$HBOX with nine potential 
sites each.  These families include binding sites for OCT1 (octamer binding protein 1) 
and related OCT TFs and homeobox TFs such as EN2, GBX2 and VAX1.  The next most 
prevalent families with 8 TFBS each are V$HOMF, V$HOXF and V$ZF02.  The V$HOMF 
and V$HOXF are matrix families for further homeobox TFs while the V$ZF02 matrix 
family contains binding sites for a set of proteins which contain zinc finger DNA binding 
domains.  As was mentioned earlier in total there are 50 different kinds of matrix 
families present in the SV40 promoter (table 5.1).  Without analysing the promoter in a 
more functional manner by the removal of specific TFBSs it is impossible to say with 
any certainty which sites are most important for expression from this promoter just 
using this search. 
Table 5.2 also shows the top 20 individual matrices found in the SV40 promoter.  This 
shows the redundancy seen when searching sequences using this option with the top 
hits being V$SP1.02 and V$GC.01 with 11 and both having very similar binding sites 
and were part of the V$SP1F matrix family.  This is the same number of sites as seen 
when analysing the promoter using the matrix families’ option.  Although this tells us 
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that all the V$SP1F sites bind similar factors this is not unsurprising.  However, one 
interesting result that cannot be seen from looking at the matrix family results 
summary table is that of the 13 V$KLFS sites identified seven of these are capable of 
binding KLF7.  This is interesting because it is known that KLF7 is a ubiquitously 
expressed KLF protein (Matsumoto et al., 1998) and therefore is likely to be expressed 
in CHO cells.  It might also suggest that the SV40 promoter might rely on the 
ubiquitously expressed proteins such as SP1 and KLF7 for its expression.  The majority 
of the rest of the individual matrices are homeobox related factors whose roles might 
be less important in our context due to their expression and function being in mainly 
developing organisms.  However, it is known that some homeobox proteins are 
involved in cancer and in particular ovarian cancers (Basu & Roy, 2013; Christensen et 
al., 2008; Crijns et al., 2007) and the cell lines used in this thesis are CHO cells which 
are essentially immortal cancer cell lines.  Although they may have roles post 
development these are less well defined and it may be sensible to consider TFBSs for 
TFs which are known to be ubiquitously expressed more worthy of further attention 
before these homeobox factors.  Other individual matrices that should be mentioned 
are the 4 V$NFKAPPAB65.02, V$AP1F, V$E2F1_DP1.01 and V$E2F4 sites identified.  
Both the NFKB and AP1 proteins have been well studied and shown to be important in 
the expression of many genes (Fujioka et al., 2004) while some E2F proteins are known 
to be ubiquitously expressed and are regulators of the cell cycle (Trimarchi & Lees, 
2002).  All may play roles in expression from the SV40 promoter. 
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Table 5.2 – Top 20 MatInspector results for the SV40 early promoter searched using both 
matrix families and individual matrices 
Matrix families  Individual matrices 
Matrix Family  Match Total  Matrix  Match Total 
V$KLFS  13  V$SP1.02  11 
V$SP1F  11  V$GC.01  11 
V$OCT1  9  V$SP1.03  9 
V$HBOX  9  V$KLF7.02  7 
V$HOMF  8  V$ISX.01  6 
V$HOXF  8  V$NOBOX.02  6 
V$ZF02  8  V$LBX2.01  6 
V$AP1R  7  V$SHOX2.01  6 
V$CART  7  V$ALX4.01  6 
V$STEM  6  V$MSX1.01  5 
V$AP1F  4  V$SP1.01  5 
V$RREB  4  V$AP1.01  4 
V$NFAT  4  V$NFKAPPAB65.02  4 
V$GCMF  4  V$GBX1.01  4 
V$E2FF  4  V$E2F1_DP1.01  4 
V$LHXF  4  V$E2F4.01  4 
V$ETSF  3  V$MSX2.01  4 
V$DLXF  3  V$HLXB9.01  4 
V$BCDF  3  V$MSX.01  4 
V$CEBP  2  V$KLF6.01  4 
The table shows the numbers of potential TFBS identified in the SV40 promoter sequence by 
MatInspector.  The left hand side of the table shows the results when searching for matrix families and the 
left hand side shows the results for individual matrices.  Only the top 20 hits are shown for each and the 
full results can be found in the appendix. 
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The most prominent matrix family identified by MatInspector for the CMV promoter 
was by far V$CREB with 23 potential sites, 15 more than any other matrix family (table 
5.3).  The V$CREB matrix family contain binding sites for many related proteins from 
ATF proteins and also CREB proteins which have similar binding sites and also wide 
ranging roles in processes such as cell growth, survival and apoptosis (Persengiev & 
Green, 2003; Hai & Hartman, 2001).  Although it is impossible to say with any 
certainty, but this large number of sites for this particular family suggests they will 
have some role to play in the expression from the CMV promoter to some extent.  
However, it should also be mentioned that the consensus binding sequence for 
ATF/CREB is a palindromic sequence (5’ – TGACGTCA – 3’) (Hai & Hartman, 2001) and 
therefore for the majority of sites identified, will be found in pairs with a site on both 
the + and - strand.  The next most prevalent matrix families are V$E4FF, V$HOMF and 
V$HOXF with 9 sites each.  Both V$HOMF and V$HOXF were also found in similar 
numbers in the SV40 promoter.  The V$E4FF matrix family contains binding sites for 
the E4F1 protein which is ubiquitously expressed and has been shown to be important 
for adenovirus E1a inducible early gene expression (Fernandes & Rooney, 1997; Lee & 
Green, 1987; Raychaudhuri et al., 1987).  The fact that adenovirus E1a protein cleaves 
E4F1 to produce a transcriptionally active form suggests it potentially is not important 
for CMV promoter expression if the E4F1 is not actively cleaved in the chosen cell line 
and thus acting as a transcriptional repressor (Fernandes & Rooney, 1997; Lee & 
Green, 1987; Raychaudhuri et al., 1987).  Removal of the E4F1 sites from the CMV 
promter could potentially improve its expression.  Again as with the SV40 promoter 
just looking at the matrix families present it is impossible to tell which TFBSs are 
actually functional and important for expression. 
When looking at table 5.3 and the individual matrices the top 20 are dominated by 
both ATF and CREB sites.  Given the number of V$CREB sites identified this is not 
surprising and many of these are redundant matches which overlap.  This does show 
the large number of related proteins which could potentially bind this promoter.  One 
of the most prevalent V$CREB individual matrices is V$ATF6.02 with nine matches.  In 
chapter 3 we showed how ATF6(50) and ERSE could be used to control 
transcription/expression.  However, upon closer inspection none of the V$ATF6.02 
191 
Nathan West The University Of Sheffield 
sites made up a complete ERSE (no adjacent NF-Y site) and therefore even if these 
ATF6 sites are functional in the CMV promoter they are likely to function differently to 
what was shown in chapter 3.  Different individual NF-κB matrices also feature quite 
prominently and even though again many of these were redundant matches it shows 
how many different forms of NF-κB might be capable of binding the CMV promoter.  
As well as individual matrices for ATF/CREB and NF-κB factors another prevalent matrix 
was the V$E4F.01 which has nine potential sites.  This is the same as found for matrix 
families and is not surprising due to the fact the V$E4FF family is only composed of this 
single individual matrix for the E4F1 TF.  If the numbers of potential TFBSs present for a 
particular group of factors reflect an involvement in the regulation of a promoter then 
from this basic search we would expect ATF/CREB, NF-κB and E4F factors to be 
involved in regulation of the CMV promoter.  This assumption might be logical and will 
possibly be true to a certain extent but caution should be taken.  This will be the case 
for some promoters but not for others and it also is entirely possible that TFBSs found 
only in small numbers could be just as important if not more for the regulation of a 
promoter.  
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Table 5.3 – Top 20 MatInspector results for the CMV major immediate-early promoter 
searched using both matrix families and individual matrices 
Matrix families  Individual matrices 
Matrix Family  Match Total  Matrix  Match Total 
V$CREB  23  V$CREB1.01  10 
V$E4FF  9  V$ATF.01  10 
V$HOMF  9  V$CREB.02  10 
V$HOXF  9  V$ATF.02  10 
V$MYBL  8  V$CREB2.01  9 
V$BRNF  7  V$ATF2.01  9 
V$SORY  6  V$ATF6.02  9 
V$NF1F  6  V$CREB.03  9 
V$E2FF  6  V$E4F.01  9 
V$RXRF  5  V$CREB2CJUN.01  8 
V$SP1F  5  V$JUNDM2.01  8 
V$KLFS  4  V$ATF1.01  8 
V$HNF6  4  V$NFKAPPAB65.02  7 
V$NFKB  4  V$NFKAPPAB.02  5 
V$NKX6  4  V$NFKAPPAB.01  4 
V$RORA  4  V$HIVEP1.01  4 
V$AP1R  4  V$CREL.01  4 
V$GLIF  4  V$NFKAPPAB65.01  4 
V$SRFF  4  V$SRF.01  4 
V$NFAT  4  V$HOXC8.01  4 
The table shows the numbers of potential TFBS identified in the CMV promoter sequence by 
MatInspector.  The left hand side of the table shows the results when searching for matrix families and the 
left hand side shows the results for individual matrices.  Only the top 20 hits are shown for each and the 
full results can be found in the appendix. 
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Table 5.4 shows the top 20 MatInspector hits for the EF1α promoter.  The most 
identified matrix family was the V$E2FF with 12 sites.  As mentioned earlier this is 
composed of E2F proteins and related factors, many of which are ubiquitously 
expressed and involved in cell cycle regulation and synthesis of DNA in mammalian 
cells (Gaubatz et al., 2000; Nevins, 1998).  The next most prevalent were V$EGRF and 
V$ZF02, with 11 potential sites.  The V$EGRF matrix family is composed of binding sites 
for EGR (early growth response) proteins which are involved in immune responses 
(Gomez-Martin et al., 2010).  While, as mentioned earlier, the V$ZF02 family contains 
binding sites for a set of related zinc finger DNA binding domain proteins.  The next 
most prevalent matrix families are V$KLFS with 9 and V$NKXH, V$SP1F and V$PAX5 
with 7 each.  V$KLFS and V$SP1F were both mentioned earlier when talking about the 
SV40 promoter.  Both V$NKXH and V$PAX5 matrix families contain the binding sites for 
different types of homeodomain proteins (Stanfel et al., 2005; Pilz et al., 1993; Adams 
et al., 1992). 
When looking at the individual matrices in table 5.4, the EF1α promoter unlike the 
SV40 and CMV promoters, has fewer individual matrices identified for its top hits.  
MatInspector identified 5 possible V$GRHL1.01, V$SP1.01, V$NM23.01 and 
V$ZBTB7.03 sites for each individual matrix with all four being from different matrix 
families.  In comparison the top hits for both the SV40 and CMV had 11 and 10 
respectively.  The individual matrices for EF1α unlike the other promoters were not as 
dominated by 2-3 matrix families.  This could possibly be due to the EF1α promoter not 
being made up of repeated DNA sequences and the larger variety of potential TFBSs 
present.  This also makes it more difficult to make any assumptions about the TFs 
which might possibly be important in regulation of the EF1α promoter. 
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Table 5.4 – Top 20 MatInspector results for the human EF1α promoter searched using both 
matrix families and individual matrices 
Matrix families  Individual matrices 
Matrix Family  Match Total  Matrix  Match Total 
V$E2FF  12  V$GRHL1.01  5 
V$EGRF  11  V$SP1.01  5 
V$ZF02  11  V$NM23.01  5 
V$KLFS  9  V$ZBTB7.03  5 
V$NKXH  7  V$AHRARNT.03  4 
V$SP1F  7  V$ZF5.01  4 
V$PAX5  7  V$SP1.03  4 
V$ETSF  6  V$GRHL3.01  4 
V$HESF  6  V$NGFIC.01  4 
V$HOMF  5  V$EGR2.01  4 
V$NDPK  5  V$MAZR.01  4 
V$GRHL  5  V$KKLF.01  4 
V$MAZF  5  V$GC.01  4 
V$STAT  5  V$PAX5.02  3 
V$ZF5F  4  V$E2F1_DP1.01  3 
V$AHRR  4  V$MYCMAX.03  3 
V$CREB  4  V$HELT.01  3 
V$HEAT  4  V$KLF7.01  3 
V$EBOX  4  V$ZFX.01  3 
V$ZFXY  3  V$ZFP57.01  3 
The table shows the numbers of potential TFBS identified in the EF1α promoter sequence by 
MatInspector.  The left hand side of the table shows the results when searching for matrix families and the 
left hand side shows the results for individual matrices.  Only the top 20 hits are shown for each and the 
full results can be found in the appendix. 
 
In summary MatInspector identified both a higher number of matrix families and more 
TFBSs in the both the CMV and EF1α promoters compared to the SV40 promoter.  This 
reflected the differences in strength between the SV40 promoter and the other two 
promoters.  Although the CMV had less matrix families and potential TFBSs than the 
EF1α promoter the matrix families found in the CMV had more redundant matches in 
terms of individual matrices.  So although the EF1α could possibly bind TFs from a 
greater number of matrix families, the CMV may bind a greater number of individual 
TFs.  It was also shown that both the SV40 and CMV promoters had more TFBSs when 
compared to representative sequences while the EF1α promoter had a similar number.  
This was probably due to not only the greater length of the EF1α promoter but also 
that the SV40 and CMV promoters contain repeated sequences. 
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If the results from MatInspector, in terms of the number of both matrix family and 
individual matrices, where solely used as guide for experimentally studying which TFs 
are important in the regulation of each promoter it might suggest that factors from the 
SP1 and KLF families as well as homeobox TFs for the SV40 promoter.  ATF/CREB TFs, 
the E4F1 TF, NF-κB TFs and homeobox TFs for the CMV promoter and factors from the 
E2F and EGR families for the EF1α.  The individual matrices for the EF1α unlike the 
SV40 and CMV promoter came from a greater number of matrix families which made it 
harder to make assumptions about the TFs possibly important in its regulation. 
Although studying the promoters this way gives a large amount of information in terms 
of potential TFBSs, it is limited in so much that it is impossible to really deduce which 
sites or types of sites are actually important for transcription from these promoters.  
One thing to consider is that although these sites have been identified by MatInspector 
many of these sites could have just occurred through chance and play no role in 
regulation of these promoters.  Looking at the top hits might suggest that these sites 
may be important but due to the different patterns of bp’s in their sequences some 
sites may appear more often than others in DNA sequences generally.  In the next 
section each promoter was analysed for TFBSs which are found to be overrepresented 
in each promoter sequence when compared to both genomic and promoter 
backgrounds.   
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5.5.2 – Overrepresented TFBS in the SV40, CMV and EF1α promoters 
To see which TFBSs appeared more often and statistically significantly in these three 
promoter sequences than would be expected the SV40, CMV and EF1α promoters 
were analysed for the presence of overrepresented TFBSs and compared to both 
genomic and promoter backgrounds from Mus musculus.  The hypothesis being that 
TFBSs that appeared in numbers statistically significantly greater than the average of a 
representative sample might potentially play a role in the regulation of a promoter. 
Table 5.5 shows the results for the SV40 promoter compared to a genomic 
background.  Similar to the MatInspector results it was shown that both the related 
V$SP1F and V$KLFS matrix families have the highest Z-scores and are the top results, 
being the most statistically significantly overrepresented matrix families.  This is also 
the case when compared to a promoter background (table 5.6).  This further suggests 
some role for these families of factors in the regulation of the SV40 promoter.  In total 
19 matrix families were found to be overrepresented when compared to both 
backgrounds and of these 19, 16 appeared in both sets of search results (22 matrix 
families in total).  In total when compared to a genomic background, of the 19 matrix 
families identified, this composed of a 107 TFBSs and 114 TFBSs when compared to a 
promoter background.  When compared to the raw results from MatInspector (table 
5.1) the matrix families identified make up less than half (38%) of the total matrix 
families (50) while the number of TFBSs make up between 66-70% of the total number 
of potential TFBSs (163). 
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The same search for the CMV promoter unsurprisingly showed the V$CREB matrix 
family as statistically overrepresented when compared to both a genomic background 
(table 5.7) and a promoter background (table 5.8).  However, the most significantly 
overrepresented matrix family is the V$E4FF and this is also true for both background 
comparisons.   In terms of the total numbers of matrix families identified as 
overrepresented when compared to the genomic background there was 13.  This 
increased to 18 when compared to a promoter background.  12 of these matrix 
families were found in both background comparisons (19 matrix families in total).  This 
difference in the number of matrix families identified between backgrounds also 
meant that the number of TFBSs rose from 89 to 115 when looking at the genomic and 
promoter background comparisons respectively.   Comparing these numbers to the 
MatInspector results (table 5.1) the total number of matrix families identified 
compared to a genomic and promoter background is around 17% and 23% respectively 
when compared to the total for MatInspector (77).  In terms of the numbers of 
individual TFBS those found to overrepresented accounted for 40% and 51% of the 
total identified by MatInspector (225) for both a genomic and a promoter background. 
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The most overrepresented matrix family in the EF1α promoter was V$EGRF when 
compared to a genomic background (table 5.9) and V$E2FF when compared with a 
promoter background (table 5.10), although both of these matrix families are 
overrepresented compared with each background.  In terms of the total numbers 
identified there was more overrepresented matrix families (19) and individual TFBS 
(101) when compared to a genomic background then there was when compared to a 
promoter background (11 and 70).  All 11 overrepresented matrix families shown to be 
overrepresented compared with a promoter background were also overrepresented 
compared to a genomic background.  This change between backgrounds was quite 
different when compared to the results for both the SV40 and CMV promoters.  When 
the results of the search for overrepresented TFBS in the EF1α promoter is compared 
to the results of the MatInspector search (table 5.1) the total number of matrix 
families identified compared to both a genomic and a promoter background are 17% 
and 10% of the total number of matrix families identified by MatInspector.  For the 
total number of TFBSs when compared to a genomic and a promoter background they 
are 37% and 26% respectively of the total number of potential TFBS identified by 
MatInspector. 
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Although as with the MatInspector search there are limitations to the assumptions 
that can be made with these results it is interesting the differences seen between the 
two viral promoters and the mammalian EF1α promoter.  Both the total numbers of 
overrepresented potential TFBSs in the SV40 and CMV promoters make up a larger 
proportion (66-70% and 40-51%) of the total identified by MatInspector compared to 
the EF1α promoter (37-26%).  This could be simply due to the EF1α sequence being 
two times the length or greater than the viral promoters in length and the repeated 
nature of the viral promoter sequences.  The increased length would increase the 
expected numbers of each matrix family in both backgrounds and therefore the 
required number of TFBSs for a matrix family to be statistically overrepresented.  
Whereas with repeated shorter sequences (viral promoters) you would expect less 
expected numbers in a background sequence but would possibly get more than 
expected if a potential TFBS was found in part of a repeated viral promoter sequence.  
However the more interesting difference is the fact that there was a decrease in the 
numbers of overrepresented matrix families identified between genomic and 
promoter backgrounds in the EF1α promoter but an increase for the CMV promoter.  
This cannot be simply due to the size of the promoters and has to be due to the 
different kinds of TFBSs present in each promoter, the origin of the promoters and also 
origin of the backgrounds used for comparison.  The TFBSs identified in the EF1α 
promoter were less likely to occur in genomic background but more likely to occur in 
promoters and hence the decrease in overrepresented matrix families, while the TFBSs 
in the CMV promoter are more likely to occur in a genomic background and less likely 
to occur in a promoter background.  Since the EF1α promoter is the human homolog 
and the backgrounds used for comparison came from M. musculus it is not that 
surprising that a mammalian promoter has less overrepresented TFBSs when 
compared to a mammalian promoter background than a genomic background.  At least 
between these promoters there seems to be a distinct difference between those of a 
viral and that of a mammalian origin as we have also seen when analysing the 
sequences using MatInspector. 
In summary and in comparison to the results from MatInspector TF families which may 
play a role in regulation of the SV40 promoter include both the SP1 and KLF families 
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and homeobox TFs again.  TFBSs for AP1 and RREB factors both appeared near the top 
of both tables (5.5 & 5.6) for the SV40 promoter.  AP1 (Activating protein 1) is 
heteromeric protein complex which is composed of JUN, FOS and ATF dimmers and 
shown to be important in the regulation of differentiation, proliferation and apoptosis 
(Hess et al., 2004).  The protein RREB-1 (Ras-responsive element binding protein 1) 
binds the RREB site and has been shown to be involved in many forms of cancer 
(Costello et al., 2012; Zou et al., 2011; Oxford et al., 2007; Thiagalingam et al., 1996). 
The ATF/CREB family and E4F1 TFBSs as well as having the highest number of identified 
sites they were also the most overrepresented.  NF-κB TFBSs were also shown to be 
over-represented along with NF1 (Nuclear factor 1) TFBSs which were not mentioned 
previously.  NF1 factor binding sites were the third most statistically overrepresented 
TFBSs in the CMV promoter for both background comparisons and NF1 TFs have been 
shown to act as transcriptional activators (Pjanic et al., 2011).  It should be noted 
though that the NF1 TFBS can be palindromic (Devries et al., 1987).  E2F factor TFBSs 
were also shown to be overrepresented in the CMV promoter compared to both 
backgrounds. 
Like the SV40 and CMV promoter the top two MatInspector hits for the EF1α 
promoter, E2F and EGR family TFBSs, were also the also overrepresented.  Some of the 
most statistically overrepresented TFBSs in both backgrounds involved different zinc-
finger families of TFs which are less well defined in terms of specific families and 
functions compared to the other families of TFs mentioned so far. 
This search might help reduce the number of potential candidates of TFs which are 
potentially important in the regulation of each of these promoters compared to the 
MatInspector results, but only if the hypothesis that overrepresentation is a sign that a 
TFBS is important in a promoter’s regulation.  This will not be true for all promoters 
but it could possibly be truer for promoters which are composed of repeated 
sequences.  It has been shown that clusters of TFBSs for the same TF, termed 
homotypic clusters of TFBSs (HCTs), are important in the regulation of some genes and 
this was first shown in invertebrates and they have also been identified in the 
promoters and enhancers of human genes (Gotea et al., 2010; Lifanov et al., 2003).  
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One study showed that increases in the concentration of the TF NF-κB lead to 
increases in expression of genes which contained multiple NF-κB TFBSs in their 
promoters (Giorgetti et al., 2010).  NF-κB TFBSs were found to be overrepresented in 
the CMV promoter.  Although we do not have proof that this occurs in the CMV it is 
possible that some of the overrepresented TFBSs and even some that were not 
overrepresented may function this way not only in the CMV promoter but in the other 
promoters as well. 
Further experimentation would be needed to show whether the presence of multiple 
TFBSs for the same factor does indeed play a part in the regulation of these promoters.  
The simplest way of doing this is either through the over-expression or chemical 
induction of specific TFs.  As well as looking for overrepresented TFBSs to identify 
potential TFBSs which are important for the regulation of the promoters studied 
another program in the Genomatix Software Suite, ModelInspector, allows you to 
search for so called TFBS modules which have known functionality and this was carried 
and the results presented in the next section. 
 
5.5.3 – ModelInspector analysis of the SV40, CMV and EF1α promoters 
The previous searches have identified potential TFBSs and those that are 
overrepresented in the promoters studied.  Although this has given some insight into 
which TFs might be involved in each promoter the program ModelInspector gives more 
evidence on the functionality of some of the TFBSs present.  It searches sequences for 
modules which are composed of two or more TFBSs which are within a certain 
distance and orientation of each other and have been shown in the literature to be 
important for the expression of a specific gene or expression from a certain promoter.  
Although lab work would still need to be carried out to confirm their functionality, this 
is more informative than searching solely for individual TFBSs due to the fact that most 
TFs do not normally function as single factors. 
Table 5.11 shows the results of the ModelInspector search of the SV40 promoter.  33 
model matches in total from ten different modules were identified in this sequence.  
Six of these different modules involved SP1 or related factors.  The most prevalent 
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model involved different variants of SP1F_SP1F and 11 were found in total.  Not all of 
these were identical and differed slightly in the SP1 or related factors involved while 
also in the distance between the TFBSs.  Given the high numbers of V$SP1F sites 
identified by MatInspector this is perhaps not surprising that these sites are also 
involved in model matches as well.  The next most prevalent model was ETSF_SP1F 
with 5 matches, followed by KLFS_SP1F and SP1F_ETSF with 4 and then E2FF_SP1F 
with 2.  The top five model matches all involved SP1 or related factors.  Along with the 
previous searches this adds further evidence that SP1 and its related factors are 
important for expression from the SV40 promoter.  Other factors which might be 
important in SV40 expression which have not been mentioned include CEBP, MYB, AP1 
and NFKB factors.  In total eight different matrix families are involved in the modules 
identified in the SV40 promoter.  To what extent each TF has on expression from the 
SV40 promoter it is unknown but it is likely that it will not solely rely on a single TF or 
group of related TFs such as SP1 and its related factors. 
Looking at the matrix families involved in the model matches we can see that V$SP1F 
had the greatest number of TFBSs with 11 followed by V$KLFS and V$ETSF with six 
each, both V$NFKB and V$E2FF had two identified sites while the rest had one.  There 
were 30 TFBSs identified in total by ModelInspector in the SV40 promoter from eight 
different matrix families. 
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Table 5.11 – Results for ModelInspector search of the SV40 early promoter 
Model matches  Matrix families involved 
Model  Matches  Matrix family  Number 
SP1F_SP1F  11  V$SP1F  11 
ETSF_SP1F  5  V$ETSF  6 
KLFS_SP1F  4  V$KLFS  6 
SP1F_ETSF  4  V$E2FF  2 
E2FF_SP1F  2  V$NFKB  2 
ETSF_NFKB  2  V$AP1F  1 
SP1F_KLFS  2  V$CEBP  1 
AP1F_NFKB  1  V$MYBL  1 
KLFS_KLFS_NFKB  1  Total  30 
MYBL_CEBP  1     
Total  33     
The table shows the results for the SV40 early promoter when analysed using the program 
ModelInspector.  The left hand side of the table shows the modules identified along with the number 
model matches in the promoter.  The right hand side of the table shows the individual matrix families 
involved along with the numbers identified in the sequence.  Some of the potential TFBSs within the 
promoter sequence appeared in more than one model match but this was counted as a single TFBS. 
 
The results of the ModelInspector search of the CMV promoter are presented in table 
5.12.  29 matches were identified within the CMV promoter which composed of 22 
different modules.  The top seven hits all had two matches each while the remaining 
matches only had a single hit.  As was shown with MatInspector V$CREB matrices were 
again identified in high numbers with five out of the top six model matches and six in 
total containing V$CREB matrices.  Nine modules involved at least one V$SP1F site, 6 
involved V$NFKB, and 4 involved V$NF1F.  Looking at the matrix families involved we 
can see that ten potential V$CREB TFBSs were identified followed by 6 each of V$NF1F, 
V$NFKB and V$SP1F.  In total 17 different matrix families were involved in the model 
matches identified and 48 different potential TFBS. 
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Table 5.12 – Results for ModelInspector search of the human CMV major immediate-
early promoter 
Model matches  Matrix families involved 
Model  Matches  Matrix family  Number 
CREB_NFKB  2  V$CREB  10 
CREB_SP1F  2  V$NF1F  6 
CREB_YY1F  2  V$NFKB  6 
NF1F_EBOX  2  V$SP1F  6 
NFAT_CREB  2  V$YY1F  4 
NFKB_CREB  2  V$NFAT  3 
SP1F_YY1F  2  V$EBOX  2 
CEBP_NFKB  1  V$ETSF  2 
CEBP_SP1F  1  V$AP1F  1 
CREB_NFAT_NFAT  1  V$CAAT  1 
EREF_SF1F  1  V$CEBP  1 
ETSF_NFKB  1  V$EREF  1 
ETSF_SP1F  1  V$FKHD  1 
ETSF_SRFF  1  V$HNF1  1 
FKHD_NF1F  1  V$SF1F  1 
NF1F_NF1F_HNF1  1  V$SRFF  1 
NFKB_AP1F  1  V$KLFS  1 
SP1F_CAAT  1  Total  48 
SP1F_KLFS  1     
SP1F_NF1F  1     
SP1F_NFKB  1     
YY1F_SRFF  1     
Total  29     
The table shows the results for the human CMV major immediate-early promoter when analysed using 
the program ModelInspector.  The left hand side of the table shows the modules identified along with the 
number model matches in the promoter.  The right hand side of the table shows the individual matrix 
families involved along with the numbers identified in the sequence.  Some of the potential TFBSs within 
the promoter sequence appeared in more than one model match but this was counted as a single TFBS. 
Table 5.13 shows the model matches identified for the EF1α promoter.  22 matches 
were identified and this involved 18 different modules.  The highest recurring model 
was ETSF_KLFS with 3 matches followed by ETSF_NFKB and KLFS_SP1F with two.  The 
remaining modules had a single match.  V$ETSF was found more than any other matrix 
family in terms of the number of modules it was part of (7) followed by V$SP1F (6).  In 
terms of the matrix families involved there were 18 different families and a total of 35 
individual TFBS.  V$ETSF was the most prevalent family with 7 sites followed by V$KLFS 
and V$SP1F with 5 and V$HAML, V$HIFF and V$NFKB with 2.  The remaining matrix 
families had a single site. 
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Table 5.13 – Results for ModelInspector search of the human EF1α promoter 
Model matches  Matrix families involved 
Model  Matches  Matrix family  Number 
ETSF_KLFS  3  V$ETSF  7 
ETSF_NFKB  2  V$KLFS  5 
KLFS_SP1F  2  V$SP1F  5 
EBOX_EREF  1  V$HIFF  2 
ETSF_ETSF  1  V$HAML  2 
ETSF_HAML  1  V$NFKB  2 
ETSF_HIFF  1  V$AP1F  1 
ETSF_SP1F  1  V$AP1R  1 
HAML_AP1F  1  V$AP2F  1 
HIFF_ETSF  1  V$EBOX  1 
NBRE_AP1F  1  V$EREF  1 
NFAT_AP1R  1  V$NBRE  1 
NFKB_NKXH  1  V$NFAT  1 
P53F_SP1F  1  V$NKXH  1 
SORY_PAX6  1  V$P53F  1 
SP1F_AP2F  1  V$PAX6  1 
SP1F_KLFS  1  V$SORY  1 
SP1F_YY1F  1  V$YY1F  1 
Total  22  Total  35 
The table shows the results for the human EF1α promoter when analysed using the program 
ModelInspector.  The left hand side of the table shows the modules identified along with the number 
model matches in the promoter.  The right hand side of the table shows the individual matrix families 
involved along with the numbers identified in the sequence.  Some of the potential TFBSs within the 
promoter sequence appeared in more than one model match but this was counted as a single TFBS. 
 
Comparing the results of the ModelInspector searches between the three different 
promoters we can see that the SV40 promoter is quite different from the other two at 
least in terms of the numbers of matrix families involved.  Although the SV40 promoter 
had the highest number of model matches (33) when compared to the CMV (29) and 
EF1α (22) promoters it had the lowest number of different matrix families involved 
(10).  There seemed a bias towards V$SP1F sites with it being the most identified 
matrix family, SP1F_SP1F modules being the most prevalent as well as SP1F being 
involved with six of the ten different modules found (60%).  In terms of model matches 
none of the other two promoters had this bias towards a single factor.  The CMV 
promoter did have 11 V$CREB sites but in terms of model matches it was always 
involved with another matrix family and although involved in six different modules this 
was out of 22 different modules in total (27%).  V$ETSF was the most prevalent matrix 
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family in the EF1α promoter with seven TFBS and was involved in seven different 
modules but this was out of the 18 in total (39%).  These results would suggest that the 
SV40 promoter may be highly reliant on SP1 factors for its expression and fits in with 
previous work which has shown SP1 to be important factor for transcription from the 
SV40 promoter (Saffer et al., 1990; Dynan & Tjian, 1983).  Other factors are probably 
involved in the expression from the SV40 promoter and are either required or aid SP1. 
Looking at the ModelInspector results for the CMV and EF1α promoters although they 
both had less model matches in total the number of different modules identified were 
greater, 22 and 18 respectively, then the SV40 (10).  Unlike the SV40 promoter the 
CMV and EF1α did not seem to rely so heavily on a signal TF or TF family and both had 
a much greater variety in terms of both modules and also the matrix families involved.  
The CMV had 17 different matrix families and 48 individual TFBS, the EF1α had 18 and 
35 while the SV40 had 8 and 30.  It is possible that it is this extra variety of possible TFs 
that make the CMV and EF1α promoters stronger than the SV40 promoter.  A lack or 
limited supply of SP1 may limit expression from the SV40 promoter were as the CMV 
and EF1α promoters maybe less reliant on a single TF family.  Alternatively the TFs 
most important for expression from the CMV and EF1α promoters might be stronger 
transcriptional activators.  
In summary the results shown by the ModelInspector searches for each promoter 
provide stronger evidence then the previous searches for potential TFBSs which are 
important in the regulation of these promoters due to the modules identified being 
shown to be functional in the corresponding literature that was used to construct 
them.  The ModelInspector results should be used as a guide as to which TFs and TFBSs 
should be studied in each promoter to gain further understanding of their regulation. 
As well as trying to identify TFBSs which may be potentially important for the 
regulation of these promoters we also want to understand why these promoters, 
especially the CMV, interfere or compete and have negative effects on the expression 
from a co-expressed promoter.  One hypothesis is that there is competition for shared 
TFs.  In the next section we look at TFBSs which are shared/common between the 
three promoters. 
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5.5.4 – Common TFBS in the SV40, CMV and EF1α promoters 
One of the hypotheses of why these three promoters interfere with the expression of 
one another is that there is competition for shared TFs.  One simple way of 
investigating this is to compare the three promoters for the potential TFBSs they 
contain, as identified by MatInspector, and share between themselves.  As shown 
earlier the SV40 promoter has TFBSs from 50 different matrix families while the CMV 
and EF1α have 77 and 122 respectively (table 5.1).  However, how many of these 
matrix families are present in all three promoters and how much do the numbers of 
different potential TFBSs identified by MatInspector for each promoter from the 
different matrix families’ overlap?  As well as looking at which were shared between all 
three, we also looked at which were shared between just two of the promoters.  
Whether the matrix family was overrepresented was also taken into account.  Venn 
diagrams were also produced to show how the numbers and proportion of both the 
different matrix families and the different TFBSs identified in each of promoters were 
shared between each promoter.  This was also done for the ModelInspector results. 
In total for the MatInspector searches of all three promoters TFBSs from 137 different 
matrix families were identified.  Table 5.14 shows the matrix families which are 
present in all three promoters and they are in order of the total number of matches.  
28 different matrix families were shown to be present in all three promoters (table 
5.14 & figure 5.2).  This is 56% of the matrix families identified for the SV40 promoter 
(50 matrix families), 36% for the CMV (77 matrix families) and 25% for the EF1α 
promoter (112 matrix families).  14 of the matrix families for the SV40 were also shown 
in the previous section to be overrepresented compared to either a genomic or 
promoter background or both (table 5.14).  A further 14 matrix families were also 
found either just in the CMV promoter (7) (table 5.15 and figure 5.2) or the EF1α 
promoter (7) (table 5.16 & figure 5.2).  Four of the seven matrix families shared just 
between the SV40 and CMV promoters were found to be overrepresented in the SV40 
in either or both background comparisons, while for those shared just between the 
SV40 and EF1α this was two out of seven.  In total 20 out of 22 overrepresented matrix 
families in the SV40 were found in either one or both of the CMV and EF1α promoters.  
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Of the 50 matrix families found in the SV40 promoter, 70% were found in either the 
CMV (35) or EF1α (35) promoter with 84% (42) in either or both (figure 5.2).   
As mentioned earlier for the CMV promoter, the 28 different matrix families shared by 
all three promoters (table 5.14 & figure 5.2) makes up ~36% of the total matrix families 
(77 matrix families) identified by MatInspector and nine of these matrix families were 
also shown to be overrepresented.  Seven more matrix families are also shared only 
with the SV40 promoter, one of which is overrepresented (table 5.15).  The CMV 
promoter therefore shares 35 matrix families in total with the SV40 which is 45% of 
the matrix families identified by MatInspector (77).  There are 60 matrix families 
shared between the CMV and EF1α promoters which are 78% of the total number 
CMV matrix families (77) and five of these matrix families are overrepresented in the 
CMV promoter.  15 out of the 19 overrepresented matrix families in the CMV 
promoter were shared we either the SV40 or EF1α promoter or both.  Of the 77 matrix 
families found in total in the CMV promoter, 45% (35) were found in the SV40, 78% 
(60) in the EF1α promoter with 87% (67) in either or both (figure 5.2). 
The EF1α promoter (112 matrix families) shares 25% of its matrix families (28) with 
both the SV40 and CMV and 7 of these matrix families are overrepresented (table 5.14 
& figure 5.2).  In total it shares 35 different matrix families with the SV40 promoter, 
which is around 31% of the total number of matrix families (112) and 10 of these are 
overrepresented in the EF1α promoter (table 5.14, 5.16 & figure 5.2).  With the CMV 
promoter the EF1a shares 60 matrix families which are 54% of the total numbers of 
matrix families found in the EF1α promoter (112) and eight are overrepresented in the 
EF1α promoter.  11 out of the 19 overrepresented matrix families in the EF1α 
promoter were shared with either the SV40 or CMV promoter or both.  In total, of the 
112 different matrix families identified in the EF1α promoter, 31% (35) are shared with 
the SV40 promoter, 54% (60) with the CMV and 60% (67) with both. 
The number of shared potential TFBSs from the different matrix families identified in 
each promoter was also compared.  In figure 5.3 we can see the overlap between the 
different promoters.  52 TFBSs were found in all three of the promoters and this was 
32% of those identified by MatInspector in the SV40 promoter (163 TFBSs), 23% of 
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those in the CMV (225 TFBSs) and 19% of those in EF1α promoter (274 TFBSs).  The 
SV40 promoter shared 81 TFBSs (50% of the total number of TFBS in the SV40 
promoter) with the CMV, 78 TFBSs (48%) with the EF1α promoter and 107 (66%) of its 
TFBSs with both.  In turn the CMV shared 81 TFBSs (36% of the total number of TFBS in 
the CMV promoter) with the SV40, 106 TFBSs with the EF1α promoter (47%) and 135 
(60%) TFBSs with both promoters.  The EF1α promoter shared 78 TFBSs with SV40 
(28% of the total number of TFBS in the EF1α promoter), 106 TFBSs with the CMV 
promoter (39%) and 132 TFBSs (48%) with both the SV40 and CMV promoters. 
In summary, the SV40 promoter shares a greater proportion of both its matrix families 
and the potential TFBSs identified by MatInspector with the CMV and EF1α promoters 
then both these promoters do with the SV40 promoter.  This is mainly because of the 
lower numbers found in the SV40 compared with the other two promoters but the fact 
the SV40 shares around 70% similarity in terms of its matrix families with either the 
CMV and EF1α, and 50% and 48% similarity respectively in terms of the TFBSs 
potentially present in the SV40 promoter, shows that there is significant overlap 
between both the matrix families and TFBSs present and this could be a possible cause 
for the promoter interference/competition in the previous chapter and why the SV40 
promoter was the most affected by co-expression with another competing promoter. 
In terms of those matrix families that were overrepresented in the SV40 promoter 
(table 5.5 & 5.6) 20 of the 22 matrix families were found either in the CMV or EF1α or 
both promoters.  The most overrepresented matrix family was the V$SP1F family (11 
TFBSs) and this was also overrepresented for both the CMV (5 TFBSs) and EF1α (7 
TFBSs) promoters (table 5.14).  The V$E2FF matrix family was overrepresented in all 
three promoters (table 5.5 – 5.10) with 4 TFBSs in the SV40, 6 in the CMV and 12 TFBSs 
in the EF1α promoters.  Only these two matrix families were overrepresented to one 
or both background comparisons in all three promoters.  The V$KLFS family was also 
overrepresented in the SV40 promoter (13) and again it shared sites with both CMV (4 
TFBSs) and the EF1α (9 TFBSs) but V$KLSF was only overrepresented in the EF1α 
promoter.   
216 
Nathan West The University Of Sheffield 
Five matrix families were overrepresented in both the SV40 and CMV promoters and 
as well as those mentioned in the last paragraph (V$SP1F and V$E2FF) they include the 
V$HOMF (8 & 9 TFBSs respectively), V$HOXF (8 & 9) and V$NFAT (4 in each) families.  
These first two are families of homeobox TFs and have been mentioned earlier in this 
chapter.  The V$NFAT family contains TFBSs for NFAT (nuclear factor of activated T-
cells) factors which have been shown to be involved in immune responses and has also 
a role in the development and metastasis of cancer (Pan et al., 2013).  The SV40 also 
shares 5 overrepresented matrix families with the EF1α promoter and as well as 
V$SP1F and V$E2FF these include V$KLFS (13 and 9 TFBSs respectively), V$ZF02 (8 and 
11) and V$ZFXY (2 and 3).   The V$ZFXY family contains TFBSs for the ZFY family of TFs 
which are implicated in mammalian sex determination with ZFX also playing a role in 
stem cell self-renewal and in some forms of cancer (Jiang et al., 2013; Tan et al., 2013; 
Zhou et al., 2011; Galan-Caridad et al., 2007; Poloumienko, 2004).  TFs which bind the 
matrices of the V$ZF02 family have less well defined roles between them but one TF, 
ZF9, has been shown to work with the SP1 TF in the regulation of some genes (Yasuda 
et al., 2002; Kim et al., 1998).   
In summary, 8 out of 22 of the SV40 promoters’ matrix families were also found to be 
overrepresented in either the CMV or EF1α promoter or both.  The V$SP1F and V$E2FF 
matrix families are the only two matrix families which were shown to be 
overrepresented in both the CMV and EF1α promoters.  This could be one potential 
reason why the CMV and EF1α promoters interfered with expression more from the 
SV40 promoter then they did with each other in chapter 4. 
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Table 5.14 – Common TFBS – matrix families which are present in all three promoters 
 
 
 
 Promoter 
Matrix Family  Match Total  SV40  CMV  EF1α 
V$CREB  28  1  23
g, p  4 
V$KLFS  26  13
g, p  4  9
g 
V$SP1F  23  11
g, p  5
g, p  7
g 
V$HOMF  22  8
p  9
p  5 
V$E2FF  22  4
g  6
p  12
g, p 
V$ZF02  21  8
g, p  2  11
g 
V$HOXF  19  8
g, p  9
g, p  2 
V$HBOX  15  9
g, p  3  3 
V$EGRF  13  1  1  11
g, p 
V$AP1R  13  7
g, p  4  2 
V$ETSF  12  3  3  6 
V$PAX5  11  2  2  7
g, p 
V$MYBL  11  1  8
g, p  2 
V$NFKB  9  2  4
g, p  3 
V$NFAT  9  4
g, p  4
p  1 
V$CART  9  7
g, p  1  1 
V$LHXF  9  4  3  2 
V$AP1F  8  4
g, p  2  2 
V$GRHL  7  1  1  5
g, p 
V$RORA  7  2  4
g, p  1 
V$GCMF  7  4
g, p  2  1 
V$RREB  6  4
g, p  1  1 
V$RUSH  6  2  1  3 
V$NOLF  5  2
g  1  2 
V$NR2F  5  1  1  3 
V$HAND  5  2  1  2 
V$PAX6  5  1  2  2 
V$ABDB  5  1  1  3 
Total TFBS  338  117  108  113 
The table shows matrix families which are found in all three of the promoters analysed along with the 
total number found and the number of TFBSs identified in each promoter by MatInspector.  The letters 
next to the number denote – g = overrepresented compared to a genomic background and p = 
overrepresented compared to a promoter background and this taken from the searches carried out in the 
previous section for overrepresented TFs (5.5.2). 
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Table 5.15 – Common TFBS – matrix families which are present in two of the promoters – 
SV40 and CMV 
 
 
 
 Promoter 
Matrix Family  Match Total  SV40  CMV 
V$OCT1  12  9
g, p  3 
V$STEM  7  6
g, p  1 
V$DLXF  5  3
p  2 
V$SNAP  5  2  3
p 
V$BRN5  5  1  4 
V$BCDF  4  3
p  1 
V$ATBF  2  1  1 
Total  40  25  15 
The table shows matrix families which are found in two of the three promoters analysed, SV40 early and 
human CMV major immediate-early, along with the total number found and the number of TFBSs 
identified in each promoter by MatInspector. The letters next to the number denote – g = overrepresented 
compared to a genomic background and p = overrepresented compared to a promoter background and this 
taken from the searches carried out in the previous section for overrepresented TFs (5.5.2). 
 
 
Table 5.16 – Common TFBS – matrix families which are present in two of the promoters – 
SV40 and EF1α 
 
 
 
 Promoter 
Matrix Family  Match Total  SV40  EF1α 
V$NDPK  7  2  5
g, p 
V$ZFXY  5  2
g, p  3
g, p 
V$CEBP  5  4  1 
V$OAZF  3  1  2
g 
V$ZICF  3  2
g, p  1 
V$AP2F  3  2  1 
V$BRAC  2  1  1 
Total  28  14  14 
The table shows matrix families which are found in two of the three promoters analysed, SV40 early and 
human EF1α, along with the total number found and the number of TFBSs identified in each promoter by 
MatInspector.  The letters next to the number denote – g = overrepresented compared to a genomic 
background and p = overrepresented compared to a promoter background and this taken from the 
searches carried out in the previous section for overrepresented TFs (5.5.2). 
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Table 5.17 – Common TFBS – matrix families which are present in two of the promoters – 
CMV and EF1α 
 
 
 
 Promoter 
Matrix Family  Match Total  CMV  EF1α 
V$BRNF  9  7
p  2 
V$NKXH  9  2  7 
V$STAT  8  3  5 
V$RXRF  8  5
g  3 
V$SORY  8  6  2 
V$NF1F  7  6
g, p  1 
V$GLIF  7  4
g, p  3 
V$PARF  7  4  3 
V$YY1F  6  3  3 
V$AHRR  5  1  4
g 
V$NKX6  5  4
p  1 
V$SRFF  5  4
  1 
V$HEAT  5  1  4 
V$PDX1  4  3  1 
V$CTCF  4  1  3 
V$GREF  4  2  2 
V$XBBF  4  3  1 
V$IRXF  3  1  2 
V$SAL2  3  1  2 
V$RBPF  3  1  2 
V$EREF  3  2  1 
V$CLOX  3  2  1 
V$CAAT  3  1  2 
V$LEFF  3  2  1 
V$FKHD  3  2  1 
V$PAX1  2  1  1 
V$GZF1  2  1  1 
V$NBRE  2  1  1 
V$ZF10  2  1  1 
V$PAX3  2  1  1 
V$PLAG  2  1  1 
V$DMRT  2  1  1 
Total  143  78  65 
The table shows matrix families which are found in two of the three promoters analysed, human CMV 
major immediate-early and human EF1α, along with the total number found and the of TFBSs identified 
in each promoter by MatInspector.  The letters next to the number denote – g = overrepresented compared 
to a genomic background and p = overrepresented compared to a promoter background and this taken 
from the searches carried out in the previous section for overrepresented TFs (5.5.2). 
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Figure 5.2 – Venn diagram showing the numbers and proportion of matrix families shared between 
the SV40, CMV and EF1α promoters identified by MatInspector.  
families identified in each promoter by MatInspector were compared an
was constructed to show how the matrix families were shared between the different promoters.  The 
numbers below the names of each promoter show the total number of matrix families present.
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Figure 5.3 – Venn diagram showing t
between the SV40, CMV and EF1
potential TFBSs identified in each promoter by MatInspector were compared and a proportional Venn 
diagram was constructed to show how the TFBSs were shared between the different promoters.
numbers below the names of each promoter show the total number of potential TFBSs present.
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The results from the ModelInspector searches (section 5.5.3) were also compared for 
both the common matrix families and potential TFBSs that were found in the modules 
of each promoter (table 5.18, figure 5.4. & 5.5).  In total five different matrix families 
were shared between all three promoters and this was 63% of the total found in the 
SV40 promoter (8 matrix families), 29% for the CMV (17) and 28% for the EF1α 
promoter (18) (table 5.18 & figure 5.4).  The SV40 promoter shared one more with the 
CMV promoter alone making the total shared with the CMV 6 (75%).  The SV40 
promoter did not share any matrix families with the EF1α promoter alone.  In total the 
SV40 shared 75% (6) of its matrix families (8) with either the CMV or EF1α or both 
promoters.  The CMV promoter shared 5 matrix families (29%) with both the SV40 and 
EF1α promoters, 6 with the SV40 (35%) and 9 with the EF1α promoter (53%).  The CMV 
shared in total 10 of its 17 matrix families (59%) with either the SV40 or EF1α promoter 
or both.  As mentioned earlier the EF1α promoter shares 5 of its 18 (28%) identified 
matrix families with both the SV40 and CMV promoters and 9 in total with the CMV 
promoter (50%).  It shares none alone with the SV40 promoter.  Therefore 50% (9) of 
the EF1α promoters’ matrix families (18) can be found in either or both of the SV40 or 
CMV promoters. 
In terms of the potential TFBSs identified by ModelInspector in each promoter 10 
TFBSs were shared between all three promoters (figure 5.5) and this was 33% of those 
identified in the SV40 promoter (30 TFBSs), 21% of the CMV (48 TFBSs) and 29% of 
those found in the EF1α promoter (35 TFBSs).  The SV40 shared 12 TFBSs with the CMV 
(40%), 19 with the EF1α promoter (63%) and 21 (70%) with either or both the CMV and 
EF1α promoters.  Of the 48 TFBSs in the CMV promoter it shared 12 with the SV40 
promoter (25%), 14 with the EF1α (29%) and 16 TFBSs (33%) with either or both of the 
other two promoters.  35 TFBSs were identified in the EF1α promoter by 
ModelInspector and 19 of these were shared with the SV40 (54%), 14 with the CMV 
(40%) and 23 TFBSs (66%) with either the SV40 or CMV or both promoters. 
Of the different matrix families identified by ModelInspector only one, V$SP1F, was 
shown to be overrepresented compared to either a genomic or promoter background 
or both in all three of the promoters (table 5.18).  The SV40 promoter had the most 
V$SP1F TFBSs with 11 which is slightly more than one third of the TFBSs identified by 
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ModelInspector in this promoter (30).  The CMV had 5 and the EF1α had 6 but these 
made up less of their total numbers of TFBSs identified by ModelInspector.  The 
V$KLFS family was overrepresented in the SV40 promoter with 6 sites but was not 
overrepresented in either of the other two promoters.  The CMV had 2 V$KLFS TFBSs 
while the EF1α had 5.  The V$ETSF family was present in all three promoters, the SV40 
and the EF1α promoters had 6 and 7 TFBSs respectively while the CMV had 2.  All three 
promoters had one V$AP1F site while V$NFKB TFBSs were also present in all three but 
with the SV40 and EF1α promoter having 2 each and the CMV having 6.  These 6 
V$NFKB TFBSs were considered to be overrepresented in the CMV promoter in 
comparison to both backgrounds. 
 
Table 5.18 – Shared matrix families from those identified using ModelInspector  
 
 Promoter 
Matrix family  SV40  CMV  EF1α 
V$SP1F  11
g, p
  6
g, p
  5
g
 
V$KLFS  6
g, p
  1  5 
V$ETSF  6  2  7 
V$NFKB  2  6
g, p
  2 
V$AP1F  1  1   1 
V$CEBP  1  1  - 
V$YY1F  -  4  1 
V$NFAT  -  3  1 
V$EBOX  -  2  1 
V$EREF  -  1  1 
The table shows the matrix families shared between the three promoters when analysed by 
ModelInspector and the number of TFBSs identified in each promoter.  The letters next to the number 
denote – g = overrepresented compared to a genomic background and p = overrepresented compared to a 
promoter background. 
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Figure 5.4 – Venn diagram showing the numbers and proportion of matrix families shared between 
the SV40, CMV and EF1α promoters identified ModelInspector.  
identified in each promoter by ModelInspector were compared a
constructed to show how the matrix families were shared between the different promoters.  The numbers 
below the names of each promoter show the total number of matrix families present.
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Figure 5.5 – Venn diagram showing
between the SV40, CMV and EF1
potential TFBSs identified in each promoter by ModelInspector were compared and a proportional Venn 
diagram was constructed to show how the TFBSs were shared between the different promoters.  The 
numbers below the names of each promoter show the total number of potential TFBSs present.
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This section has shown which matrix families and potential TFBSs that the SV40, CMV 
and EF1α promoters have in common from both the MatInspector and ModelInspector 
searches.  They have both shown that the matrix families and TFBSs identified in the 
SV40 promoter, which are also common to either the CMV or EF1α promoter, make up 
a greater proportion of the total identified in SV40 than the proportion in either the 
CMV or EF1α respectively.  It was also shown that the SV40 promoter shared more of 
its matrix families which were overrepresented (8 out of 22) with the other two 
promoters and also that a larger number of these overrepresented matrix families 
were also overrepresented in either the CMV (5) or EF1α (5) or both promoters.  There 
were less overrepresented matrix families (2) which were found to be overrepresented 
and common in between the CMV and EF1α promoters.  Taken this and what was 
shown in the previous sections that the SV40 promoter potentially has less TFBSs 
which are also from a smaller number of matrix families and that V$SP1F TFBSs make 
up a large proportion of the of the modules and related TFBSs identified in the SV40 
promoter it would seem likely that this promoter would be more affected by the 
presence of a competing promoter especially one which had a greater variety of TFBSs 
but which also shared common factors with the SV40 such as SP1 TFBSs. 
Although not all the matrix families and their TFBSs identified will be functional in the 
SV40, or in the other promoters, the fact that the SV40 promoter shares such a large 
percentage of its matrix families with either of the other two promoters or both 
suggests there would likely be competition for TFs which are important for expression 
from the SV40 promoters.  Even if the TFBSs in the CMV and EF1α are not functional or 
important in their own expression they could still bind TFs, probably only loosely, 
which are needed for the SV40, removing them from the available pool of TFs and 
limiting their availability.  This could be seen as transcriptional squelching which is 
believed to be caused by competition for a limited transcriptional regulator (Huliak et 
al., 2012; Cahill et al., 1994b; Prywes & Zhu, 1992) which in this case could be a TF/s.  It 
seems highly probable that the presence of shared TFBSs contributes to the promoter 
interference/competition that occurs between the SV40 and CMV or EF1α promoters 
and the fact as well as being the weakest promoter that most of the matrix families 
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present in the SV40 are also present in the other two promoters could be one reason 
why the SV40 is more affected by competition from another promoter. 
Throughout this chapter TFBSs from the V$SP1F family have been continually 
identified in all three of the promoter sequences but especially in the SV40 promoter.  
Not only were TFBSs from the V$SP1F family the second most prevalent sites identified 
in the SV40 (table 5.2), with V$SP1.02 being the most prevalent individual matrix 
identified (table 5.2) they were also the most overrepresented compared to both a 
genomic (table 5.5) and promoter (table 5.6) background.  V$SP1F sites were also 
involved in the majority of modules and also the most prevalent matrix family 
identified in the SV40 by ModelInspector (table 5.11).  This would suggest that SP1 
family of TFs play a role in regulation of the SV40 promoter.  The fact that V$SP1F 
family TFBSs are also found in the other two promoters, found in TFBS modules and 
also overrepresented, V$SP1F being the only matrix that was overrepresented when 
the results of the ModelInspector results were analysed, suggests that it also plays 
some role in the regulation of the CMV and EF1α promoters even if it’s to a lesser 
extent.  This made SP1 TFs a likely candidate for there to be competition over when 
more than one promoter is present.  In the next section a recombinant form of SP1 is 
expressed to see the effects on all the promoters studied as well as whether its 
presence reduces competition between promoters and rescues expression.  
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5.5.5 – Promoter interference/competition: Over-expression of the TF 
SP1 from a CMV driven promoter and its affect on a competing promoter 
driving SEAP or GFP expression 
In chapter 4, section 4.5.4, all combinations of SEAP and GFP vectors utilizing the SV40, 
CMV and EF1α promoters were co-transfected at a one-to-one ratio in terms of DNA 
vector copy number.  SEAP protein and mRNA expression was quantified to show the 
effect of a competing GFP vector and the differential promoter 
interference/competition effects of the different promoters used.  This was repeated 
again but GFP expression as well as SEAP was measured and a vector expressing the TF 
SP1, driven by a CMV promoter, was also transfected.  This was done due to the results 
of analyses done in the previous sections in this chapter of the three promoters which 
showed that the matrix family V$SP1F was present and overrepresented in all three 
promoters while also being the most prevalent and overrepresented in terms of TFBS 
modules identified.  The idea was that if SP1 and its related TFs are involved in 
expression from all three promoters it might be a limiting factor when more than one 
vector is expressed and are in competition for transcriptional resources.  This may be 
especially true for the SV40 due to its potentially heavy reliance on SP1 factors as 
identified by the analysis of potential TFBSs and also the fact it was the most affected 
by co-expression of a competing vector/promoter (chapter 4).  Transfection of an SP1 
vector therefore should lead to an increase in available SP1 protein making it less of a 
limiting factor and increase or rescue the expression of SEAP or GFP when compared 
to the results when a CMV-GFP or -SEAP vector is co-transfected.  The CMV promoter 
was chosen initially to drive expression of the SP1 TF because the CMV promoter had 
been shown previously to affect the expression of a competing promoter more than 
the SV40 and EF1α promoters. 
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5.5.5.1 – SV40 promoter 
From figure 5.6 – A. we can see that similar to the results in chapter 4 (figure 4.9) that 
the production of SEAP protein and SEAP mRNA was reduced from the SV40-SEAP 
vector when a competing GFP vector was co-transfected.  The CMV-GFP vector had the 
biggest negative effect on both SEAP protein and mRNA while the SV40-GFP vector had 
the least.  Co-transfection of CMV-GFP reduced SEAP protein expression to around 
54% and SEAP mRNA to about 37% of the control.  The reduction in SEAP mRNA was 
not as great as seen in chapter 4 and one reason for this could be that less DNA was 
used in these transfections due to the larger size of the recombinant SP1 gene and 
therefore its vector compared to the other vectors used.  When the CMV-SP1 vector 
was co-expressed with the SV40-SEAP vector the levels of SEAP protein and mRNA 
expression were higher than for the CMV-GFP and around 79% and 82% of the control.  
This suggests that over-expression of SP1 can transactivate the SV40-SEAP vector and 
help increase expression compared to the CMV-GFP vector co-transfection. 
As well as analysing SEAP expression, GFP expression was also measured.  As well as a 
SV40-GFP control co-transfection of SV40-GFP and CMV-SP1 was also carried out to 
see if it had similar effects on GFP as it did on SEAP expression.  Only GFP protein 
expression was measured but from the results in figure 5.6 – B. we can see that GFP 
expression was more affected then SEAP expression was by the presence of a 
competing vector/promoter.  Co-expression with all three SEAP vectors leads to 
significant decreases in GFP expression.  GFP expression was ~28%, ~17% and ~12% of 
the SV40-GFP control for the SV40, EF1α and CMV-SEAP vectors respectively.  
However, when SV40-GFP was co-transfected at a one-to-one ratio with CMV-SP1 GFP 
expression increased significantly compared to CMV-SEAP and was around 76% of the 
control.  This would further suggest over-expression of SP1 is capable of 
transactivating the SV40 promoter and helps alleviate some of the competition 
between the SV40 and CMV promoter. 
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Figure 5.6 – Graph showing the effect on SEAP protein and mRNA expression from the SV40
SEAP vector and GFP expression from the SV40
(vector copy number) with either three different GFP vectors
expression of the transcription factor SP1 driven by CMV
EF1α and CMV-GFP and CMV-SP1 with the SV40
effects of co-transfection of SV40, EF1α
1:1 ratio in CHO-S cells.  The 1:1 ratio is in terms of DNA vector copy number rather than t
of DNA in µg’s.  1.06 x 1011 copies of the SEAP,
amount of transfected DNA was still, however, kept consistent in all transfections by using the empty 
control vector.  Cell media was collected 48 hours post
while SEAP mRNA expression was also quantified after recovering the transfected cells.  GFP expression 
was measured while cells were still in the media and culture plate.  
control sample.  Mean values significantly different (
asterisks (* p < 0.05, ** p < 0.01, *** p
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5.5.5.2 – EF1α promoter 
As with the SV40-SEAP vector the EF1α-SEAP vector was co-transfected with the three 
different GFP vectors as well as the CMV-SP1 vector.  Figure 5.7 – A. shows the results 
and again like the SV40-SEAP vector the results were similar to the corresponding 
experiment in chapter 4 in terms of the effects on SEAP mRNA expression.  Co-
transfection of the CMV-GFP vector again had the biggest negative effect on both SEAP 
protein and mRNA expression and the SV40-GFP the least.  The SV40-GFP had no 
significant effect on either SEAP protein or mRNA while the EF1α-GFP vector caused a 
small decrease in SEAP protein (~95% of the control) but a larger decrease in SEAP 
mRNA (~60% of the control).  A reduction to ~84% and ~38% of the control for SEAP 
protein and mRNA was seen when the CMV-GFP vector was co-transfected.  As with 
the SV40-SEAP vector although the general trend seen was the same as chapter 4 the 
levels of reduction were again not exactly the same.  This will be discussed later 
although one reason has been given already in the previous sub-section – 5.5.5.1.  Co-
expression of CMV-SP1 with EF1α-SEAP again, as with the SV40-SEAP vector, increased 
SEAP expression above that seen for CMV-GFP.  SEAP protein expression slightly 
increased to around 91% of its control while SEAP mRNA increased to about 75%.  This 
suggest that SP1 can play a role in the expression from an EF1α promoter. 
As with the SV40-GFP vector the same was done with the EF1α-GFP vector to see the 
effects of SP1 on GFP as well as SEAP expression (figure 5.7 – B.).  GFP expression was 
reduced more significantly than SEAP when GFP expression was under the control of 
the EF1α promoter but the same pattern that has been observed in chapter 4 and 
previously in this chapter was seen once again.  Expression from the GFP-EF1α vector 
was least affected by the SV40-SEAP vector (no decrease), reduced to around 74% of 
the control when co-transfected with EF1α-SEAP and to around 62% when the CMV-
SEAP vector was present.  When the CMV-SP1 vector was co-transfected with the 
EF1α-GFP vector only a small increase compared to co-transfection of CMV-GFP was 
seen, from ~62% to ~67 of the control.  This was much smaller than was seen for the 
SV40-GFP vector. 
One explanation of why the increase in EF1α-GFP expression was negligible when co-
expressed with CMV-SP1 compared to the SV40-GFP vector could be the possible 
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effect of the SP1 TF on cell growth.  Over-expression of SP1 in one study showed it to 
inhibit cell-cycle progression (Deniaud et al., 2009).  The mRNA produced from the 
EF1α promoter can be called a TOP mRNA due to the presence of a 5’ TOP at the cap 
site of the mRNA (Shibui-Nihei et al., 2003).  TOP mRNA is more actively translated in 
growing cells (Hamilton et al., 2006; Meyuhas, 2000; Biberman & Meyuhas, 1997).  If 
SP1 over-expression did inhibit cell-cycle progression then SP1 might still increase the 
expression of mRNA from the EF1α promoter, as was seen with the increases in SEAP 
mRNA, but the TOP mRNA it produces might not be as actively translated causing no 
increase in SEAP or GFP protein expression. 
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Figure 5.7 – Graph showing the effect on SEAP protein
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5.5.5.3 – CMV promoter 
As in the previous two sub-sections the experiment was repeated but this time with 
CMV-SEAP.  Figure 5.8 – A. shows the results are similar to chapter 4 and with the 
same pattern as all the previous experiments.  As in chapter 4 the SV40-GFP vector had 
no negative effect on SEAP protein and mRNA expression from the CMV-SEAP vector.  
When co-transfected with EF1α-GFP, SEAP protein and mRNA expression were 
reduced to ~89% and ~88% of their controls, respectively.  Co-transfection of the CMV-
GFP vector once again had the biggest negative effect with SEAP protein and mRNA 
being decreased to ~87% and ~52% of their controls.  SEAP mRNA expression from the 
CMV-SEAP vector was increased when co-transfected with the CMV-SP1 vector and 
compared to the results for co-expression of CMV-GFP, although there was no 
significant difference in SEAP protein expression.  mRNA expression was similar to that 
seen in the control.  As with the other SEAP vectors the increases in SEAP mRNA 
suggest that the CMV-SEAP vector and its promoter could be directly affected by over-
expression of SP1. 
The effects on GFP expression from the CMV-GFP vector were also measured when co-
transfected with CMV-SP1 and the three SEAP vectors (figure 5.8 – B.).  The results for 
the SEAP vectors were quite similar to those seen on the EF1α-GFP vector.  SV40-SEAP 
had no negative effect while EF1α and CMV-SEAP reduced GFP expression to ~72% and 
~64% of the CMV-GFP control.  However, when co-transfected with the CMV-SP1 
vector the result was more similar to that seen for SV40-GFP vector (figure 5.6 – B.) 
rather than for EF1α-GFP (figure 5.7 – B.).  GFP expression increased compared to 
CMV-SEAP co-transfection, from ~64% of the control to ~109% of the control.  This 
slight increase was not statistically significant compared to the CMV-GFP control.  This 
result is further evidence that the CMV promoter can respond to the SP1 over-
expression. 
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Figure 5.8 – Graph showing the effect on SEAP protein
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5.5.5.4 – Comparisons and conclusions 
The results from this set of experiments had the same pattern as the similar 
experiments carried out in chapter 4 in so much that SV40-SEAP vector was again the 
most negatively affected in terms of both SEAP protein and mRNA expression while 
the CMV-SEAP was the least affected when co-expressed with a competing GFP vector 
(table 5.19).  The CMV-GFP vector was shown to be the GFP vector which most 
negatively affected SEAP expression and the SV40-GFP had the least affect.  The EF1α-
GFP had a much greater negative influence on SEAP expression then SV40-GFP but not 
to the same extent as the CMV-GFP vector. 
Although there were similar patterns seen between these experiments and the 
experiments in chapter 4 there were subtle differences.  Mainly that decreases in SEAP 
protein expression on the whole were greater in this chapter than in the previous.  For 
SEAP mRNA expression the opposite was true.  This could be due to a few possible 
reasons but the main difference between the experiments in this chapter and the last 
is the number of copies of each vector which were used.  In the last chapter 1.66 x 106 
copies of each vector were transfected but in this chapter this was reduced to 1.06 x 
106 copies, a 1.57-fold reduction.  The reason for this was that the recombinant SP1 
gene which was transfected was much larger then both the SEAP and GFP genes.  The 
change in the number of copies of both SEAP and GFP transfected is bound to have 
some affect on the promoter interference/competition between competing vectors 
and on SEAP protein and GFP expression.  A reduction in DNA vector copies present 
will likely put less pressure on the cells transcriptional machinery to some extent which 
will affect promoter competition and mRNA production.  In turn this will also affect 
protein expression but this affect will not necessarily mirror the change in mRNA 
expression.  In summary, the levels of promoter interference/competition will change 
depending on the amount of DNA or copies of DNA vectors transfected and changes in 
mRNA and protein will not necessarily correlate with each other and this had been 
shown previously in this thesis especially in terms of SEAP mRNA and protein 
expression. 
As well as measuring SEAP expression when co-transfecting the SEAP and GFP vectors, 
GFP expression was measured and compared to a GFP control for each promoter used 
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(table 5.19).  GFP expression was reduced when in the presence of a competing SEAP 
vector compared to its control.  The reductions in GFP expression, in terms of fold 
change from their control, were greater then what was seen for SEAP expression but 
once again there were familiar patterns in the results.  The GFP vector containing the 
SV40 promoter saw the biggest negative fold changes in GFP expression when co-
transfected with the SEAP vectors.  These changes followed the familiar pattern of the 
SV40 promoter containing SEAP vector having the least affect (-3.55-fold change), the 
EF1α-SEAP vector having a greater effect (-5.83-fold change) then the SV40 vector and 
the SEAP vector utilizing the CMV promoter having the greatest negative effect (-8.04-
fold change).  A similar pattern was seen for both the EF1α and CMV-GFP vectors but 
the reductions in GFP expression were not as great as seen for the SV40-GFP vector.  
The SV40-SEAP vector had no negative effect on GFP expression from either the EF1α 
or CMV-GFP vectors while the EF1α-SEAP vector reduced GFP expression 1.36 and 
1.40-fold and the CMV-SEAP reduced expression 1.62 and 1.57-fold, respectively for 
these two GFP vectors.  As with the SEAP results we can see that the presence of a 
competing CMV promoter has the biggest negative influence while a competing SV40 
promoter has the least. 
The most interesting result and the main purpose of this set of experiments however, 
was the effect of co-transfection of an SP1 expression vector.  The SP1 vector utilized 
the CMV promoter and this was chosen because we had already seen in chapter 4 that 
the CMV promoter had the greatest negative effects on a competing promoter.  We 
hypothesized from the earlier work in this chapter that the SP1 TF might be involved in 
expression or at least capable of binding all three of the promoters used in this study.  
SP1 has already been shown to bind and activate the SV40 promoter (Saffer et al., 
1990; Dynan & Tjian, 1983). 
When CMV-SP1 was co-expressed with the SEAP vectors we saw an increase in SEAP 
mRNA when compared to the results of co-transfection of the CMV-GFP vector for all 
SEAP vectors (table 5.19).  For all three SEAP vectors the amount of SEAP mRNA 
expressed roughly doubled compared to the amount seen when co-expressed with 
CMV-GFP.  This could be evidence of transactivation of these promoters by SP1.  For 
the SV40-SEAP this also involved an increase in SEAP protein expression but this 
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increase was still below the level of SEAP protein expression seen for its control.  SEAP 
protein expression increased slightly when the EF1α-SEAP vector was co-transfected 
with CMV-SP1 compared to CMV-GFP but there was no increase seen in SEAP protein 
expression from the CMV-SEAP vector.   
CMV-SP1 had a greater effect on GFP expression especially for the SV40 and CMV-GFP 
vectors (table 5.19).  GFP expression when co-expressed with CMV-SP1 increased 
compared to co-transfection of CMV-SEAP.  For the EF1α-GFP vector this increase was 
negligible (1.08-fold increase), while for the CMV-GFP vector there was 1.71-fold 
increase in GFP expression which even slightly surpassed the level of the CMV-GFP 
control.  However, by far the biggest increase in GFP expression was seen when CMV-
SP1 was co-transfected with SV40-GFP.  GFP expression was 6.11-fold higher than 
when CMV-SEAP was co-expressed. 
Taking into account both of the SEAP and GFP results when CMV-SP1 was co-
transfected it would seem that SP1 does play some role in the expression of these 
promoters to some extent or at least in the competition between promoters.  It has 
already been shown that SP1 is an important factor especially for the SV40 promoter 
(Saffer et al., 1990; Dynan & Tjian, 1983) and while it also known to be involved in CMV 
promoter expression it is slightly less important than for the SV40 but only in terms of 
it being one of multiple TFs, such NF-κB and ATF/CREB factors, which can also influence 
CMV transcription (Bakovic et al., 2000; Luu & Flores, 1997; Yurochko et al., 1997; 
Olive et al., 1990).  SP1 have also been shown previously to bind to the EF1α promoter 
and possibly play some role in its regulation (Wakabayashiito & Nagata, 1994).  The 
results from our experiments, especially the increases in SEAP mRNA seen, add further 
evidence that SP1 plays a role in transcription from all these promoters.  It also points 
to competition for this TF as possibly being one of the causes of promoter 
interference/competition, i.e. – the competition for a shared TF or TFs. 
Further work is needed to confirm though that the increases seen in SEAP and GFP 
when CMV-SP1 was co-expressed compared to a CMV GFP or SEAP vector was the 
result of SP1 over-expression rather than just the absence of GFP or SEAP.  This should 
first involve confirmation that the recombinant SP1 is actually expressed in our cells.  It 
239 
Nathan West The University Of Sheffield 
then may involve the co-transfection of different amounts of decoy DNAs which could 
compete not only for endogenous SP1 protein but also any additional recombinant SP1 
protein.  Although the fact that the CMV-SP1 vector itself also contains SP1 sites could 
further complicate the results and their interpretation.  It would also be informative to 
express SP1 from vectors using the SV40 and EF1α promoter to see how the results 
differ from the CMV-SP1 vector. 
Although we have seen that SP1 is likely to be a TF that plays some role in the 
regulation of all three of these promoters and therefore also competition between 
them it will not be the only important factor.  Other factors will also be involved in 
expression from these promoters and it is also likely that both shared and unshared 
factors will have an influence on the levels of not only expression but also promoter 
interference/competition.  The greater promoter strengths of the CMV and EF1α 
promoters are likely to rely on both their increased variety of matrix families and TFBSs 
and also the possibility that some of these factors or combinations of these factors 
may be stronger transcriptional inducers then SP1.  Future work for further 
investigation of the interactions between competing promoters will be presented in 
the next section. 
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Table 5.19 – Fold change in SEAP protein and mRNA expression and GFP expression when 
the different SEAP and GFP vectors are co-transfected at a one-to-one ratio plus the effect 
of co-transfection of an SP1 expressing vector 
  
SEAP expression 
  
SV40-SEAP 
 
EF1α-SEAP 
 
CMV-SEAP 
GFP vector/SP1 
 
Protein 
 
mRNA 
 
Protein 
 
mRNA 
 
Protein 
 
mRNA 
SV40-GFP 
 
-1.06 
 
-1.29 
 
-1.02 
 
-1.01 
 
-1.03 
 
+1.09 
EF1α-GFP 
 
-1.50 
 
-1.90 
 
-1.05 
 
-1.68 
 
-1.12 
 
-1.14 
CMV-GFP 
 
-1.87 
 
-2.69 
 
-1.19 
 
-2.66 
 
-1.15 
 
-1.93 
CMV-SP1 
 
-1.27 
 
-1.22 
 
-1.09 
 
-1.33 
 
-1.17 
 
+1.02 
  
GFP expression 
SEAP vector/SP1 
 
SV40-GFP 
 
EF1α-GFP 
 
CMV-GFP 
SV40-SEAP 
 
-3.55 
 
+1.25 
 
+1.04 
EF1α-SEAP 
 
-5.83 
 
-1.36 
 
-1.40 
CMV-SEAP 
 
-8.04 
 
-1.62 
 
-1.57 
CMV-SP1 
 
-1.31 
 
-1.50 
 
+1.09 
The numbers in the top part of the table represent the fold change in SEAP protein and mRNA expression 
when compared to the control for the respective SEAP vector.  The numbers in the bottom part of the 
table represent the fold change in GFP expression when compared to the control for the respective GFP 
vector.  SEAP, GFP and SP1 vectors were co-transfected at a one-to-one ratio in terms of DNA vector 
copy number (1.06 x 1011 copies of each vector).  Fold changes come from the data in figures 5.6 (SV40-
SEAP & -GFP), 5.7 (EF1α-SEAP & -GFP) and 5.8 (CMV-SEAP & -GFP). 
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5.6 – Further Discussion, Final Conclusions and Future 
Directions 
5.6.1 – Further discussion 
In this chapter, a promoter analysis of three commonly used promoters for 
biopharmaceutical production was carried out to help answer two main questions.  
Which TFs and TFBSs are potentially important for the function and regulation of the 
SV40, CMV and EF1α promoters and how they may affect interference/competition 
between these promoters?   
Using a variety of programs from the Genomatix Software Suite we identified potential 
TFBS in each of the three promoters.  The initial searches using MatInspector gives a 
large number of predicted TFBSs.  Many of these will not be functional.  However it did 
show that the weakest promoter the SV40 had less predicted TFBSs and that these also 
came from fewer matrix families.  In terms of both the potential TFBSs and their matrix 
families the SV40 shared a greater proportion of both with the CMV and EF1α 
promoters.  Of the matrix families found to be overrepresented in the SV40 promoter 
a greater proportion of these were also overrepresented in either or both the other 
two promoters then was the case for either the CMV or EF1α promoters. 
ModelInspector searches of the promoter sequences gave more information on TFBSs 
that may be functionally important in these promoters.  There were major differences 
between the SV40 and both the CMV and EF1α promoters.  Although the SV40 had a 
higher number of model matches these matches were composed of a smaller number 
of different modules and different TFBSs.  The search seemed to show that the SV40 
promoter might have a bias to SP1 TFs as they were involved in the majority of 
modules identified and had the highest number of TFBSs.  Both the other two 
promoters had a greater number of different modules and different TFBSs.  The SV40 
promoter again was shown to share a greater proportion of its TFBSs and the 
respective matrix families with both the CMV and EF1α promoters then both these 
latter two promoter did.  The V$SP1F family was only matrix family to be 
overrepresented in all three promoters from the results of the ModelInspector search. 
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The results of these searches suggest that the SV40 may be a weaker promoter due to 
containing less potential TFBSs and that it is also the most negatively by promoter 
interference because it has less TFs from different matrix families but while also 
sharing a large proportion of these sites with both the CMV and EF1α promoters.  The 
greater variety of potential TFBSs in both the CMV and EF1α may lead to them being 
both stronger promoters and also more capable at competing with another for 
expression.  
These searches also highlighted that SP1 factors were potentially important TFs in the 
expression for all three promoters.  This is in agreement with the published literature 
which has shown SP1 to play a role in transactivation of both the SV40 and CMV 
promoters (Wu et al., 1998; Luu & Flores, 1997; Yurochko et al., 1997; Saffer et al., 
1990; Dynan & Tjian, 1983).  Over-expression of SP1 was shown to rescue expression 
of from SEAP and GFP vectors caused by promoter interference/competition from the 
CMV promoter.  This showed that SP1 can possibly play a role in the expression from 
all the promoters studied.  Indeed SP1 is important in both the basal and constitutive 
activation of many endogenous promoters (Infantino et al., 2011; Kaczynski et al., 
2003).  However, it is unlikely that the competition for SP1 will be the only source of 
promoter competition.  TFs for the other TFBSs identified by ModelInspector and 
shared between the three promoters will also be a source of competition and might 
also have a greater impact.  This includes factors such as KLF factors, ETS factors, AP1 
factors and NF-kB factors. 
KLF TFs as already mentioned earlier are highly related to the SP1 TFs and are 
important in many cellular processes (McConnell & Yang, 2010).  They bind similar 
sequences and depending on the cellular context and promoter a KLF factor can act as 
both a transcriptional activator or repressor (Kaczynski et al., 2003).  KLF11 has been 
shown to activate the SV40 promoter (Martin et al., 2000). 
ETS TFs are a large family of TFs (27 member) and have roles in apoptosis, 
proliferation, development, differentiation, angiogenesis, tissue remodelling and 
cancer (Shaikhibrahim & Wernert, 2012; Meadows et al., 2011; Randi et al., 2009; 
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Hashiya et al., 2004).  The family member ERF can repress expression from the CMV 
promoter (Bain et al., 2003). 
AP-1 factors play roles in cell proliferation and survival (Shaulian & Karin, 2001) and 
has also been shown to activate the SV40 promoter (Harshman et al., 1988).  They 
have also been shown to co-activate the CMV promoter (Isern et al., 2011; Lee et al., 
2004; Lembo et al., 1994). 
NF-kB factors are a very widely studied family with roles in inflammation and cancer 
(Hoesel & Schmid, 2013) and it has been shown to activate the SV40 (Tabakin-Fix et al., 
2004; Espel et al., 1990; Kawakami et al., 1988) and CMV promoter (He & Weber, 
2004; Lee et al., 2004; Prosch et al., 1995). 
The knowledge that these factors have been shown to already function in either the 
SV40 or CMV promoter or both is further evidence they could be potential sources of 
competition.  Also the fact that these factors were identified by ModelInspector shows 
the power of the program to identify potentially functional TFBSs.  Whether the 
modules identified in each promoter function in the same manner as they do in the 
studies they were taken from is unknown.  Promoter interference/competition could 
be further studied by the over-expression of more of these potentially important 
transcription factors and each promoter’s response might reflect the importance of 
that factor for its regulation. 
As well as competition for TFs such as the ones previously mentioned it is likely that 
competition will occur not only occur for them but that there will also be competition 
for general TFs, transcriptional machinery and the initiation of transcription.  Even 
though there are common TFBSs and TFs in all three of the promoters studied they will 
initiate transcription using different sets of TFs and the strength of transcriptional 
initiation is likely to vary.  This will also be a source of promoter 
interference/competition. 
The fact that these promoters use multiple TFBSs and also the fact that they can 
interfere considerably with the expression of another promoter make these promoters 
less than ideal candidates for expression of multiple genes at differing expression 
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levels.  The creation of synthetic promoters which rely on only a small number of TFs 
and where promoters differ in the transcription factors they bind may help create 
promoters which not only differ in strength but also removes one source of promoter 
interference/competition and potentially allow different promoters to function more 
independently and maintain their own levels of expression even in the presence of 
another promoter.  If this is achievable this could potentially be another method for 
controlling the expression of multiple genes in the same system. 
 
5.6.2 – Final conclusions 
A MatInspector search of SV40 promoter showed it to contain less numbers and 
variety of potential TFBSs then both the CMV and EF1α.  It also shared a greater a 
proportion of its potential TFBSs with the CMV and EF1α promoters.  Both these could 
be indications of why this promoter was weaker and also more negatively affected by 
the presence of a stronger promoter. 
When searching the promoters using ModelInspector the SV40 had a greater number 
of matches returned then both the CMV and EF1α promoter.  However these matches 
were composed of TFBSs from a smaller number of matrix families and also less TFBSs 
in total.  These TFBSs were also shared to a greater proportion with the sites found in 
both the CMV and EF1α promoter.  The CMV promoter shared less of its potential 
TFBSs identified using ModelInspector than both SV40 and EF1α promoters.  This could 
be an indication of why the CMV promoter was both stronger and interfered with the 
expression of the SV40 and EF1α more than they did with expression from the CMV 
promoter. 
One source of promoter interference/competition could be the competition for a 
limited amount of a shared TF.  V$SP1F TFBSs were shown to be not only involved in 
TFBS modules for all three promoters they were also considered to be 
overrepresented.  This made V$SP1F TFs one potential source of competition.  Co-
expression of a vector for the expression of the TF SP1 under the control of the CMV 
promoter increased SEAP mRNA and GFP expression from SEAP and GFP vector 
utilizing all three promoters when compared to co-expression of a CMV GFP or SEAP 
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vector.  This suggests that when there is an excess of this TF promoter interference 
caused by a CMV promoter is reduced.    
However, promoter interference is unlikely to be caused by competition for a single 
shared TF, such as SP1, it will involve multiple TFs and also the rate at which each 
promoter can initiate transcription which will be related to the level of transcriptional 
activation caused by the different combinations of TF binding in the different 
promoters.  The clearance or retention of bound TFs to the promoters will also affect 
promoter competition as this will impact on the available pools of TFs. 
Although these promoters are useful because they function in many cell lines they will 
not be sufficient for the controlled expression of multiple genes due to the presence of 
multiple different TFBSs for multiple TFs suggesting they have redundancy built into 
them making their expression hard to control.  New synthetic promoters will be 
needed and one idea for a potential strategy for controlled expression of multiple 
genes is presented in the next section. 
 
5.6.3 – Future directions 
To further understand which TFs are important for the regulation of all three of these 
promoters it will be necessary to express more than just the SP1 TF.  TFs from the AP-
1, KLF, ETS and NF-κB families could be used as these were also involved in modules for 
all three promoters. 
Alternatively decoy DNAs (Brown et al., 2013) could be co-expressed to limit the 
availability of specific TFs.  The level of reduction seen from a promoter when a decoy 
for specific TF is used would be a reflection of the importance of that TF. 
The fact that all three of these promoters contain multiple TFBSs for multiple different 
TFs and the fact the CMV promoter can severely interfere with expression of another 
promoter, especially a weaker promoter such as the SV40, make using combinations of 
these promoters ill suited for the expression of multiple genes were discrete control of 
differing levels of expression may be required. 
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An expression system which uses engineered TALEs (transcription activator–like 
effectors) and synthetic promoters capable of binding them could be one potential 
strategy to control the expression of multiple genes.  TALEs have the advantage that 
they have two domains, one which can be engineered to bind almost any DNA 
sequence and another which can be made to recruit transcriptional machinery (Perez-
Pinera et al., 2013; Cermak et al., 2011; Miller et al., 2011; Zhang et al., 2011; Boch et 
al., 2009; Moscou & Bogdanove, 2009).  Multiple TALEs could be engineered to bind 
multiple specific sequences in a library of synthetic promoters.  It may then be possible 
to control gene expression multiple ways such as altering the amount of TALE 
expressed, the number of a specific TALE binding sequences in a synthetic promoter, 
the use of multiple TALEs and the presence of multiple TALE binding sequences in 
synthetic promoters. 
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Chapter 6 – Thesis Discussion and Future 
Perspectives  
6.1 – Discussion and future perspectives 
In this thesis the development of a tunable protein expression system for use in 
mammalian cells has been presented along with a comparison of three commonly 
used promoters (SV40, CMV and EF1α), their effects on expression from a competing 
co-expressed promoter (promoter interference/competition), their potential TFBSs 
and how common TFBSs could be one source of this promoter 
interference/competition.  Each results chapter had its own discussion and this section 
will not to cover all the same points and instead show how this research fits in with the 
current knowledge and the future challenges of biopharmaceutical production in 
mammalian cells. 
There are numerous published studies presenting a variety of cell engineering 
attempts to improve recombinant protein production in mammalian cells.  This has 
involved the over-expression/suppression of genes/proteins to improve cell growth 
and survival as well as to improve the production capacity (protein synthesis and 
secretion) of mammalian cells for increased recombinant protein production (Lee et 
al., 2013; Nishimiya et al., 2013; Pybus et al., 2013; Dreesen & Fussenegger, 2011; 
Peng et al., 2011; Ku et al., 2010; Hwang & Lee, 2009; Kuystermans & Al-Rubeai, 2009; 
Peng & Fussenegger, 2009; Majors et al., 2008b; Mohan et al., 2007).  The main goals 
for increasing the production of a therapeutic recombinant protein is to lower the cost 
of production for recombinant proteins which are already well expressed and to 
improve the expression of proteins whose low expression make them unviable for 
large scale production.  Recombinant proteins that have low production titres can be 
termed “difficult-to-express” (DTE) proteins.  DTE proteins can suffer problems in one 
or more of the following processes – transcription, translation, protein 
folding/assembly and secretion.  This can result in bottlenecks in recombinant protein 
production and a specific protein can be over-expressed to try and remove this 
bottleneck.  Although this can sometimes prove successful the expression of a single 
protein can sometimes just move the bottleneck.  Therefore the expression of multiple 
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genes/proteins will be required to improve the production of some DTE proteins.    
Although the expression of multiple genes has been carried out (Lee et al., 2013; 
Nishimiya et al., 2013) many studies just involve the high level expression of two or 
more genes using strong constitutive promoters and the results can be both cell line 
and protein specific.  The expression of proteins such as XBP1 and mTOR are 
considered good targets for over-expression due to the fact they have influence over 
multiple target genes but both proteins, especially XBP1, will also have cell line and 
product specific effects (Ku et al., 2008).  In both these attempted strategies there is a 
lack of discrete control over the expression of the proteins over-expressed and due to 
the cell line and protein specificity of many cell engineering strategies there is unlikely 
to be generic solution which can be used for all cell lines and recombinant proteins.  
Therefore, there will be a need for gene/protein expression systems were the 
expression of multiple genes can be controlled to reflect the requirements of a 
particular cell line or a specific product.  As well as using such systems for the 
improved expression of DTE proteins this will also be applicable to already high 
producing cell lines were there might be a need to turn these cell lines into so called 
super producers to further lower the cost of production. 
The work in this thesis has been carried out largely with the view of multi-gene 
expression technology for mammalian cells producing recombinant proteins in mind.  
In chapter 3 a tunable protein expression system for multiple genes was presented.  
Controlled gene expression has mainly been focused on promoters whose expression 
can be turned on or off given the correct stimulus (Blount et al., 2012; Hurley et al., 
2012).  Although complex synthetic gene regulatory networks have been created most 
of the work on such systems has been carried out in prokaryotes or in eukaryotic 
microbial systems.  Complex synthetic gene circuits for use in mammalian cells have 
been created (Muller et al., 2013; Auslander et al., 2012) but there no published 
studies on their application in biopharmaceutical production.  The complexity of such 
circuits may also mean that it is difficult for researchers who are not experts in 
mammalian synthetic biology to adapt them for their own applications.  Many of the 
circuits also do not necessarily allow the simultaneous expression of multiple genes at 
different but chosen levels of expression.  We believe the system we have developed is 
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a simpler method for the controlled/tunable expression of multiple genes at multiple 
different levels of expression. 
As stated earlier the majority of cell line engineering strategies use strong constitutive 
promoters to express proteins.  Depending on the protein and its effect on the cell, 
high expression may have negative rather than positive consequences such as shifting 
the bottleneck in protein production or severely inhibiting cell growth.  Expression may 
be manipulated by lowering the amount of transfected vector DNA for expression of 
the protein, but with strong promoters such as the CMV the window for manipulating 
between high and low expression can be quite small and make attaining intermediate 
levels of expression difficult.  This could be solved by using a weaker promoter such as 
the SV40 but if more than one protein is to be expressed and high levels of expression 
of one protein is required, while intermediate levels of the other is also needed 
problems will be encountered if a strong promoter is used for high expression and a 
weaker promoter used of intermediate expression.  Promoter interference is likely to 
occur and complicate matters further which has also been shown in this thesis.  The 
system presented in chapter 3 took advantage of promoter interference to increase 
the range of expression.  The ERSE sequences present in the reporter protein vectors 
allowed these vectors to not only maintain the intermediate expression of a reporter 
protein when its binding factor ATF6(50) was co-expressed, in some situations 
(depending on the amount of ATF6(50) expressed and the number of ERSE used in the 
reporter vector), it also allowed it to achieve levels of expression as high as that seen 
from a CMV driven vector.  Using both the absence and presence of differing numbers 
of ERSEs and also differing the amount of ATF6(50) co-expression high levels of SEAP 
protein expression was achieved along with intermediate (or medium) levels of GFP 
expression. 
It is envisioned that the system could be further developed for situations where 
multiple bottlenecks have been discovered in the production of a recombinant protein 
(i.e. – a DTE proteins) and there is need for the expression of multiple genes to help 
resolve them.  It is unlikely that the same level of expression will be required for all 
genes expressed and it is also unlikely that the optimal levels of gene expression will 
be achieved through manipulating the numbers of copies of each transfected gene 
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vector, especially if strong constitutive promoters such as the CMV are used.  Using the 
system presented in chapter 3 it will make it easier to find the optimum levels of 
expression for each gene due to the control in expression of multiple genes given by 
the system.  A system such as this one is likely to be restricted to use initially in 
transient expression experiments.  However, transient expression is vitally important 
for producing a rapid supply of a pre-clinical recombinant protein and also for initially 
testing a cell line engineering strategy.  Large scale transient production is also being 
studied to try and make it a viable means of production (Baldi et al., 2007).  The use of 
this system will not necessarily be restricted to the improvement of biopharmaceutical 
production but could also be applicable in other biotech areas as well. 
An alternate strategy for the expression of multiple genes could be through the use of 
multiple synthetic promoters which do not severely interfere with the expression of 
another promoter.  It was shown that three commonly used promoters, the SV40, 
CMV and the EF1α promoters all interfere with expression of a competing promoter 
and the strength of interference was related to the transcriptional strength of the 
promoter.  The SV40 promoter was shown to be the weakest promoter and the most 
negatively affected by the presence of another promoter.  All three promoters 
contained potential TFBSs for multiple TFs.  The SV40 had the least number and variety 
of TFBSs and also shared a greater number of its potential TFBS with both the CMV and 
EF1α.  Its limited choice of TFs compared to both the CMV and EF1α promoter may be 
one reason why this promoter was relatively weaker and because it shared TFBSs with 
these promoters one reason why it was most affected by competition from another 
promoter.  The large numbers of potential TFBSs found in all three promoters, 
although a large proportional of these may not be functional, it did show the potential 
complexity of the regulation of these promoters.  This will make it difficult to 
predictably control there expression.  Strong promoters such as the CMV also have a 
small window of expression again making control gene expression a challenge.  Once 
more than one promoter is added to a system, promoter interference/competition will 
occur and the problems of control increase.  This we likely further increase with the 
addition of more promoters.  Although both the CMV and SV40 promoters were used 
in the expression system present in chapter 3 the use of ATF6(50) and ERSEs were 
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needed to manipulate expression.  SV40, CMV and EF1α when used in there standard 
forms will not be suited to for future engineering strategies for the controlled 
expression of multiple genes.  There may also be difficulties when trying to re-engineer 
them and it is likely that a “bottom up” synthetic biology approach will be needed to 
create more suitable promoters for multi-gene expression systems. 
The design of synthetic promoters which do not share binding sites for TFs may be one 
approach to create promoters which do not suffer from competition for shared TFs.  
However, due to the use of different TFBSs there could still be promoter competition 
between synthetic promoters due to the different endogenous TFs potentially having 
different levels of transcriptional activation and therefore differing in their abilities to 
recruit factors involved in the initiation of transcription.  It may be possible to 
overcome this by controlling the expression from a synthetic promoter using a similar 
strategy as in chapter 3, but through use of a synthetic transcriptional activator.  At the 
end of chapter 5 the possible use of TALEs was mentioned for the controlled 
transcriptional activation of synthetic promoters.  A system using synthetic TFs (TALEs) 
and synthetic promoters may also be capable of functioning more predictably in a 
number of cell lines more so than synthetic promoters whose expression relies on 
endogenous TFs whose expression will differ significantly.  The ability to customize 
TALEs means they can also act as a transcriptional repressor which further increases 
the capabilities of controlling expression. 
In the future there will be an increasing need for any expression system that controls 
the expression of multiple genes for production of recombinant proteins in CHO cells 
for developments in other technologies that increase our understanding of 
recombinant protein production. 
The greatest aid in this will be the further development of –omics approaches.  These 
approaches will not only help in the identification of genes/proteins as targets for 
manipulation but also in analysing the effects of future gene engineering strategies.  
The publication of the CHO genome was a landmark moment for researchers in the 
CHO community (Xu et al., 2011).  Since then genomes from other CHO cell lines as 
well as the genome of Cricetulus griseus have also been sequenced and made publicly 
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available (Brinkrolf et al., 2013; Lewis et al., 2013).  All this information is also made 
easily available at http://www.chogenome.org/ with the being continually updated 
(Hammond et al., 2012).  Publication of the CHO genome has also helped in the 
progression of other –omics approaches such as transcriptomics, proteomics and 
metabolomics.  All these approaches will not only aid in the design and 
implementation of multi-gene engineering strategies in CHO cells but also in every 
area of CHO cell research. 
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